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Abstract 
This work comprises the development of hybrid inorganic-organic materials based on highly pure 
nano-hydroxyapatite (n-HAp). Chitosan (CS) was selected as the organic component, in order to 
develop n-HAp/CS products mimicking bone composition. The following main processing stages 
were considered: (1) dispersion preparation in which n-HAp is incorporated into the chitosan 
solution; (2) phase separation/solvent elimination in which the fixation of structural forms takes 
place; (3) purification and potential sterilization procedures. 
Dispersion preparation is a key step since it implies the inclusion of HAp nanoparticles into the 
chitosan solution. This stage was carried out by physically mixing the HAp nanoparticles with 
the chitosan solution. The effect of different parameters on the resulting particle size and 
electrostatic stability (zeta potential) of the dispersions was studied. Results reflected that 
chitosan acts as a good stabilizer (zeta potential >+30 mV) of HAp nanoparticles in slightly 
acidic environment (pH 5.5), and such good stability was proven to be consistent along time. 
Taken into consideration these results, a method for the preparation of n-HAp/CS dispersions by 
fast stirring (ultraturrax) was developed. With mixing times <100 ms, the used fast stirring set 
up allowed the production of highly homogeneous and stable n-HAp/CS dispersions (pH 5.5), and 
it was determined that using HAp/CS weight ratio of 70/30 and n-HAp concentration of 20 g/l, 
the produced dispersions were suitable materials for the production of n-HAp/CS hybrids in 
different forms. 
In the phase separation/solvent elimination stage, two different structural forms were developed: 
microparticles and scaffolds. Spray drying was used to produce the hybrid n-HAp/CS 
microparticles. The effect of pH of the n-HAp/CS dispersion (5.5 and 7.0) and the presence of 
KCl on the final n-HAp/CS microparticle’s properties were studied. It was evidenced that KCl 
has no beneficial effect on the stability of the n-HAp/CS dispersions, and it appeared as a 
contaminant on the formed microparticles. Moreover, the generated microparticles presented 
differences depending on the pH at which the n-HAp/CS dispersion was prepared. Doughnut-like 
n-HApCS-5.5 microparticles (15.8-µm average size in volume) were found preferred over n-
HApCS-7.0 microparticles, which require one step more in the productive process and presented a 
tendency to form large agglomerates. The produced microparticles are advantageous, as they 
allow HAp's superior properties at the nanoscale to be preserved in the form of microparticles 
that are suitable materials to develop injectable systems, drug delivery systems, or be shaped into 
solid substrates with increased surface area. 
A simple 3-step production process was developed to produce n-HAp/CS hybrid materials in the 
form of scaffolds. The process consists in: (1) n-HAp/CS dispersion preparation; (2) freeze-drying 
stage to fix scaffold shape; and (3) supercritical CO2 (scCO2) extraction to remove acetic acid and 
promote sterilization. It was shown that scCO2 extraction step is a suitable purification procedure 
since it allowed the successful removal of acetic acid, with the advantage of not compromising the 
microarchitecture achieved by freeze-drying unlike other tested methods based on neutralization 
with alkaline solutions. The produced scaffolds were sterile and exhibited suitable properties for 
non-load bearing bone graft applications; therefore, the developed 3-step process has great 
potential to produce ready-to-use n-HAp/CS scaffolds mimicking bone composition and structure. 
Given the achieved results, three different n-HAp/CS hybrid products were successfully produced: 
dispersions, powder (microparticles), and scaffolds. The generated n-HAp/CS hybrid materials 
mimic bone composition, are composed of highly pure HAp nanoparticles, and displayed suitable 
properties for different potential applications. 
  
Resumo 
Este trabalho compreende o desenvolvimento de materiais híbridos inorgânico-orgânico baseados 
em nano-hidroxiapatite (n-HAp) de elevada pureza. Para este fim, escolheu-se para componente 
orgânico o quitosano (CS), de modo a produzir materiais híbridos n-HAp/CS que reproduzam a 
composição óssea utilizando as seguintes etapas de processamento: (1) preparação das dispersões 
base por incorporação da n-HAp numa solução de quitosano; (2) fixação da forma dos materiais 
por processos de separação de fase/eliminação de solvente; (3) purificação final e potencial 
esterilização dos materiais. 
A preparação da dispersão é um passo importante, implicando a introdução das nanopartículas de 
HAp numa solução de quitosano. Esta etapa foi realizada utilizando o método da mistura simples. 
Foi estudado o efeito de diferentes parâmetros no tamanho de partícula e na estabilidade 
eletrostática (potencial zeta) das dispersões. Os resultados indicaram que o quitosano atua como 
agente estabilizador (potencial zeta >+30 mV) das nanopartículas de HAp em ambiente ácido 
(pH 5.5) e que este efeito se mantêm ao longo do tempo. Considerando estes resultados, 
desenvolveu-se um método para preparação das dispersões n- HAp/CS por mistura rápida 
(ultraturrax). Utilizando tempos de mistura <100 ms, foi possível obter dispersões (pH 5.5) 
homogéneas e estáveis. Com base na configuração de mistura rápida desenvolvida, determinou-se 
que as dispersões produzidas com HAp/CS de 70/30 e uma concentração de 20 g/l, eram 
adequadas para a produção de diferentes formas de materiais híbridos n-HAp/CS. 
Foram desenvolvidas duas formas estruturais diferentes por separação de fases/eliminação de 
solvente: micropartículas e scaffolds. As micropartículas foram produzidas pela tecnologia de 
spraydrying. Foi estudado o efeito do pH das dispersões de n-HAp/CS (5.5 e 7.0) e da presença 
de KCl nas propriedades finais das micropartículas. Evidenciou-se que o KCl não beneficia a 
estabilidade das dispersões aparecendo como um contaminante nas micropartículas produzidas. 
Além disso, as micropartículas apresentaram diferenças em função do pH usado para a preparação 
das dispersões. As micropartículas n-HApCS-5.5 (tamanho médio 15.8 µm em volume) 
apresentaram forma de donut e vantagens sobre as micropartículas n-HApCS-7.0, as quais 
requerem um passo adicional na preparação e mostraram tendência para formação de aglomerados 
de grandes dimensões. As micropartículas formadas permitiram preservar as propriedades 
superiores da HAp nanométrica utilizada. Estas apresentam potencial para serem utilizadas no 
desenvolvimento de sistemas injetáveis de libertação controlada, ou moldadas em formas sólidas 
com área superficial incrementada. 
Para a produção de scaffolds, foi desenvolvido um processo simples em 3 passos: (1) a preparação 
da dispersão n-HAp/CS; (2) liofilização para a fixação estrutural; e (3) extração com CO2 
supercrítico (scCO2) para a remoção do ácido acético remanescente do processo de liofilização e 
esterilização simultânea. Demonstrou-se que a extração com scCO2 é um método de purificação 
vantajoso visto que possibilitou a remoção do ácido acético com sucesso sem comprometer a 
integridade estrutural do scaffold obtida durante o processo de liofilização, contrariamente aos 
métodos baseados em neutralização com soluções alcalinas. Os scaffolds produzidos apresentaram 
propriedades adequadas para aplicações como enxertos ósseos de baixa solicitação de carga. 
Assim, o processo de 3 passos desenvolvido apresenta elevado potencial para a produção de 
scaffolds prontos a usar, que reproduzem a composição e estrutura óssea. 
Em síntese, os resultados obtidos permitiram o desenvolvimento de três produtos híbridos n-
HAp/CS: dispersões, pós (micropartículas), e scaffolds. Os materiais híbridos obtidos simulam a 
composição óssea, são compostos por nano-partículas de hidroxiapatite de elevada pureza, e 
possuem propriedades adequadas a diferentes aplicações. 
 
  
Resumen 
Este trabajo comprende el desenvolvimiento de materiales híbridos inorgánico-orgánico con base 
en nano-hidroxiapatita (n-HAp) de alta pureza. Para ello, se eligió quitosano (CS) como 
componente orgánico de modo que los materiales híbridos n-HAp/CS fueron producidos con base 
en las siguientes etapas principales: (1) preparación de dispersiones, en la cual la n-HAp entra en 
contacto con el quitosano; (2) separación de fases/eliminación de solvente, en la cual el material 
adquiere una forma estructural determinada; (3) procedimientos de purificación y esterilización. 
La etapa de preparación de la dispersión es clave, dado que implica la incorporación de la HAp en 
la solución de quitosano. Esta etapa se llevó a cabo mezclando físicamente las nanopartículas de 
HAp con la solución de quitosano. Se estudió el efecto de diferentes parámetros en el tamaño de 
partícula y la estabilidad electroestática (potencial zeta) de las dispersiones en cuestión. Los 
resultados revelaron que el quitosano actúa como buen agente estabilizador (potencial zeta > +30 
mV) de las nanopartículas de HAp en medios ligeramente ácidos (pH 5.5), y tal estabilidad es 
consistente a lo largo del tiempo. Tomando en cuenta estos resultados, se desarrolló un método 
para la preparación de dispersiones n-HAp/CS mediante mezcla rápida (ultraturrax). Con 
tiempos de mezcla <100 ms, la configuración usada permitió la producción de dispersiones (pH 
5.5) altamente homogéneas y estables. Asimismo, se determinó que, con una proporción másica 
HAp/CS de 70/30 y una concentración de n-HAp de 20 g/l, las dispersiones obtenidas son 
apropiadas para la producción de diferentes formas de materiales híbridos n-HAp/CS. 
Por consiguiente, en la etapa de separación de fases/eliminación de solvente se produjeron dos 
formas diferentes de híbridos: micropartículas y scaffolds. Las micropartículas fueron producidas 
por spray-drying. Se estudió el efecto del pH de las dispersiones (5.5 y 7.0) y la presencia de KCl 
en las propiedades finales de las micropartículas. Se evidenció que el KCl no favorece la 
estabilidad de las dispersiones, e incluso aparece como un contaminante en las micropartículas. 
Por otra parte, las micropartículas producidas mostraron diferencias dependiendo del pH al cual 
fueron preparadas las dispersiones. Las micropartículas n-HApCS-5.5, con 15.8 µm de tamaño 
medio en volumen y morfología de dona, se fueron preferidas que las n-HApCS-7.0, las cuales 
requieren de un paso extra en el proceso de producción y además presentan tendencia a formar 
aglomerados de gran tamaño. Las micropartículas obtenidas tienen la ventaja de que permiten 
conservar las propiedades superiores de la HAp nanométrica en la forma de micropartículas, que 
son materiales apropiados para el desenvolvimiento de sistemas inyectables, de liberación 
controlada de fármacos, o pueden ser moldeadas en sustratos sólidos con alta área superficial. 
Para la producción de materiales híbridos n-HAp/CS en la forma de scaffolds se desarrolló un 
proceso simple de 3 pasos, el cual consiste en: (1) preparación de las dispersiones; (2) liofilización 
para fijar la forma del scaffold; (3) extracción con CO2 supercrítico (scCO2) para remover el ácido 
acético residual y promover la esterilización. Se probó que la extracción con scCO2 es un método 
de purificación adecuado dado que fue posible remover exitosamente el ácido acético, con la 
ventaja de que no se compromete la forma estructural fijada durante la liofilización, a diferencia 
de los otros métodos con base en neutralización con solución alcalina. Se comprobó la esterilidad 
de los scaffolds producidos, así como la idoneidad de sus propiedades para ser usados como 
injertos óseos que no requieren soporte de carga. Así, el proceso de 3 pasos desarrollado mostró 
gran potencial para la producción de scaffolds n-HAp/CS listos para usar, y que simulan la 
composición y estructura del hueso natural. 
En síntesis, los resultados obtenidos permitieron el desarrollo de tres materiales híbridos n-
HAp/CS diferentes: dispersiones, polvo (micropartículas), y scaffolds. Estos materiales imitan la 
composición ósea, están compuestos de HAp de alta pureza, y presentan propiedades apropiadas 
para diferentes potenciales aplicaciones. 
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1 Introduction 
Bone, teeth, cartilage and skin, wood, nacre, crustacean carapaces and mollusc shells, are 
some of the many examples of hybrid materials that have existed in nature for millions of 
years. All of them exhibit extraordinary properties that cannot be attained by the individual 
components themselves, motivating many scientists to develop synthetic hybrid materials 
mimicking nature. 
Hybrids are often produced in nature as hierarchical structures in which particulate, fibrous, 
and porous structural features are present at different scale. As a matter of fact, nature has 
the remarkable ability to combine organic and inorganic components at the nanoscale, 
producing smart materials in such a level of integration that allows, not only the 
accommodation of a maximum of elementary functions in a small volume, but also the 
optimization of complementary possibilities, functions and hierarchies [1, 2]. 
The possibility to produce materials with combined properties of their components is a very 
ancient challenge. From the Egyptian inks to the green ceramics of China, man has embraced 
the task of designing and processing hybrid materials for ages. One beautiful example is the 
Maya blue, a robust pigment used by Mayas in their Ancient paintings, which combines the 
colour of an organic pigment (natural blue indigo) with the resistance of an inorganic host, a 
mineral known as palygorskite, chemical formula Si
8
O
20
Al
2
Mg
2
OH( )
2
H
2
O( )
4
⋅ 4H
2
O , allowing 
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the preservation of the paintings against the adversities of time and environment for 
centuries [2]. 
In the industrial era, hybrids started being successfully commercialized and became part of 
the manufacturing technology. It can be said that paints were the bridge between Mayas and 
modern applications of hybrids. However, it was only in the nineteen-eighties that the 
concept of “organic-inorganic hybrid” was developed with the expansion of soft (mild 
conditions) inorganic chemistry processes. Since then, the study of this type of materials at 
all scale ranges, lately with special interest in the nanoscale, became a growing field of 
research yielding innovative, advanced materials with high added value [2]. 
Scientists and engineers started combining materials, usually by incorporating a basic 
structural material in the form of particles, fibbers, or lamellae, into a matrix of a second 
substance, resulting in a novel material with improved mechanical properties. The structural 
building blocks that are incorporated into the second substance are predominantly inorganic 
in nature and, can assume different sizes. These early produced hybrid materials had 
heterogeneous composition, with inorganic units ranging from a few micrometers to 
millimeters, being often visible at naked eye. Soon it became evident that if the inorganic 
units are as small as the organic building blocks, more homogeneous materials could be 
obtained, allowing a further tuning of the properties at molecular and nanoscale levels. Such 
observation is now more tangible with today’s technological breakthroughs, in particular the 
availability of physico-chemical characterization methods that have given a positive twist to 
the field of nanoscience, opening many perspectives for approaches to new materials [3]. 
 
1.1 Motivation and objectives 
A great interest has been given to synthetic and stoichiometric hydroxyapatite (HAp) as a 
biomaterial due to its similarity with the mineral phase found in hard tissues [4]. It possesses 
exceptional biocompatibility [5] and bioactivity [6, 7] with respect to bone cells and 
surrounding tissues, which makes it a suitable material for the replacement of small parts of 
bone, filling of cavities in dentistry, and coating of metallic implants [8]. Additionally, this 
bioceramic has a high capacity of ad- and absorption, making it an excellent candidate for 
1 Introduction 
3 
drug delivery applications, such as long–acting drugs for anticancer treatment of bone 
tumours [9, 10]. 
Bones are not only the frame that supports human body, allowing its mobility and protecting 
it against injury, but also the storehouse for minerals that are essential for the functioning of 
other life-sustaining systems in the body. For these reasons, healthy bones are critically 
important for the overall health and quality of life. Unfortunately, bone is the second tissue 
most frequently transplanted, second only after blood transfusions. The clinical need to 
replace, restore, or regenerate bone tissue comprises the fields of dental, maxillofacial, 
orthopaetic, spinal, and cranial surgery, being osteoporosis the most important cause of 
fracture in the elderly [11-13]. The International Osteoporosis Foundation reported in 2010 
an estimation of 3.5 million new fractures in the EU caused by osteoporosis, representing an 
economic burden of approximately 37 billion EUR [14]. 
Medical solutions for bone repair and regeneration are still a major challenge. Even though 
they present serious drawbacks, biologically derived bone grafts have been implanted for 
many years, as temporary or permanent prosthesis. Among the available possibilities, 
autologous grafts (autografts) are still considered the “golden standard” today. They are 
usually well accepted and integrate rapidly with the surrounding tissue; however, the number 
of donor sites is very limited, and additional traumas and scars are involved requiring further 
healing at the patient’s donation site, long-term postoperative pain, with the risk of possible 
infections [12, 15]. Alternatively, the so-called xenograft, obtained from other animal species, 
is commercially available but it presents a high risk for viral infections, usually resorbs faster 
than autogenous bone, and has low osteogenicity and high immunogenicity. The use of 
allografts, obtained from another individual of the same species, present similar limitations, 
such as potential risks of transmitting bacterial and viral infections, as well as tumour cells. 
Moreover, there is a strong possibility of immunological and blood group incompatibility [16]. 
Given such scenario, the development of man-made materials appears as a promising option 
that, in comparison with orthodox treatments, have great potential to improve the 
regeneration of bone or its replacement when damaged, with the advantage that they are 
easily available and might be processed and modified to suit specific needs [11, 17]. They can 
be shaped to adapt to defects of different forms and sizes, and produced with particular 
properties such as antimicrobial capacity, or loaded with active ingredients such as anti-
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inflammatory drugs [18]. Nevertheless, despite of the evident clinical need for this type of 
materials, the bone graft substitutes market is still relatively small. According to a review 
published in 2010 in Materials Today [18], the global annual production of bone graft 
substitutes is close to 10 tons with a price of about 100 USD per gram. Synthetic materials 
represent only about 15% of the global market, but with a promising growing rate of about 
10% per year. 
In this light, the development of hydroxyapatite-based hybrid materials is very promising not 
only in terms of market opportunities, but also due to the contribution it could impart to 
regenerative medicine, particularly for hard tissue regeneration. The incorporation of nano-
hydroxyapatite (n-HAp) into polymeric materials, particularly natural polymers, is 
recognized as one of the most viable approaches to produce materials mimicking natural 
bone. Besides the expected biodegradability, natural polymers can be biologically active 
promoting better interactions with cells and, therefore, excellent cell adhesion and growth 
[19]. In particular, the combination of n-HAp with chitosan (CS) has been of great interest 
for the production of non-load bearing bone grafts, given the advantageous properties of 
chitosan that allows the manufacturing of n-HAp/CS materials with improved properties. 
Among other features, chitosan promotes osteoblasts adhesion and proliferation, possesses 
antimicrobial properties, can be processed using mild conditions and shaped into different 
forms [20]. 
The aim of this work is to develop high-added value hybrid materials based on highly pure, 
nanometric hydroxyapatite. For this purpose, chitosan has been selected as the organic 
component, and the production of three different forms of n-HAp/CS hybrid materials, 
having in view different potential applications, was studied: dispersions, powder 
(microparticles), and scaffolds. In order to obtain these different forms of the n-HAp/CS 
hybrids, the following main processing stages were considered (see Figure 1.1): (1) dispersion 
preparation in which n-HAp is incorporated into the chitosan solution; (2) phase 
separation/solvent elimination in which the fixation of structural forms as microparticles and 
scaffolds takes place; (3) purification and potential sterilization procedures. Different 
parameters and processing conditions were evaluated in order to define the best formulation 
to achieve adequate properties of the final products. 
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Figure 1.1. Schematic representation of the main processing stages considered in this thesis: 
(1) dispersion preparation; (2) phase separation/solvent elimination in which the fixation of 
structural forms as microparticles and scaffolds takes place; (3) purification and potential 
sterilization procedures 
 
The work developed in this thesis is organized in the following chapters: 
Chapter 2 consists of a compilation of the main achievements that have been published on 
hydroxyapatite-based hybrid materials, focusing on the combination of hydroxyapatite with 
chitosan. This chapter also includes fundamental definitions about hydroxyapatite and 
chitosan, their chemistry and structure-properties relationship. Methods for the preparation 
of n-HAp based hybrid materials with chitosan are introduced and further discussed in the 
remaining chapters. 
Based on the method of physically mixing n-HAp particles with chitosan in solution, 
Chapter 3 presents the preparation and characterization of aqueous dispersions of n-HAp, 
alone or in the presence of chitosan. This chapter includes an introduction focused on the 
basic principles of colloidal science and characterization techniques. Additionally, an 
experimental part in which the n-HAp dispersions were prepared by ultrasonication and 
characterized in terms of particle size and zeta potential is presented. Considering that the 
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incorporation of HAp nanoparticles into an acidic environment (chitosan solution) can 
influence HAp solubility, phase stability and surface chemistry, this chapter also discusses 
the effect of different parameters, such as pH, chitosan content and the presence of salts 
(KCl) on the resulting particle size and electrostatic stability of the dispersions. 
Chapter 4 is dedicated to the production of n-HAp/CS hybrid microparticles. First, a 
method for the preparation of n-HAp/CS dispersions by fast stirring (ultraturrax) is 
presented. The produced nanodispersions were characterized in terms of particle size and zeta 
potential, and the results were analysed taking into account the study carried out in Chapter 
3. Afterwards, the n-HAp/CS dispersions were used as base materials for the production of 
microparticles by spray drying. Given that the n-HAp paste used to prepare the n-HAp/CS 
dispersions contains KCl in its formulation, the effect of the presence of this salt on the final 
microparticles properties was analysed. Moreover, two different types of microparticles were 
prepared based on different pH values (5.5 and 7.0) of the original n-HAp/CS 
nanodispersions and a comparative study is presented. Finally, in order to infer if the spray-
drying conditions have an effect on the degradation of chitosan, the n-HAp/CS microparticles 
were characterized in terms of thermal degradation, and results were compared with 
analogous samples prepared by freeze-drying. 
The development of a 3-step process for producing n-HAp/CS hybrid scaffolds is presented in 
Chapter 5. The developed process comprises sequentially the following stages: dispersion 
preparation, freeze-drying, and supercritical CO2 extraction. Supercritical CO2 extraction is 
introduced as an innovative purification step with potential sterilization capacity. Different 
process parameters, as temperature (40 and 75 ºC) and number of extraction cycles (1 and 
2), were tested, while keeping the pressure constant at 8.0 MPa. The advantages of this 
method were studied over other currently used procedures, often based on neutralization with 
an alkaline solution. The produced scaffolds were evaluated based on key features required 
for bone regeneration, such as micro-architechture (interconnected pores and porosity), 
swelling capacity, and mechanical properties. Moreover, microbiological and cytotoxicity 
assays are carried out in order to assess the sterility of the produced scaffolds, and their 
ability to promote cell attachment and growth. 
Finally, Chapter 6 comprises the main conclusions of the thesis, as well as suggestions for 
future work. 
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2 State of the art 
Due to its excellent bioactivity [1, 2] and biocompatibility [3], hydroxyapatite (HAp) has 
been widely used for hard tissue regeneration, being incorporated in dental and orthopaedic 
implants mainly as powders, granules, and scaffolds. The chemical and structural similarity 
of synthetic HAp to minerals in natural bone makes it a great candidate as a bone substitute 
material. However, at the nanostructural level, natural bone is composed not only by a 
mineral but also by an organic component, collagen, that provides resilience and ductility to 
bone, complementing the stiffness provided by the mineral phase [4]. Therefore, with the aim 
of emulating natural bone, efforts have been focused in combining calcium phosphates (Ca-
P), particularly HAp, with biodegradable and/or natural polymers. 
The first attempt to produce an implantable polymer/Ca-P composite was carried out in 
1981 and consisted in the development of HAp/polyethylene formulations by pioneer Prof. 
William Bonfield and his colleges [5]. Ever since, many studies have been conducted in this 
field, including the use of FDA-approved, synthetic-biodegradable polymers such as poly(L-
lactic acid) (PLA) [6], poly(glycolic acid) (PGA) [7], and their copolymers (PLGA), with 
applications as drug carriers, bone fixation screws, plates, resorbable sutures, among others 
[8, 9]. 
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More recently, the combination of nano-hydroxyapatite (n-HAp) with natural polymers 
became a new trend. Besides the expected biodegradability, natural polymers can be 
biologically active promoting better interactions with cells and, therefore, excellent cell 
adhesion and growth [10]. In this context, chitosan, the main derivative of natural polymer 
chitin, appears as a great candidate gathering a wide list of desirable properties for bone 
regeneration. 
This chapter is a compilation of fundamentals in bone tissue engineering, focusing recent 
advances on the use of hydroxyapatite and chitosan as biomaterials for bone regeneration, 
and progresses in what concerns the fabrication of HAp/CS hybrid materials. 
 
2.1 Overview of bone biology 
Natural bone is a complex hybrid material which extracellular matrix composed of 
approximately 60-70% of an inorganic mineral, precipitated onto 20-30% of an organic 
matrix, and a small portion of water [11, 12]. Structurally, it is highly organized in a 
hierarchical manner, from the nano- to the macroscale, as shown in Figure 2.1. At the 
nanoscale, the mineral phase consists of calcium-phosphate, plate-like nanocrystals, with 2-6 
nm thick, 30-50 nm width and 60-100 nm long, chemically and structurally very similar to 
synthetic nano hydroxyapatite [11, 12] (see Table 2.1). 
At a microscale, bone can be divided in two categories based on density: cortical and 
cancellous bone. Cortical or compact tissue is very dense, with a porosity of 3-5%, and forms 
the outer layer of bone, providing support and protection. The less-dense inner part is 
constituted by cancellous bone, also known as trabecular or spongy bone; it is highly porous, 
with 30-90% porosity, and contains the bone marrow [4, 12-14]. Together, the cortical and 
trabecular tissues form the skeletal element of bone. However, bone is also a very dynamic 
tissue that constantly experiences modelling and remodelling processes as a consequence of 
mechanical and metabolic changes. 
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Figure 2.1. Hierarchical organization of bone 
(Reproduced from Burr and Allen, 2013 [4]) 
 
Five primary cells dictate bone formation and remodelling: mesenchymal stem cells (MSCs), 
osteoblasts, osteocytes, osteoclasts and bone lining cells. MSCs are found in the bone marrow 
and in the periosteum, the fibrous layer on the outside surface of bone. They are multipotent 
stromal cells that can differentiate into osteoblasts, the single-nuclei cells in charge of bone 
matrix protein secretion and bone mineralization. After completing their main function of 
synthesizing bone matrix, osteoblasts undergo three different transformations: they remain 
entrapped in bone as osteocytes, they flatten into bone lining cells, and the remnants suffer 
apoptosis. 
Osteocytes are the most abundant cells present in bone, representing more than 90% of cells 
within the bone matrix and surfaces, and their main function is the coordination of 
osteoblasts and osteoclasts functions in response to mechanical and hormonal signals. Bone 
lining cells are relatively inactive forms of osteoblasts which function is to cover inactive 
surface of bone; they may recover the ability to synthesize bone matrix and participate in the 
regulation of calcium exchanges. Finally, osteoclasts are the cells responsible for the 
resorption of mineralized bone. All these cells work together in a balanced way to maintain 
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the integrity of healthy bone, as well as to regenerate bone that has suffered trauma or 
disease. In the last case, when the size defect is critical, bone grafts are necessary to assist 
bone healing [4, 12, 14]. 
 
Table 2.1. Typical composition of the inorganic phase of adult human calcified tissues and 
hydroxyapatite (Adapted from Bose et al., 2012 [13]) 
Composition Enamel Dentin Bone Hydroxyapatite 
Calcium  36.5 35.1 34.8 39.6 
Phosphorus (as P)  17.7 16.9 15.2 18.5 
Ca/P (molar ratio) 1.63 1.61 1.71 1.67 
Sodium  0.5 0.6 0.9 - 
Magnesium  0.44 1.23 0.72 - 
Potassium  0.08 0.05 0.03 - 
Carbonate (as )  3.5 5.6 7.4 - 
Fluoride  0.01 0.06 0.03 - 
Chloride  0.30 0.01 0.13 - 
Pyrophosphate (as )  0.022 0.10 0.07 - 
Total inorganic  97 70 65 - 
Total organic  1.5 20 25 - 
Water  1.5 10 10 - 
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2.2 The ideal bone graft 
Considering the compositional, structural, mechanical and biological complexity of natural 
bone, the design of an ideal bone graft is not an easy task. The requirements for a graft 
intended to mimic all features of bone are numerous and diverse, however, there are a few 
key factors that must be fulfilled. Based on O’Brien (2011) [10], they can be summarized in 
terms of biocompatibility, biodegradability, mechanical properties, structural requirements 
and manufacturing technology. 
2.2.1 Biocompatibility 
An indispensible requirement of bone grafts is biocompatibility. This term can be defined as 
the ability of a material to support normal cellular activity, including molecular signalling 
systems, without causing any systematic or local effects to the host tissue [15]. Therefore, the 
graft should be osteoconductive, that is, it should promote cell adhesion on its surface and 
migration within its pores, cell proliferation and formation of ECM. In addition, 
osteoinductive property is necessary, that is, the bone substitute must induce the formation 
of new bone through the reclusion of progenitor cells and biomolecular signalling [15, 16]. 
Along with osteoconductive and osteoinductive properties, degradation products of the bone 
graft should be non-toxic and easily excreted by metabolic pathways [17]. 
2.2.2 Biodegradability 
The main objective of a bone graft is to assist tissue regeneration by providing a bridge that 
will fill critical size bone defects in such a way that it allows the body’s own cells to replace, 
over time, the implanted substitute. Therefore, grafts should not be permanent and they 
must degrade in vivo in a controlled manner, ideally at a rate that closely matches the rate of 
new tissue formation in the implantation site [10, 15, 18]. 
2.2.3 Mechanical properties 
One of the main challenges in bone tissue engineering is, still today, to achieve an adequate 
balance between mechanical properties and structural requirements, such as high porosity. 
The bone substitute should be able to support mechanical stresses in the implantation site 
from the moment of grafting throughout the whole remodelling process, which leads to a 
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further challenge considering that healing times vary with age; tissue of a younger individual 
normally requires less time to heal than that of the elderly. In addition, the graft should be 
able to resist surgical handling during the implantation process [10]. 
2.2.4 Structural requirements 
The structural features of the bone substitute are critical since they can affect both, its 
mechanical properties and its capacity to promote osteogenesis, the formation of bone tissue. 
Bone grafts can be cortical, cancellous, or a combination of both, each one with different 
mechanical and structural properties, which can be used in different applications depending 
on the surgical requirements. Cortical bone grafts are less frequently used and they are often 
applied onlay, i.e. it is applied or laid on the surface of the tissue, to provide structural 
support and strength. Cancellous bone grafts, on the other hand, lack of mechanical strength 
but are characterized for inducing osteogenesis. This type of bone substitute is commonly 
implanted in non-union fractures, maxillofacial and dental defects, spinal fusion, and other 
small defects [19]. 
Typically, cancellous bone grafts take the form of 3D-porous scaffolds, and the ability to 
promote adequate osteogenesis greatly depends on its architecture. Scaffolds should be highly 
porous, to guarantee cellular penetration, and their pores should be interconnected, both to 
allow the diffusion of nutrients to cells as well as the exit of waste and degradation products 
out of the scaffold [10]. 
2.2.5 Manufacturing technology 
Last but not least, clinical and commercial viability are key factors to consider when 
engineering bone grafts. The manufacturing process should be cost effective and easily 
scalable from laboratorial to industrial production. Additionally, it is important to consider 
the clinician’s point of view, since they are the ones ultimately using the product. For 
example, they typically prefer a bone graft that can be easily adapted into different shapes 
and an off-the shelf product ready to be implanted; the less extra surgical procedures prior 
implantation, the better [10]. 
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2.3 Commercially available materials for bone grafts 
Solutions for bone repair include the use of materials that, if not autologous, are either from 
natural origin or synthetic. Biological or natural bone grafts are those obtained from either 
human or animal origin; thus, autogenous, allogenous, and xenogenous grafts are all within 
this classification [20]. Synthetic grafts, also known as alloplastic grafts, include the use of 
polymers but mainly ceramic-based materials such as hydroxyapatite, calcium sulphate, and 
bioactive glass [20, 21]. There is also the alternative of using composite and hybrid materials, 
commonly consisting in the combination of ceramic-based materials with polymers.  
Autogenous grafts are obtained from non-essential bones of the same individual receiving the 
graft. They fulfil all primordial properties for bone regeneration as they are osteoconductive, 
osteoinductive, and they carry osteogenic cells and growth factors without the risk of 
transmitting immune or infective diseases. Nevertheless, due to the requirement of a surgical 
donor site, this type of graft can lead to post-operative pain, blood loss or hematomas, 
possibility of infection and aesthetic deformity, among other complications [22]. 
Bone grafts obtained from another individual of the same species are called allogenic; they 
are harvested from cadavers, making them readily available in different shapes and sizes. 
Allografts are also osteoinductive and osteoconductive but not osteogenic, since they lack of 
viable cells. They can be acquired from bone banks unprocessed and frozen, thus including all 
growth factors and normal ultrastructure. Otherwise, their processing includes steps such as 
defatting, removing the bone marrow, and commonly freeze-drying, which changes the graft’s 
mechanical properties making them less resistant. Finally, they have to be sterilized before 
use. This type of graft overcomes the limitations presented by autografts, but presents some 
limitations such as high cost, risk of rejection, and there are still concerns related to disease 
transmission in spite of undergoing sterilization [23]. 
The term xenograft refers to bone substitutes acquired from a species other than human, 
frequently bovine bone tissue. Usually, all organic material is removed from the animal tissue 
by a high temperature treatment, followed by a chemical procedure with a strong base, such 
as NaOH, to obtain a porous HAp material. Xenogenic materials are readily available and 
show adequate absorption characteristics; however, they exhibit the same disadvantages than 
allografts, with additional risk of transmission of zoonoses, allergenic response, and a more 
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likely rejection of the graft [19]. In addition to ceramic-based xenografts, another readily 
available biological graft is the so-called demineralized bone matrix (DBM). It is obtained 
mainly from human, bovine or equine bone tissue through decalcification and sterilization, 
resulting in a sponge-like collagen material [20, 23]. Some commercially natural bone 
substitute materials are listed in Table 2.2. 
 
Table 2.2. List of some commercially available biological grafts 
Company Product Name Composition/source Form Ref 
Ace Surgical 
Supply Co., Inc. 
Nu-Oss® 
Both, mineral phase and DBM 
derived from bovine tissue 
Granules and 
blocks 
[24] 
AlloOss® 
Both, mineral phase and DBM 
derived from human tissue 
Particles, blocks 
and putty 
AlloSourceTM 
AlloFuse® 
Derived from DBM of human 
tissue 
Gel, paste and 
putty 
[25] 
AlloFuse® Plus 
Derived from DBM and ground 
cancellous bone of human tissue 
Paste and putty 
Biomet3iTM Endobon® 
Derived from mineral phase of 
bovine bone  
Granules [26] 
Botiss Dental 
GmbH 
Cerabone® 
Derived from mineral phase of 
bovine bone  
Granules and 
blocks 
[27] 
Maxgraft® 
Derived from cancellous and 
cortical bone of human tissue 
Granules and 
blocks 
D-bone® D-bone® 
Derived from mineral phase of 
bovine bone  
Granules [28] 
DePuy SynthesTM 
Allograft Bone 
Chips and Blocks 
Derived from cancellous and 
cortical bone of human tissue 
Chips and blocks 
[29] 
DBXTM Material 
Derived from DBM of human 
tissue in sodium hyaluronate 
carrier 
Putty and strip 
 
  
2 State of the art 
17 
 
 
Table 2.2 (continuation). List of some commercially available biological grafts 
Company Product Name Composition/source Form Ref 
Exactech 
Optecure® 
Derived from DBM of human 
tissue and a hydrogel carrier 
provided separately 
Dry mix kit 
(powder with 
hydrogel) [30] 
Optecure® +ccc 
Cortical cancellous chips 
derived from human tissue 
Chips (1-3 mm) 
Geistlich Pharma 
Geistlich Bio-
Oss® 
Derived from mineral phase of 
bovine bone  
Granules 
[31] 
Geistlich Bio-Oss 
Collagen® 
90% Geistlich Bio-Oss 
(granules) and 10% Porcine 
collagen 
Scaffold 
Ost-
Developpement 
Laddec 
Derived from mineral phase of 
bovine bone  
Chips and blocks 
[32] 
Lubboc 
Derived from mineral phase of 
bovine bone  
Chips, grafts and 
blocks 
Osteohealth® 
Equimatrix® 
Derived from mineral phase of 
equine bone  
Granules 
[33] OSSIF-i semTM 
Both, mineral phase and DBM 
derived from human tissue 
Particles, sponge 
strip and filler 
Optimatrix® 
Derived from DBM of porcine 
tissue 
Membrane 
SigmaGraft 
Biomaterials 
InterOss® 
Derived from mineral phase of 
bovine bone  
Granules [34] 
Tecnoss® 
Tecnoss® mp3 
and Tecnoss® 
putty 
Derived from mineral phase of 
equine bone and additional 
collagen gel 
Pre-hydrated 
bone mix, putty 
[35] 
Tecnoss® Gen-
Oss and Tecnoss® 
Chips 
Derived from mineral phase of 
equine bone  
Granules and 
chips 
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With regard to synthetic materials, ceramic-based grafts are the most commonly used, 
especially based on hydroxyapatite and β-tricalcium phosphate (β-TCP), due to the 
advantages they present in what concerns osteoconductivity, long shelf life, unlimited supply, 
and absence of risk of disease or virus infection. In addition, they can be produced with 
different shapes, porosity and composition; commercially they are usually sold as granules, 
injectable pastes, and cements, among other forms [23, 36]. As for the disadvantages of these 
alloplastic grafts, the synthesis of HAp and β-TCP with the desire characteristics (Ca/P 
ratio, crystallinity and morphology, etc.) can be challenging and, despite its hardness and 
porosity, they are brittle, limiting their applications [23]. 
In efforts to improve the overall properties of ceramic materials, they have been combined 
with other components, mainly polymers, to produce composite and hybrid materials. Many 
scientists use these terms interchangeably and there is still no clear borderline between them. 
For the purposes of this work, the terms are used according to IUPAC definitions [37]; 
therefore, a composite is a material constituted by two or more components comprising 
multiple, different non-gaseous phases such that at least one of which is a continuous phase. 
The term hybrid refers to a material composed by an intimate mixture of organic or 
inorganic components, or both, in which normally the components interpenetrate on scales of 
less than 1 µm.  
A number of biodegradable polymers, both synthetic and natural, have been used in 
combination with ceramic materials, including PLA, PGA, PLGA, collagen, alginate, and 
chitosan, among others. In this context, the combination with collagen has been widely 
studied and currently the market offers a variety of ceramic/collagen products. Chitosan-
based products on the other hand, besides the many studies proving its suitability for tissue 
regeneration, have not yet reached the market at great scale. A list of some commercially 
available calcium phosphate-based alloplastic, composites and hybrid grafts is shown in 
Table 2.3. 
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Table 2.3. List of some commercially available alloplastic and composites grafts 
Company Product Name Composition Form Ref 
Artoss GmbH NanoBone® 
HAp (76% for granules, 61% for 
blocks and putty) and silicon 
dioxide (24% granules and 39% 
blocks and putty) 
Granules, blocks 
and putty 
[38] 
Baxter Actifuse 
Silicate substituted calcium 
phosphate 
Granules and 
scaffolds 
[39] 
Berkeley Advanced 
Biomaterials Inc 
Bi-Ostetic Tricalcium phoshpate and HAp 
Granules, blocks 
and cylinders 
[40] 
Bi-Ostetic Foam 
Type I bovine collagen, tri-calcium 
phosphate and HAp 
Foam 
Biocomposites® 
Ltd. 
geneX® β-TCP and calcium sulphate Putty 
[41] 
Allogran-RTM β-TCP Granules 
Ceramed 
NeoBone® 
75% HAp and 25% tricalcium 
phosphate 
Granules, blocks 
and wedges 
[42] 
NeoCement® 
Solid phase: tetracalcium 
phosphate and tricalcium 
phosphate. Liquid phase: citric 
acid, chitosan and apyrogenic 
water. 
Cement (to be 
mixed before use) 
k-IBS® 
Calcium phosphate granules and 
chitosan 
Injectable gel 
n-IBS® 100% HAp nanoparticles Injectable 
Curasan Cerasorb M® >99% β-TCP Granules [43] 
Sunstar Degradable 
Solutions AG 
Guidor® easy-graft® 
β-tricalcium phosphate (β-TCP) 
granules coated with PLGA, mixed 
with BioLinker® (N-methyl-2-
pyrrolidone (NMP) liquid 
activator) 
Granules [44] 
DePuy SynthesTM 
chronOSTM 100% β-TCP Granules and 
scaffolds 
[29] 
Norian® 
Carbonated apatite and 
polylactide/glycolide copolymer 
fibers 
Injectable and 
fast-set putty 
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Table 2.3 (continuation). List of some commercially available synthetic and composites grafts 
Company Product Name Composition Form Ref 
Exactech OpteMxTM 60% HAp and 40% β-TCP 
Granules and 
scaffolds 
[30] 
Fluidinova 
nanoXIM-HAp100 
100% HAp nanoparticles in pure 
water at concentrations 15.0 wt.% 
and 30.0 wt.% 
Paste 
[45] nanoXIM-HAp200 
100% HAp nanoparticles 
agglomerates 
Powder 
nanoXIM-TCP200 
100% Ca-deficient HAp 
nanoparticles agglomerates with 
90%  β-TCP phase purity 
Powder 
Heraeus Kulzer 
GmbH 
Ostim® 
100% HAp nanoparticles suspended 
aqueous phase at concentrations 
35.0 wt.% 
Paste [46] 
Hoya 
Technosurgical 
Corporation 
Apaceram HAp 
Particles and 
scaffolds 
[47] 
Implandent Ltd. Osteogen® Calcium apatite (non specified) Powder [48] 
KerrTM Bioplant® 
Calcium hydroxide and 
Biodegradable polymer (non-
specified) 
Spherical beads [49] 
Stryker GmbH & 
Co. 
HydroSet® 
Injectable 
Powder: Di-, tri- and tetra-calcium 
phosphate. Liquid: Sodium 
phosphate, polyvinyl-pyrrolidone 
and water 
Paste (to be mixed 
before use) 
[50] BoneSave® 
80% tricalcium phosphate and 20% 
HAp 
Granules 
BoneSource® HAp Cement 
Vitoss® BBTrauma 
β-tricalcium phosphate and 
bioactive glass (non-specified) 
Scaffold 
Teknimed S.A.S Cementek® 
Calcium apatite (non specified) 
powder plus separate aqueous 
solution. 
Injectable (to be 
mixed before use) 
[51] 
Zimmer BiometTM 
Calcitite 100% HAp Granules 
[52] 
IngeniOsTM 100% HAp or 100% β-TCP Particles 
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2.4 Hydroxyapatite as biomaterial for bone regeneration 
Hydroxyapatite (HAp) is a member of a large isomorphous series of minerals called apatites 
that means deceivers in Greek, name given due to the diversity of form and colour. Apatites 
can be found in nature mainly in mineral deposits and in mammalians bones and teeth [53]. 
The apatite profusely found in sedimentary rocks is essentially carbonate fluoroapatite, 
whereas the one found in bones and teeth is very similar, in terms of crystallography and 
chemical composition, to HAp [53, 54]. 
The stoichiometry of HAp is represented by the formula Ca10(PO4)6(OH)2; it is a double salt 
of tricalcium phosphate and calcium hydroxide with a Ca/P ratio of 1.67. Deviations from 
Ca/P stoichiometric ratio can lead to phase impurities in HAp, such as tricalcium phosphate 
or CaO, that may affect biological responses [55]. At physiological temperature and pH 
ranging from 4 to 12, it is considered the most stable and less soluble calcium phosphate of 
all [55, 56]. However, the solubility of HAp, which is partly responsible for vital properties 
such as biocompatibility and bioactivity, depends on several factors; thus, the study of its 
dissolution mechanisms and rate is a subject of great interest. 
The solubility rate of HAp depends on differences in shape, crystal size, porosity, crystallinity 
and crystallite size. In general, it is soluble in acidic solutions, insoluble in alkaline ones and 
slightly soluble in distilled water, which increases with addition of electrolytes. Therefore, 
solubility varies depending on the surrounding environment; for example, in physiological 
environments it is affected by the presence of amino acids, proteins, enzymes, and other 
organic compounds. 
Barbucci (2002) [57] explains the solubility equilibrium dynamics of calcium phosphates in 
wet and biological environments, starting from the influence of their chemical nature on the 
solubility product value. Phosphate-containing compounds in solution are ruled by the 
following equilibria: 
 H
3
PO
4
↔ H
2
PO
4
- + H+ pKa = 2.1192   (2.1) 
  H2PO
−
4
↔ HPO
4
2- + H+ pKa = 7.2076   (2.2) 
 HPO2−
4
↔ PO
4
3- +H+ pKa = 12.0000   (2.3) 
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These equations show that in a very acidic solution, H
2
PO
4
-  species are predominant, near 
neutrality HPO
4
2-  is favoured, and PO
4
3-  species are dominant in basic solutions. 
Consequently, in the presence of Ca2+  the precipitation of HAp is favoured in a basic 
environment; thus, with the contribution of the OH-  groups, its solubility product (KSP) is: 
 
 K
SP
= Ca2+⎡⎣ ⎤⎦
5
PO
4
3-⎡⎣ ⎤⎦
3
OH-⎡⎣ ⎤⎦   (2.4) 
 
Then, in acidic conditions, below pH values of 4.3 – 4.8, HAp becomes very slowly soluble 
and undergoes the following transformation as a result of the decrease in  concentration 
and the presence of : 
 
 Ca
5
PO
4( )3 OH + 4H+ → 3CaHPO4+ 2Ca2++ H2O   (2.5) 
 
2.4.1 Structure-properties relationship 
Chemical composition and crystallinity of HAp are two of the main factors that directly 
influence biological responses. Hydroxyapatite can be found in two different crystal forms, 
hexagonal and monoclinic. The hexagonal structure is most frequently found, with P63/m 
space group and lattice parameters of a=b=9.432, c=6.881, and γ=120º. In this structure, 
tetrahedral PO4 groups are held together by interspersed Ca ions. The Ca ions are arranged 
in two distinct sites, the so-called Ca(I) are accurately aligned in columns, and the Ca(II) are 
organised in equilateral triangles centered on the screw axis. Finally, the hydroxide groups 
(OH) are found on the screw axes arranged in a column (see Figure 2.2) [58]. 
 
 OH
−
 H
+
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Figure 2.2. Schematic representation of hexagonal HAp 
(Reproduced from Brunton et al., 2013 [59]) 
 
The atomic arrangement in HAp structure is directly related to its properties and potential 
biomedical applications. In aqueous media, HAp presents different net charges in its crystal 
planes; a and b planes are positively charged, while charges in c plane, are negative. 
Therefore, it is expected that a and b planes tend to attract acidic groups of proteins, 
whereas the c planes attract basic groups of proteins [55, 60, 61]. Moreover, morphology of 
HAp particles has an effect on their net charge; due to the elongation of HAp particles along 
the c-axis in their typical rod-like morphology, it is believed that the net charge of the 
particles would be shifted positive, giving a higher specificity of adsorption onto negatively 
charged proteins [61]; nevertheless, this is influenced by the pH of the aqueous medium 
which, at the same time, influences the dissolution mechanism and rate of HAp, as previously 
explained. 
Dissolution mechanism and rate of HAp are, to a great extent, responsible for HAp’s well 
known osseointegration and bioactivity properties, where osseointegration refers to the ability 
to bind to the bone, whereas bioactivity is the ability of a material to induce a specific 
biological activity such as forming Ca-containing minerals. It has been proposed that these 
two remarkable properties are due to a mechanism that happens at the HAp-tissue interface 
after implantation, starting by the dissolution of HAp [55, 62, 63]. Following dissolution, the 
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super-saturated solution at the interface causes the re-precipitation of calcium and phosphate 
ions, with the formation of carbonate apatite [64]. At this point, an exchange of ions between 
the HAp implant and the host bone starts, promoting both, bone bonding through the 
deposition of the ions on the collagenous matrix, and the adsorption of the host bone proteins 
to HAp surface [55, 62, 63]. Finally, attracted by the high concentration of phosphate and 
calcium ions, MSCs migrate to the implant surface, differentiate into osteoblasts, and start 
producing new bone [63]. An illustration of this mechanism is shown in Figure 2.3. 
Besides chemical composition, crystallinity and morphology, particle size is another key 
property that affects biological responses to HAp-containing grafts and, thus, its performance 
throughout the mechanism described above. In its nanometric form, nano-hydroxyatatite has 
been proven to be more advantageous to the conventional micrometric sized HAp in what 
concerns the promotion of osteoblast adhesion, differentiation and proliferation, 
osseointegration, and deposition of Ca-containing minerals on its surface [65, 66]. 
 
 
Figure 2.3. Schematic diagram representing the proposed mechanism that occurs at the 
surface of hydroxyapatite after implantation. (1) Dissolution of HAp after implantation; (2) 
Continuation of solubilisation of HAp; (3) Ionic exchange between the HAp implant and host 
bone; (4) Adsorption of proteins and organic material; (5) Cell adhesion; (6) Cell 
proliferation; (7) New bone formation; (8) New bone formed and natural bone metabolism. 
(Reproduced from Bertazzo et al., 2010 [62]) 
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Cells are sensitive to the topography of an implant, both at micro- and nanoscale, since it 
influences factors affecting protein adsorption; among them, surface chemistry, roughness, 
and surface-free energy [67, 68]. Thanks to their increased surface area and higher 
percentages of atoms at the surface, nanoscale materials have higher surface energy, 
wettability and surface reactivity when compared to conventional sized materials [69, 70], 
which is translated into increased numbers of grain boundaries, to which proteins 
preferentially adsorb. As a result, grafts containing HAp in its nanometric form have shown 
enhanced osteoblast adhesion and function, decrease fibroblast adhesion, and enhance bone 
remodelling [71, 72].	  
Finally, when it comes to biomedical applications, biodegradation of materials into non-toxic 
products is highly desirable. In this sense, HAp is an appropriate ceramic material, not only 
for bone regeneration applications but also as a drug delivery system. Its degradation 
products are  and  ions that already naturally occur in the body, since they are 
found in the bloodstream at relatively high concentrations (1-5 mM) [13]. 
2.5 Chitosan as biomaterial for bone regeneration 
Chitosan (CS) is the main derivative of natural polymer chitin, the second most abundant 
natural polysaccharide on earth, estimated to be produced almost as much as cellulose, with 
an annual production assessed in over 105 tons worldwide [73, 74]. Chitin is a white, inelastic, 
hard, nitrogenous polysaccharide found in the exoskeleton and in the internal structure of 
invertebrates, mainly in crustacean shells but also in some microorganisms, yeast and fungi 
[75]. The use of chitin-based and chitin-derived biomaterials is growing particularly for 
applications that require the biodegradability property. 
The high percentage of nitrogen give unique properties to chitin and chitosan, making them 
of commercial interest [76]. Chitosan is obtained from the partial deacetylation of chitin, 
typically by chemical hydrolysis under strong alkaline conditions or by enzymatic hydrolysis 
under the action of particular enzymes such as chitin deacetylase [77]. Therefore, chitosan is 
characterized mainly by its degree of deacetylation (DD); to be considered chitosan DD 
should be at least 50% [14]. Structures of both natural polymers are shown in Figure 2.4. 
 
Ca2+ PO
4
3+
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Figure 2.4. Structure of (a) chitin and; (b) chitosan. 
(Reproduced from Croisier & Jérôme, 2013 [77]) 
 
Most synthetic polymers commonly used for biomedical applications present more limitations 
in terms of their biocompatibility and biodegradability than natural polymers such as 
cellulose, alginate, collagen, chitin, chitosan and their derivatives. On the other hand, some 
of these natural polymers may exhibit limitations in their processability [74]. In this respect, 
the presence of the free amino and N-acetyl groups in chitosan’s structure, allows its 
solubility in aqueous, slightly acidic solutions, and therefore, allowing its processability under 
mild conditions. 
2.5.1 Structure-properties relationship 
Chitosan is a linear polymer of 1→ 4( ) - linked 2 - amino - 2 - deoxy - β  - D - glucopyranose  
characterized mainly by its degree of deacetylation (DD), usually ranging from 50-95%, and 
molecular weight, which can vary from 50 to more than 1000 kDa depending on its source 
and preparation method [14, 78, 79]. It is semi-crystalline, where its crystallinity is dependent 
on its DD, and soluble in aqueous acidic solutions, where its solubility is mostly dependent 
on the protonation of amino groups [14]. 
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Chitosan presents a wide list of desirable properties for bone regeneration and controlled 
drug delivery, namely: biocompatibility [80, 81]; mucoadhesiveness [82, 83]; hydrophilic 
character which promotes osteoblast adhesion and proliferation [84]; wound healing 
properties [85, 86]; and non-toxic biodegradation products [77, 78]. Most of these properties 
are caused mainly by its cationic nature. This polymer contains in its main backbone 
primary amino groups that become positively charged in acidic medium, as shown in Figure 
2.5 [87]. 
With a pKa around 6.0 – 6.5 [87, 88], it is both reactive and soluble as a function of pH, 
presenting solubility in the majority of organic acidic solutions including formic, acetic, 
tartaric, and citric acid [89]. Thus, at low pH, the amines are protonated so chitosan becomes 
a cationic polyelectrolyte. This polyelectrolyte property has been employed to generate 
multilayer films or capsules using layer-by-layer assembly [90, 91]. Otherwise, at high pH the 
amines are deprotonated and chitosan changes from a soluble cationic polyelectrolyte to an 
insoluble polymer. 
 
 
Figure 2.5. Cationic nature of chitosan 
(Reproduced from Dash et al. 2012 [88]) 
 
A notable effect of chitosan’s polyelectrolyte behaviour is the improved adhesion and 
proliferation of cells in the surface of chitosan-containing materials, caused by the 
electrostatic interaction of positively charged chitosan with negatively charged 
glycosaminoglycans (GAG), proteoglycans and other negatively charged molecules. GAG and 
proteoglycans are non-collagenous extracellular matrix proteins that regulate and direct the 
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construction and maintenance of the ECM [4]. Given that both cytokines and growth factors 
bond to GAG, the formation of chitosan-GAG complexes in a bone graft is beneficial because 
they can promote the retention and concentration of these desirable substances on its surface 
[78, 92]. 
In swollen state, chitosan acts as a natural bioadhesive polymer, ability that has been of 
special interest for drug delivery applications [14, 93, 94]. The mucoadhesive property of 
chitosan is caused by its electrostatic interaction between positively charged chitosan and 
negatively charged residues, namely sialic acid, on mucosal surfaces [77]. Another feature of 
chitosan attributed to electrostatic interactions is its capacity to induce haemostasis, which 
has been related to interactions of positive charges of chitosan with negatively charged red 
blood cell membranes [77, 95, 96]. 
The antimicrobial activity of chitosan, a fundamental property in wound healing processes, 
has been widely studied [96-99]. In what regards orthopaedic implants, bacterial infection is a 
major concern due to the severe consequences it can lead to, such as implant failure, 
hospitalization and sometimes even mortality of the patient [98]. Mechanisms explaining 
antibacterial and antifungal activity of chitosan are more complex. The first mechanism 
proposes that the high affinity of cationic groups of chitosan towards the anionic components 
in microorganisms’ cell wall, such as Gram-negative lipopolysaccharide and cell surface 
proteins, alters the cells permeability preventing the mass transport of essential materials 
across the cell wall. The second mechanism proposes the inhibition of the microbial RNA 
synthesis due to the bonding of protonated amino groups of chitosan with the cell DNA [77, 
79, 100].  
Another important property of chitosan is its biodegradability. A wide range of biomedical 
applications, including matrices for controlled drug release, resorbable devices such as bone 
cements, and scaffolds for tissue engineering, require the controlled degradation of the 
biomaterials over time in order to let the natural tissue develop and completely replace the 
foreign element [101]. Chitosan’s biodegradability takes place by lysozyme action, an 
abundant enzyme found in the human body, through the degradation into small glycomino 
chains, with degradation rate being inversely related to the degree of deacetylation. 
Regarding the biocompatibility of the degradation products, it has been reported that these 
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products undergo a quick elimination by the kidney, thus avoiding accumulation in the body 
[14, 101]. 
In addition to all the above-mentioned desirable properties, the solubility of chitosan in 
aqueous acidic medium allows its processing under mild conditions [12, 77] that, together 
with chitosan’s ability to be shaped into different forms such as porous scaffolds [102-104], 
fibers [105, 106], sponges [84] and microparticles [107-109], are advantageous features for 
tissue engineering applications [14]. Another advantage is its availability in large quantities 
and at adequate commercial grades [110]. 
 
2.6 HAp/CS hybrid materials 
The combination of nano-hydroxyapatite (n-HAp) with chitosan (CS) has been of special 
interest for biomedical applications, particularly for bone regeneration. Hydroxyapatite by 
itself is highly brittle, whereas chitosan, despite its capacity to promote osteogenic cells 
attachment and proliferation, it does not induce the deposition of bone minerals on its own. 
Therefore, when combining both components, HAp provides the required bioactivity while 
chitosan adds elasticity to the final material, resulting in a great candidate for non-load-
bearing bone graft applications [9, 12]. However, even though combining HAp and chitosan 
can be advantageous, the production of such hybrid system still faces several challenges. 
The final properties of any hybrid inorganic–organic system are affected by several important 
aspects that must be considered. A hybrid material consists of at least two phases separated 
by an interface, in which one of the phases is usually inorganic, consisting of filler particles, 
dispersed in the second phase, a polymeric matrix. The filler’s shape and size, properties and 
volume percentage, the matrix properties such as molecular weight, the dispersion stability of 
the filler in the polymeric matrix, and the interactions in the filler/matrix interface are some 
of the main factors influencing the properties of the hybrid [65]. Furthermore, in the case of 
hybrid materials for biomedical applications, biocompatibility, degradation rate and non-
toxicity must be considered as previously discussed. 
From a chemical point of view, there are several ways to incorporate inorganic particles 
(fillers) into organic polymers, depending on the interactions between the constituents, either 
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strong, weak, or without any chemical interactions between them. Strong interactions can be 
covalent, coordination type, and ionic bonds, whereas van-der-Waals, hydrogen bonds, and 
hydrophilic–hydrophobic are considered weak interactions. Inorganic–organic hybrid 
materials can be classified based on such interactions and the different arrangements of the 
polymer chains relative to the inorganic nanoparticles. In this regard, Kickelbick (2003) 
proposed four different types of arrangements, as shown in Figure 2.6. 
 
Figure 2.6. Schematic representation of different types of inorganic-organic hybrid materials 
based on polymeric chain arrangements relative to the inorganic particles: (a) inorganic 
particles embedded into the organic polymer; (b) interpenetrating polymer networks (IPNs); 
(c) inorganic particles chemically bound to the polymer backbone and; (d) dual inorganic-
organic hybrid polymer. 
(Reproduced from Kickelbick, 2003 [111]) 
 
The first arrangement (Figure 2.6a) takes place when, in the absence of strong interactions, 
the inorganic particles are dispersed in the organic matrix such that, depending on the 
functionalities of the components, the inorganic units undergo weak crosslinking through 
physical interactions with the polymer or, the inorganic particles are entrapped in a 
crosslinked polymeric matrix [112]. Interpenetrating polymer networks (IPNs) consist of a 
polymer comprising two or more networks that are, on a molecular scale, partially or totally 
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interlaced but not covalently bound (Figure 2.6b). In the case of inorganic–organic IPNs, 
formed for example by sol-gel reactions, one of the networks is formed by the inorganic 
component, and they can be processed either simultaneously or sequentially [113]. Finally, 
the hybrids can be produced by discrete (Figure 2.6c) or interconnected (Figure 2.6d) 
inorganic particles attached to the polymer backbone by covalent bonds [111, 112]. 
The chemical nature of chitosan makes it a versatile polymer as it can be either chemically or 
physically crosslinked. Chemical crosslinking is irreversible since a polymeric network is 
formed by covalent bonds, requiring the assistance of a crosslinking agent such as 
glutaraldehyde or genipin. Physical crosslinking, on the other hand, is reversible since linkage 
occurs through van der Waals forces, ionic attractions, hydrogen bonding, or hydrophobic 
interactions [101, 114]. Considering this, the incorporation of HAp nanoparticles into a 
chitosan solution can be done following several techniques as described in the next section. 
 
2.7 Overview of HAp/CS materials preparation, purification and 
sterilization methods 
With advances in technology, various methods for producing HAp/CS hybrid materials have 
been reported, following both, chemical and physical paths. In general, the production of 
HAp/CS materials requires a first stage of dispersion preparation, in which HAp and 
chitosan are combined to produce the base material that, in a second stage, is shaped into 
the final form. Thus, the second stage consists in the fixation of the structure – into 
microparticles, granules, scaffolds, cements, etc. – carried out by inducing phase separation 
and the elimination of the solvent. Afterwards, the produced hybrids usually have to be 
subjected to purification and sterilization processes, since their potential applications are 
within the biomedical field. One of the key issues in these sequential procedures is to 
guarantee that none of the stages compromises, among other desirable properties, the 
morphological and architectural features of the final envisaged forms (scaffolds, powders etc.) 
in order to ensure a suitable environment for cell attachment and proliferation. 
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2.7.1 Dispersion preparation 
This is the first and key stage since here is when HAp is incorporated into the chitosan 
solution. The dispersion preparation step can be done in a number of ways; among all the 
methods reported, in situ co-precipitation and simple mixing are the most popular [12, 115]. 
One of the methods preferred by some authors is the so-called in situ co-precipitation [116-
118]. In this method, the synthesis of HAp is carried out in the presence of chitosan in a 
neutral or basic environment (pH ≥ 7), therefore, causing the precipitation of chitosan along 
with HAp simultaneously. Yamaguchi et al. (2001) [116] developed a methodology that 
consisted in dripping chitosan in H3PO4 solution on a calcium hydroxide suspension. 
Homogeneous incorporation of HAp into the chitosan solution has been reported using this 
process, however, the fact that the formation of HAp occurs in the presence of chitosan can 
hinder the synthesis of HAp particles with high purity and desired morphology. 
An alternative attractive method consists in physically mixing previously synthesized HAp 
particles, usually in powder form or ultrasonically dispersed in water, into a chitosan 
solution. Typically, this technique, also called simple mixing method, is carried out at lab-
scale, by mixing both components in a vessel using a magnetic stirrer, resulting in final 
hybrid materials with quite favourable physicochemical and biological properties [119-121]. 
This is a simple and straightforward technique, that can also be advantageous in terms of 
reproducibility relative to the co-precipitation method; nevertheless it can lead to non-
homogenous dispersions at a microscopic level due to the difficulty in controlling the mixing 
between the two dissimilar phases that can undergo phase separation [65, 122] and, therefore, 
originate final materials with weaker mechanical properties when compared to other methods 
[123, 124]. 
Another important parameter to consider when preparing n-HAp/CS hybrid dispersions is 
the pH, especially if HAp has to be introduced into an acidic environment that can influence 
its solubility, chemistry and phase stability [125]. When the method of physically mixing 
both components is used, HAp is often introduced in an acidic chitosan solution, resulting in 
dispersions with pH typically around 4, potentially causing the dissolution of HAp [126]. 
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2.7.2 Phase separation/Solvent elimination 
This stage involves the structural fixation of the n-HAp/CS hybrid material in its final form, 
such as microparticles, granules, pastes, scaffolds, cements, etc. The most typical structure 
produced for bone regeneration is 3D scaffolds, which are frequently produced from the 
previously prepared n-HAp/CS dispersion by thermally induced phase separation (TIPS). 
This is a simple procedure usually carried out by freeze-drying, in which phase separation is 
induced by the formation of ice crystals upon freezing, followed by the elimination of the 
solvent by the sublimation of the ice crystals, producing the final hybrid 3D porous structure 
[12, 14, 127]. Many authors using this technique obtained n-HAp/CS based hybrid scaffolds 
with desirable high porosity and interconnected pores [6, 120, 121, 127-131]. Other popular 
phase separation/solvent elimination techniques to produce n-HAp/CS scaffolds are 
particulate leaching [132, 133], gas foaming [134], and freeze-gelation [135]. 
Another attractive n-HAp/CS structure to be produced for biomedical applications is in the 
form of microparticles. The use of microparticles in tissue engineering and regenerative 
medicine can be very beneficial from a functional point of view; these are very versatile 
structures that, thanks to their reduced size, can be used as injectable systems, shaped into a 
solid substrate with increased surface area capable to promote chemical and biological 
reactions, or even be embedded into hybrid scaffolds for controlled release of bio-active 
substances [136-138]. Among the methods that have been exploited to produce n-HAp/CS 
microparticles are: water-in-oil (W/O) emulsion [139]; supercritical assisted atomization [140], 
spray-coagulation [141], electro-spray coagulation [142], dispersion polymerization [143], and 
spray-drying [144, 145]. 
2.7.3 Purification/Neutralization 
In most cases the obtained n-HAp/CS hybrid material still contains residual substances left 
from the process. The residual substances are commonly reagents in excess, e.g. a base when 
the synthesis of HAp is carried out during co-precipitation method, or acetic acid used to 
solubilize the chitosan in the case of simple mixing method. Thus, a 
purification/neutralization step is usually necessary to eliminate the residual substances that 
can affect the final properties of the material, cause structure disruption, or even inhibit cell 
growth and proliferation. The presence, for example, of residual acid can potentially cause 
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structure disruption due to dissolution of chitosan in aqueous medium [14]. Whereas, in order 
to promote cell survival and proliferation, the culture environment must fulfil some 
fundamental physiological requirements, such as composition and pH [146], that may be 
affected due to the presence of acid and/or alkaline impurities. 
2.7.4 Sterilization 
As any medical device that is implanted in the human body, n-HAp/CS hybrid materials 
produced for biomedical applications must be subjected to sterilization. The term sterilization 
refers to a procedure, either chemical or physical, which purpose is to destroy all microbial 
life, including highly resistant bacterial endospores [147]. Typical sterilization techniques 
include saturated water steam (autoclave), dry heat, ethylene oxide (EtO), and gamma-
irradiation. These techniques have proven to be effective eliminating microorganisms, 
however, they can induce changes in the macromolecular structure of polymeric materials by 
chain scission, oxidation, hydrolysis, and depolymerisation, depending on the polymer’s 
nature and the used sterilization technique [148].  
Therefore, when designing n-HAp/CS hybrid materials, sterilization is an important 
procedure to consider. Given that chitosan is a thermo-sensitive material, common 
sterilization techniques, such as dry heat and steam, are not appropriate since they can cause 
thermal degradation of the material. Ethylene oxide and gamma irradiation, on the other 
hand, can affect its chemical properties; the use of ethylene oxide risks the deposition of toxic 
residues on the materials surfaces and high-energy gamma irradiation can cause material 
degradation as well [149]. In such a scenario, the use scCO2 as an innovative sterilization 
technique has recently emerged [149-156] and it appears as a promising technique to sterilize 
n-HAp/CS hybrid materials. 
 
2.8 Conclusions 
Hydroxyapatite is an outstanding material that has been proven to exhibit highly desirable 
properties for biomedical applications, mostly for bone regeneration due to its similarity with 
the mineral phase of bone. It has been combined with several polymers as an effort to 
produce materials with improved properties. Particularly, its combination with chitosan has 
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been of great interest for the production of non-load bearing bone grafts, given the possibility 
to generate materials mimicking bone composition and with improved properties, namely in 
what concerns elasticity. In addition, chitosan provides a wide list of desirable properties: it 
promotes osteoblasts adhesion and proliferation, possesses antimicrobial properties, it can be 
processed using mild conditions and can be shaped into different forms, to name some. 
Commercially available products for bone regeneration still consist, in a great extent, of 
biological grafts, either from human or animal sources. However, these grafts exhibit a list of 
concerning drawbacks, namely, high cost, risk of rejection, risk of diseases and zoonoses 
transmission, allergenic responses, etc. In what concerns synthetic materials, currently the 
market offers a variety of calcium phosphate-based products, alone or in combination with 
other components, mainly collagen. In this work, only one company commercialising calcium 
phosphate-based products containing chitosan was found, showing that, besides the many 
studies proving its suitability for tissue regeneration, HAp/CS hybrid materials have not yet 
made the leap from the laboratory to the market. 
Relative to the production of n-HAp/CS hybrid materials suitable for biomedical 
applications, a sequence of productive steps must be followed without neglecting purification 
and sterilization. Generally, a key first stage of dispersion preparation is required, in which n-
HAp is incorporated into the chitosan solution. A second stage consists in a phase 
separation/solvent elimination process in which the fixation of the final structural form takes 
place, to produce n-HAp/CS hybrid microparticles, pastes, scaffolds, cements, etc. Finally, as 
their potential applications are within the biomedical field, the produced hybrid materials 
have to be subjected to purification and sterilization processes. 
However, each of the above-mentioned stages faces challenges. The preparation of n-HAp/CS 
hybrid dispersions requires the introduction of HAp into an aqueous environment that can 
influence its solubility, surface chemistry and phase stability, affecting, at the same time, the 
HAp-nanoparticles/CS-matrix interface interactions and, therefore, the final properties of the 
material. The phase separation/solvent elimination stage determines important structural 
features of the final product, such as pore size and interconnectivity, particle size and 
morphology, and it can dictate the need for subsequent purification processes. Purification is 
a fundamental procedure that can be time consuming, ineffective and potentially alter the 
properties of the obtained n-HAp/CS hybrid materials. Sterilization is as well a key step, but 
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most common methods available today can cause thermal degradation or risks concerning the 
deposition of toxic residues on the materials surfaces. Finally, the overall process will have an 
important influence in the final product in terms of efficiency, costs, reproducibility, 
properties and versatility. It is of utmost importance from a clinical point of view to have 
ready-to-use products without requiring extra steps prior use, and materials that can be 
easily adapted into different shapes. 
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3 HAp and HAp/CS aqueous dispersions 
Nanoparticles are extraordinary systems that, due to their high surface area-to-volume ratio, 
exhibit unique properties. Their incorporation into polymeric matrices, yet challenging, has 
been of great interest aiming to produce final materials with enhanced properties relative to 
the individual components. It is expected that the large surface to volume ratio results in 
increased interfacial particle-matrix interactions, which can improve the overall properties of 
the hybrid material [1]. However, the physical mixture of inorganic particles and organic 
polymers leading to homogeneous dispersions can be a complex task. Intermolecular van der 
Waals forces between particles dominate when their sizes are below 100 nm, causing their 
agglomeration or clustering. In addition, the difficulty in controlling the mixing between two 
dissimilar phases can lead to separation in discrete phases, resulting in a product with poor 
properties [1, 2]. 
The mineral phase of natural bone consists of blade-like crystals of nanometric size, very 
similar to stoichiometric hydroxyapatite nanoparticles, well distributed throughout collagen 
fibres. In order to be able to mimic nature, it is desirable to produce highly homogeneous and 
stable n-HAp dispersions as base materials, with an intimate interaction between the 
nanoparticles and the organic component, to be further shaped into final structures that will 
serve as bone substitutes. Many methods have been used to prepare n-HAp dispersions using 
chitosan solutions as the organic component, since this combination is an interesting 
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approach for non-load-bearing bone graft applications, however, not many studies are found 
regarding the influence of chitosan on the stability of HAp nanoparticles. 
The objective of this chapter is to analyse the effects on particle size and zeta potential of n-
HAp aqueous dispersions, alone or in the presence of chitosan. Diluted nanodispersions are 
prepared by ultrasonication and the influence of different parameters, such as the presence of 
salts, n-HAp/CS weight ratio, pH, and storage time, is studied. 
 
3.1 Introduction 
Some studies [3, 4] have revealed that HAp nanoparticles, with sizes <100 nm, exhibit an 
improved performance in what concerns osteointegration, osteoblast adhesion and 
proliferation, synthesis of alkaline phosphatase and deposition of calcium containing minerals, 
when compared to HAp particles with larger sizes. Furthermore, nanoparticles are beneficial 
as drug delivery systems; particles with sizes from 10 to 100 nm are considered satisfactory to 
allow adequate blood circulation, and facilitate nanoparticles penetration through cell 
membranes, among other advantages [5]. For these reasons, the use of nano-sized HAp has 
been of great interest for biomedical applications. 
Dispersions of HAp nanoparticles, within the abovementioned size range, in an aqueous 
continuous medium, can be considered as colloidal systems; therefore, understanding the 
basic principles of colloidal science is important in order to be able to produce dispersions 
with the desired characteristics, mainly in what concerns homogeneity and stability. A 
colloidal system, by definition, comprises two or more phases, one of which, the dispersed 
phase, consists of sub-microscopic particles typically smaller than 1 µm but larger than 1 nm, 
that are suspended in a medium called the continuous phase. Colloids are commonly referred 
to as dispersions or suspensions because the particles are dispersed or suspended in the 
continuous phase [6, 7]. 
Particles in a colloidal system have a particular behaviour; they move randomly throughout 
the fluid, the continuous phase, in which they are suspended. Collisions of the particles with 
other particles, and with atoms or molecules of the fluid are the cause of such random 
movement known as Brownian motion [6, 8]. Usually, if the particle size is small enough, 
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Brownian motion dominates other surrounding effects such as gravity; however, under 
certain circumstances, the particles may stick to one another following collision, thus forming 
aggregates of growing size, and undergoing flocculation or coagulation processes that can lead 
to phase separation [9]. This event may be desirable for certain applications, namely water 
treatment, and can be induced by addition of a clarifying agent. On the contrary, as desired 
for the biomedical applications pretended in the present study, stability of the dispersion can 
be improved commonly by addition of surface-active agents, i.e. surfactants, but also by the 
presence of macromolecules or polymers [6]. 
In nature, biological colloids often exhibit good stability due to the presence of proteins, e.g. 
casein acts as a stabilizer of the fatty acid droplets in milk. Such stabilization is attained by 
different mechanisms; mainly, the macromolecule is adsorbed on the nanoparticles surface, 
surrounding it and avoiding the near approach from other particles. Furthermore, if charged, 
the adsorbed macromolecules layer enhances stability by repelling the other particles. This is 
common when polyelectrolytes are incorporated in the dispersions, either to provoke 
aggregation or as stabilizing agents [6]. 
The production of n-HAp based hybrid materials involves the dispersion of the nanoparticles 
in an organic component (chitosan for this particular study), which properties are strongly 
influenced by the shape, size and size distribution of the nanoparticles, the organic 
component properties, and the nanoparticle/organic matrix interface, among others [4]. 
Chitosan is a polyelectrolyte that can either cause aggregation or improve stability of the n-
HAp dispersions. In order to assess this and the other mentioned factors, two of the most 
important physical properties of colloidal systems to evaluate are the particle size and the 
zeta potential. These properties can be measured and analysed using different techniques 
such as dynamic light scattering (DLS) and laser diffraction spectroscopy (LD) for particle 
size, and electrophoretic light scattering (ELS) for zeta potential. 
3.1.1 Particle size 
Among the various available techniques to analyse particle size, choosing the right technique 
depends on a number of criteria, but most importantly, it depends on the size range of the 
sample. Table 3.1 presents the approximate working size ranges for commonly used 
characterization techniques; limits can slightly vary depending on the particular equipment. 
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Table 3.1. Typical working size ranges for 
commonly used characterization techniques 
(Adapted from Malvern® Instruments Ltd [10]) 
Technique Particle size range 
Dynamic Light Scattering 0.1 nm – 10 µm 
Laser Diffraction 10 nm – 10 mm 
Electrophoretic Light Scattering 1 nm – 10 µm 
 
3.1.1.1 Dynamic light scattering (DLS) 
When a particle is illuminated by a source of light, such as a laser, it scatters light in all 
directions. If a screen is held close to such particle, the scattered light will be reflected in the 
screen. In the case of many stationary particles being illuminated, the screen will then show a 
speckle pattern with dark and bright areas, as shown in Figure 3.1a, in which the bright 
areas correspond to the light scattered by the particles [8]. 
When particles are dispersed in a liquid, they are not stationary; instead, they experience 
Brownian motion. Thus, the resulting speckle pattern produced appears to move; the bright 
and dark areas grow and diminish (fluctuate) in intensity due to the constructive and 
destructive phase addition of the scattered light. Considering that small particles move 
quicker than larger ones, intensity fluctuations that happen along time in a particular point 
of the speckle pattern are directly related with particle size. Dynamic light scattering (DLS), 
also known as Photo correlation spectroscopy (PCS), is based on the measurement of the rate 
of such fluctuations and the calculation of particle size using Stokes-Einstein equation, which 
describes the relationship between particle size and its speed due to Brownian motion [8]. 
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Figure 3.1. DLS measurements: a) characteristic speckle pattern; 
(b) correlation function of small and large particles. 
(Reproduced from Malvern® Instruments Ltd 10] and Briers (2001) [11]) 
 
The rate of the fluctuations is determined using a digital correlator that measures the degree 
of similarity between speckle patterns at different instants over a period of time. The 
resulting correlation decreases with time as shown in Figure 3.1b; the intensity of the speckle 
pattern changes slowly for large particles that move slow, whereas it changes faster for small 
particles that move quickly [12]. This correlation function is used to produce a size 
distribution based on intensity, i.e. particle size is plotted as a function of the intensity of the 
scattered light. However, this intensity distribution can be converted to a size distribution in 
volume or in number. The difference between the three cases is shown in Figure 3.2. 
 
 
Figure 3.2. Comparison between DLS size distributions in number, in volume and in 
intensity 
(Reproduced from Malvern® Instruments Ltd 10]) 
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For a sample with the same amount of 5 nm-particles and 50 nm-particles, the ratio of 
relative percentage is 1:1 in the size distribution in number, but it increases to 1:1000 for the 
distribution in volume, since the volume occupied by the 50 nm-particles is 1000 larger than 
the one occupied by the same amount of particles with size of 5 nm. The ratio is even larger 
(1:1000000) for intensity distributions; using Rayleigh approximation, the intensity of 
scattering is proportional to the sixth power of the particle diameter [8]. 
Frequently, DLS results are stated in terms of Z-average, also known as cumulants mean 
since it is calculated by the method of cumulants. This value is often preferred because it is a 
mathematically stable value and insensitive to experimental noise. Cumulants analysis 
consists on a fit of a polynomial to the log of the correlation function,  [8, 13]: 
   (3.1) 
where the second order cumulant, , is the Z-average diffusion coefficient that, together 
with dispersant viscosity and other known parameters, is used to compute Z-average using 
Stokes-Einstein equation. Thus, Z-average along the so-called Polydispersity Index (PdI), a 
width parameter also provided by cumulants analysis, are reliable values to describe particle 
size. However, it must be used with caution; the Z-average is only comparable with other 
techniques for monomodal, spherical and monodispersed samples, otherwise, it can only be 
used to compare results obtained using the same technique, as long as samples are measured 
in the same dispersant and PdI values obtained are below 0.5 [8, 13]. 
Finally, for optimal DLS measurements, two important physical properties must be 
considered: particle size and sample concentration. Typical working size ranges for DLS are 
shown in Table 3.1. The adequate sample concentration, on the other hand, varies depending 
on the sample material. If concentration is too low not enough light is scattered to allow a 
measurement, whereas if the sample is too concentrated, measurement can be affected by 
multiple scattering, i.e. the light scattered by one particle is then scattered by another 
particle nearby. Furthermore, it is also important to keep in mind that concentrated 
dispersions may form a colloidal gel, since a gel is unsuitable for DLS measurements [8]. 
 G1
ln(G1) = a + bt + ct 2 + dt 3 + et 4 + ...
 b
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3.1.1.2 Laser diffraction spectroscopy (LD) 
When a stone is thrown vertically into static water, waves in the form of rings of different 
sizes are formed in the water around the stone. Large stones create stronger waves with 
shorter distance between the lobes than small ones. This is a simple analogy to describe what 
happens when a particle is hit by light; it creates a pattern of rings that are proportional to 
the size of the particle, a phenomenon called diffraction. Laser diffraction spectroscopy (LD) 
measures the intensities and distance among the rings, and relates them with particle size. 
Thus, unlike DLS, the motion of the particles is not relevant [14]. 
However, this measurement is not as simple as it seems because when light hits a particle it 
is not only diffracted, it undergoes absorption, diffraction, refraction and reflection, as shown 
in Figure 3.3. Therefore, the pattern created, named scattering pattern, is actually a result of 
the sum of all these phenomena, and its shape depends on the ratio particle size/incident 
wavelength. Depending on such ratio, the scattering pattern can adopt one of three shapes: 
Fraunhofer scattering, when the particles are much larger than the wavelength; Mie 
scattering, for particle sizes about the same as the wavelength size; and Rayleigh scattering, 
when particles are much smaller than the wavelength. This is mathematically described by 
the so-called Mie formula [14, 15]. 
Considering the above, LD uses a laser of known wavelength, as light source, that passes 
through an optical system, to widen the laser so it hits the whole sample; next, the scattered 
light is focused through a Fourier lens into a detector. The shape and intensity of scattering 
pattern are then detected and particle size is computed through software using the Mie 
formula. The lower limit of detection using this technique is about 400 nm, depending on the 
wavelength of the laser. Therefore, for samples with smaller particles, the use of Polarisation 
Intensity Differential Scattering (PIDS) technology is required. PIDS is based on the fact 
that the shape of the scattering pattern changes if the wavelength also changes; thus, the 
same sample is analysed using three different wavelengths (450 nm, 600 nm and 900 nm) to 
obtain different scattering patterns that are compared to each other. Since the scattering 
pattern also depends on light polarization, the measurement is made twice for each 
wavelength, once using vertically polarized light, and the second one using horizontally 
polarized light. The intensities of the scattered light are detected at six different angles, and 
the information gathered is related to particle size. By using different wavelengths, the 
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particle size/incident wavelength ratio changes for a specific particle size; consequently, 
differences in scattering patterns due to variations in wavelengths enables conclusions on 
particle size [14, 15]. 
 
 
Figure 3.3. Schematic representation of scattering phenomena that occurs when a particle is 
hit by light; from left to right: absorption, diffraction, refraction and reflection. 
(Reproduced from Keck (2008) [14]) 
 
3.1.2 Colloidal stability 
Colloidal stability was explained in the 1940s through a theory developed by scientists 
Derjaguin, Verwey, Landau and Overbeek (DVLO theory), which establishes that the 
stability of a particle in solution is determined by the total potential energy function, , 
which is a balance of the potential energy due to the solvent, , and the attractive, , 
and repulsive, , contributions [9]: 
   (3.2) 
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The contribution of  is usually negligible compared to the influence of  and ; hence, 
 is generally considered only as the sum of attractive Van der Waals forces and electrical 
repulsion caused by the net surface charge that particles undergo as they approach each 
other due to Brownian motion. Therefore, a colloidal system is stable when the particles have 
enough high repulsion to resist flocculation [9, 16]. 
Two primary mechanisms can affect the stability of dispersions: steric and electrostatic 
stabilization. In the first case, polymers are added to the colloidal system to adsorb onto the 
particles surface and form a coating that, when thick enough, causes particles separation by 
steric repulsions between polymer layers, thus weakening van der Waals forces and avoiding 
particles to adhere to each other. Whereas electrostatic or charge stabilization originates 
from the interaction of particles with charged species in the colloidal system [9]. 
One way of determining the stability of a colloidal system is by analysing the particles 
surface charge. Nowadays, one of the preferred techniques to characterize particles surface 
charge in colloidal systems is by measuring zeta potential. It is a simple and straightforward 
method, based on electrophoretic mobility, referred as Electrophoretic Light Scattering and 
explained next. 
Particles dispersed in an aqueous medium usually carry an electric charge. The net charge at 
the surface of the particle has an effect on the distribution of ions of the surrounding 
interfacial region, so that the concentration of ions of opposite charge to that of the particle 
increases close to the surface. Thereby, two distinctive parts can be identified in the 
surrounding interfacial region, as shown in Figure 3.4. The Stern layer comprises the ions 
closer to the particle surface that are strongly attached to it. An outer layer, called the 
diffuse layer, consists of ions whose bonding to the particle is weaker. Together, the Stern 
and diffuse layers, form the electrical double layer. A notional boundary located within the 
diffusion layer, known as slipping plane, delimits a region within which the ions form a stable 
entity with the particle. Thus, only the ions within this boundary travel with the particle 
when it moves due to external forces, namely gravity. Finally, the potential that exists in the 
slipping plane is called the zeta potential [8, 17]. 
 VS  VA  VR
 VT
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Figure 3.4. Electrical double layer 
(Reproduced from Malvern® Instruments Ltd [8]) 
 
Colloidal stability can be evaluated by measuring the zeta potential, which can be carried out 
by electrophoretic light scattering (ELS). This technique is based on electrophoresis, the 
phenomenon of the movement of charged particles relative to the suspending medium, 
induced by the application of an electric field. Viscous forces resist to the electrically induced 
movement of the particles; when equilibrium between these forces is reached, the particles 
then move at a constant velocity, known as mobility. The zeta potential is proportional to 
this electrophoretic mobility and thus can be computed using Henry’s equation [8, 9]. In 
general, it is considered that dispersions with absolute zeta potential values around 20 mV 
exhibit short-term stability, above 30 mV dispersions have good stability, and above 60 mV 
stability is excellent. Furthermore, for dispersions with combined steric and electrostatic 
stabilization, a minimum of absolute zeta potential of 20 mV is considered appropriate [16]. 
Several factors can affect the zeta potential, and the pH is the most critical. Negatively 
charged particles tend to acquire more negative charge with the addition of alkali (increase of 
pH). On the contrary, with the addition of acid (decrease of pH), particles become less 
negative until a point in which charge is neutralized, corresponding to a zeta potential of 0 
mV. This point in a plot of zeta potential versus pH is called the isoelectric point. If more 
acid is further added, particles can acquire a positive charge (see Figure 3.5) [8, 9]. 
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Figure 3.5. Typical plot of zeta potential versus pH showing isoelectric point 
(Reproduced from Malvern® Instruments Ltd [8]) 
 
3.1.3 Context and objectives of the present chapter 
The mixing method described in Chapter 2, is a simple and straightforward method, and 
thus very convenient. However, it implies the incorporation of HAp nanoparticles into an 
acidic environment that can influence HAp solubility, phase stability and surface chemistry 
[18]. Despite the numerous publications on the preparation of HAp and HAp/CS hybrid 
materials, studies regarding the influence of chitosan on HAp surface properties are 
insufficient. Wilson et al. (2007) [18] was the only report found in which HAp surface 
chemistry was studied after aging nanophase HAp particles in 0-2.5 wt.% chitosan acetate 
solutions for 30 days. After incorporation of HAp into chitosan solution, the HAp/CS 
mixtures had a pH around 4-5. The authors reported that HAp suffered changes in surface 
chemistry, colloid stability and chemical composition after long-term aging of HAp in 
chitosan acetate gel solutions. Such changes were attributed to solubility effects, since HAp 
becomes slowly soluble at pH values lower than 5. It was also found that chitosan strongly 
adsorbs to HAp particles and improves colloid stability. 
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No studies were found analysing the effects of important parameters, such as pH, on particle 
size and zeta potential of n-HAp/CS dispersions. In this work, aqueous dispersions of nano 
hydroxyapatite (n-HAp), alone or in the presence of chitosan (CS), were prepared by 
ultrasonication. The produced dispersions were analysed in what concerns particle size and 
zeta potential, then related with parameters such as pH, chitosan content, the presence of 
salts, and storage time. Particle size was determined by dynamic light scattering, for diluted 
dispersions, and by laser diffraction, for high concentration dispersions. Zeta potential was 
determined by electrophoretic light scattering. 
 
3.2 Materials and methods 
3.2.1 Materials  
The nanodispersions were prepared using chitosan 90/200/A1, acquired from Biolog-
Biotechnologie GmbH (Germany), corresponding to flakes with size <200 µm, deacetylation 
degree of 91.9%, and dynamic viscosity of 128 mPa·s (1% at 20 C in 1% acetic acid solution); 
and hydroxyapatite aqueous paste, nanoXIM-CarePaste (15% wt., Ca10(PO4)6(OH)2) 
provided by Fluidinova S.A. Glacial acetic acid, sodium acetate tri-hydrate, and sodium 
hydroxide, all of analytical grade, from Sigma Aldrich were used to prepare the solutions. 
3.2.2 Dispersions preparation by ultrasonication 
Aqueous dispersions of nano-hydroxyapatite (n-HAp), alone or in the presence of chitosan 
(CS), were prepared at concentrations 1.6 g/l, 6.4 g/l and 20 g/l, corresponding to mean free 
paths of 3.0, 1.5 and 0.70 respectively. Calculations of these concentrations are shown in 
Appendix A. 
Samples were subjected to different ultrasonication time periods at 50% amplitude, using an 
Ultrasonic Processor (Sonicator) QSonica Q700, with a maximum power output of 700 W, 
frequency output of 20 kHz and 12.5 mm diameter horn with replaceable tip (Figure 3.6). 
Special care was taken to assure that both, the geometry of the vessel and the position of the 
probe’s tip, were fixed. Geometric factors affect the amount of energy absorbed by the 
particles due to their relative position. Special emphasis was given to the production of n-
3 HAp and HAp/CS aqueous dispersions 
63 
HAp/CS dispersions with a weight ratio of 70/30 since it represents the typical bone 
composition. Finally, the pH of all prepared n-HAp/CS samples was checked to be of 
approximately 5.5 at room temperature. 
 
 
Figure 3.6. Ultrasonic Processor QSonica Q700 
used in the preparation of the HAp nanodispersions 
(Reproduced from QSonica, LLC. [19]) 
 
3.2.3 Characterization 
Particle size and zeta potential of the prepared nanodispersions were determined by dynamic 
and electrophoretic light scattering respectively, using a Zetasizer Nano ZS from Malvern 
Instruments; model ZEN 3600 with a 633 nm red laser. Temperature and pH were also 
monitored during each preparation process. 
Samples subjected to ultrasonication were analysed in what concerns the influence of the 
presence of salts (particularly KCl), n-HAp/CS mass ratio, pH, and storage time on particle 
size and zeta potential. The effect of pH on the zeta potential was studied by performing 
titrations using the MPT-2 Autotitrator, an external device connected to the Zetasizer Nano 
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ZS from Malvern Instruments. Moreover, dispersions with higher n-HAp concentration, alone 
and in the presence of chitosan, were characterized by laser diffraction spectroscopy using a 
Coulter LS-230. 
 
3.3 Results and discussion 
3.3.1 Dispersions preparation by ultrasonication 
When particles adhere to each other to form large clusters it becomes difficult to separate 
them back into primary particles. Frequently, high-energy inputs are required to break the 
clusters. In this context, ultrasonication has become a common laboratory method, used 
either for reduction of particle size or agglomeration disruption. This is achieved by 
transferring sound energy that stirs the particles; ultrasonic frequencies (>20 kHz) are 
converted to a mechanical rapid vibration that, when applied into a dispersion, causes 
cavitation, the formation and collapse of bubbles, in the liquid. A great amount of energy is 
released due to the collapse of thousands of microscopic bubbles, causing clusters disruption 
[19]. 
Energy efficiency was firstly considered in the present study. The optimal process parameters 
were determined by running experiments at fixed amplitude (50%) and varying 
ultrasonication time. Particle size was measured along pre-defined time intervals, and its 
variation with energy input is presented in Figure 3.7 and Figure 3.8. Dispersions of HAp 
alone (Figure 3.7) subjected to ultrasonication show that, for relatively low energy input 
(processing times of 10 to 30 s), large agglomerates were completely broken down into 
smaller ones. Zeta potential data exhibited low variability for all the examined samples, with 
values comprised between +27 and +30 mV (9.0 < pH < 10.0). 
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Figure 3.7. Z-average (filled circle) and energy loss (white square) versus ultrasonication time 
of nanodispersions of HAp alone of concentrations: (a) 1.6 g/l; (b) 6.4 g/l; (c) 20 g/l. 
All measurements show standard deviation (SD) based on 3 replicas 
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A logarithmic tendency of the z-average to decrease with ultrasonication time was also 
observed for the n-HAp/CS dispersions (Figure 3.8). However, larger particle sizes were 
detected, suggesting that HAp nanoparticles remain as clusters when dispersed in chitosan 
solutions, but with increased zeta potential that remained nearly constant at values 
comprised between +32 to +34 mV (pH 5.5). Generally, if a dispersion is not stabilized, by 
electrostatic, steric, or electrosteric effects, nanoparticles tend to cluster again shortly after 
ultrasonication. Stabilization through electrosteric effects can be achieved by addition of a 
polyelectrolyte [20]. Therefore, the observed increase of zeta potential observed in the n-
HAp/CS dispersions, relative to dispersions of n-HAp alone, may be due to electrosteric 
effects imparted by chitosan. It was also observed that the z-average of the agglomerates 
increases as the n-HAp concentration increases. Measurements of n-HAp/CS dispersions with 
a concentration of 20 g/l were unsuitable for DLS. 
Furthermore, the results obtained from the energy balance for both, n-HAp alone and n-
HAp/CS samples, within the studied range of concentrations, point out that energy loss as 
heat form increases linearly with ultrasonication time, reaching values around 25 to 30 J/g at 
100 s of ultrasonication, the higher time tested. Considering this and the tendency of particle 
size to decrease with increasing ultrasonication times, an energy input of approximately 50 
J/g (approximately 30% of energy loss), corresponding to 50 s of ultrasonication time at 50% 
amplitude, is considered optimal since higher ultrasonication times do not significantly affect 
HAp particle size. 
Dispersions with the lowest concentration ( ) are considered more suitable for 
DLS measurements. Therefore, the study of the effects of the presence of salts (particularly 
KCl), n-HAp/CS mass ratio, pH, and storage time were carried out for nanodispersions with 
, and subjected to ultrasonication time of 50 s (50% amplitude), corresponding 
to the optimal energy input. 
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Figure 3.8. Z-average (filled circle) and energy loss (white square) versus ultrasonication time 
of n-HAp/CS dispersions of concentrations: (a) 1.6 g/l; (b) 6.4 g/l. 
All measurements show SD based on 3 replicas 
 
3.3.2 Effect of KCl on particle size and zeta potential 
Surface charge of particles is strongly influenced by the presence of ions in the surrounding 
medium. Particularly, in aqueous medium there is a large content of ions usually resulting 
from the addition of ionic surfactants and electrolytes, namely acids, bases or salts [6]. 
Consequently, the ionic content of the aqueous medium strongly influences the surface charge 
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of particles that affects the electrostatic stability of the dispersion. Moreover, the presence of 
salts has an effect on the ionic strength of the medium, influencing the charge of certain 
polysaccharides, and consequently the polymer chain conformation [21] and, subsequently, 
the interfacial interactions with the particles that influences particle size and zeta potential, 
and the overall properties of the final hybrid material. 
Given that the hydroxyapatite paste used for the preparation of the nanodispersions, 
nanoXIM-CarePaste, contains KCl in its formulation, the influence of this salt on particle 
size and zeta potential was evaluated. For that, n-HAp dispersions, both alone and in the 
presence of chitosan, were prepared using the nanoXIM-CarePaste after being washed three 
times with deionized water. In parallel, dispersions containing nanoXIM-CarePaste with KCl, 
as originally provided, were also prepared and characterized. Particle size distributions (PDS) 
in number obtained for n-HAp dispersions alone and in the presence of chitosan, with and 
without KCl, are shown in Figure 3.9. Monodispersed distributions were obtained in all cases, 
and no considerable differences were observed in terms of size due to the existence of KCl. 
Therefore, particle size increase is caused by the presence of chitosan and no evidence was 
found that KCl has an effect on the particle size of n-HAp dispersions. 
While no important effect was observed in particle size due to the presence of KCl, its 
presence appears to influence the electrostatic stability of the dispersions. Zeta potential 
values of n-HAp alone and n-HAp/CS dispersions are shown in Table 3.2. HAp nanoparticles 
dispersed in water present higher zeta potential values (>+30 mV) in the presence of KCl, 
which indicates that this salt alone improves the stability of the n-HAp dispersions. However, 
the behaviour appears to be different for the hybrid dispersions, the higher zeta potential 
values obtained corresponded to the n-HAp/CS dispersions without KCl, which indicates 
that the stabilizing effect of chitosan is better without the interference of salts. In the case of 
n-HAp/CS dispersions with KCl, a good zeta potential value (+32,8 mV) was obtained as 
well, but smaller compared with n-HAp/CS without KCl (+33,7 mV). The differences 
observed could be attributed to different interactions between salt ions with the n-HAp 
particles surface and with chitosan chains, which carry a positive charge in solution. 
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Figure 3.9. Particle size distributions in number for dispersions prepared with washed 
nanoXIM-CarePaste (without KCl) and with nanoXIM-CarePaste as originally provided 
(with KCl): (a) n-HAp alone and (b) n-HAp/CS 
 
Table 3.2. Zeta potential values of dispersions of n-HAp 
prepared with washed nanoXIM-CarePaste (without KCl); 
and with nanoXIM-CarePaste as originally provided (with KCl) 
Sample 
Zeta potential 
(mV) SD 
HAp without KCl +24,1 0,6 
HAp with KCl +31,2 0,3 
HAp/CS without KCl +33,7 0,2 
HAp/CS with KCl +32,8 0,2 
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3.3.3 Effect of chitosan concentration on particle size and zeta potential 
As discussed before, larger particle sizes are obtained when HAp nanoparticles are dispersed 
in the presence of chitosan and, as observed in Figure 3.10, a linear tendency of particle size 
to increase with chitosan content was obtained. In terms of zeta potential, as soon as 
chitosan is incorporated into the n-HAp dispersions, the zeta potential increases to values 
above +30 mV, showing a linear tendency to increase with chitosan content as well. 
 
 
Figure 3.10 Effect of chitosan content on n-HAp dispersions on: 
(a) Particle size; (b) Zeta Potential 
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Being a polyelectrolyte, chitosan can cause an electrosteric stabilizing effect in the 
nanodispersions. Consequently, the stabilization is probably caused by both, steric and 
electrostatic mechanisms. Thus, the incorporation of chitosan onto n-HAp particles forms a 
coating that causes stabilization by steric repulsions; with the increase in chitosan content 
the coating gets thicker, which may also influence the observed increase in particle size. At 
the same time, charge stabilization also takes place due to the positive charges in chitosan, 
which cause a linear increase in zeta potential with chitosan content. Therefore, even when 
the presence of chitosan in n-HAp dispersions causes the increase in particle size by particle 
aggregation, it improves the stability of the dispersions, which is a desirable characteristic. 
 
3.3.4 Effect of pH on zeta potential 
The surface charge of particles dispersed in aqueous media depends upon the nature of the 
particle and the surrounding medium. In this context, ionization of surface groups and 
adsorption of charged particles are the two most important mechanisms defining surface 
charge of colloidal particles. In the first case, a surface with alkaline groups, for instance, will 
give rise to a positive charge, as shown in Figure 3.11a, which magnitude depends on the 
alkaline strength of the surface groups and on the pH of the liquid medium. Typically, by 
increasing the pH, surface ionization of positively charged particles is suppressed until the 
surface charge is reduced to zero. The opposite behaviour takes place in the case of particles 
with acid groups in the surface. In the second mechanism, shown in Figure 3.11b, charged 
species, namely ions and ionic surfactants, specifically adsorb on the particle surface leading 
to a positively charged surface in the case of cationic species, or negatively charged if 
adsorption of anionic species occurs [9]. 
In the case of ionic solids, such as hydroxyapatite, the origin of surface charge is somewhat 
more complex. The mechanism involved consists in differential ion dissolution from a crystal 
lattice, i.e. the net charge of n-HAp particles in aqueous medium arises from the unequal 
dissolution of surface ions and may result in either a net positive or a net negative surface 
charge [22]. This mechanism is, as one would expect, highly dependent on the medium pH. 
The development of the particle surface net charge affects the ions distribution in the 
surrounding interfacial region and, consequently, the zeta potential [9]. 
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Figure 3.11. Origin of surface charge by: (a) ionization of alkaline groups; 
and (b) adsorption of cationic species 
(Reproduced from Malvern® Instruments Ltda [9]) 
 
Figure 3.12 shows the results obtained from the autotitrations of dispersions of n-HAp alone (in 
water) and in the presence of chitosan. In alkaline medium (pH 9.0) dispersions of n-HAp alone 
exhibit good electrostatic stability, with a zeta potential value of around +29 mV. However, as 
the pH decreases, a tendency of zeta potential to decrease is observed, as shown in Figure 3.12a. 
With the incorporation of chitosan in the nanodispersions, on the other hand, a high zeta 
potential (>+30 mV) is obtained at low pH values (pH 5.5) and, oppose to what happens with 
dispersions of n-HAp alone, a linear tendency of zeta potential to decrease with the increase of pH 
is observed, as shown in Figure 3.12b. 
The zeta potential tendency obtained for dispersions of n-HAp alone are attributed mainly to 
variations on pH that causes changes on surface charge by differential ion dissolution mechanism. 
Whereas for the n-HAp/CS dispersions, the mechanism of charged species also takes place, since 
chitosan acquires positive charges at pH<6.5. Thus, in slightly acidic environment (pH 5.5) the 
electrostatic stability of n-HAp particles dispersed in water is poor, with zeta potential between 
+10 and +15 mV, but with the incorporation of chitosan it improves considerably reaching zeta 
potential values >+30 mV. 
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Figure 3.12. Zeta potential dependency on pH for aqueous nanodispersions of: 
(a) n-HAp dispersions alone using CH3COOH 0.20 M (1 wt.%) as titrant; and (b) n-HAp/CS 
dispersions using NaOH 0.25 M as titrant 
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3.3.5 Effect of storage time 
The electrostatic stability of n-HAp/CS dispersions was further studied by measuring zeta 
potential along time. The analysed dispersion, with  and pH ~5.5, was prepared 
using the optimized process conditions, ultrasonication time of 50 s (50% amplitude), and 
store in a refrigerator at 4 ºC. The zeta potential was measured at times ranging from 0, 
right after ultrasonication, to 30 days. Results in Figure 3.13 show that the zeta potential 
values were fairly constant along the time period analysed, ranging between +36 and +42 
mV. This suggests that the prepared n-HAp/CS dispersions exhibit good electrostatic 
stability and that this behaviour is kept along time. 
 
 
Figure 3.13. Effect of storage time on zeta potential 
 
3.3.6 Characterization of n-HAp aqueous dispersions with higher concentration 
Previously, diluted dispersions of n-HAp, with , were prepared and 
characterised to study the influence of different parameters on particle size and zeta 
potential. However, properties of colloidal systems may change as a function of 
concentration. Having in view the potential commercialization of n-HAp/CS products, the 
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production of hybrid dispersions with concentrations higher than  is desirable. 
Therefore, n-HAp/CS dispersions with concentration  were prepared and, since it 
was determined that such dispersions were unsuitable for DLS, particle size distributions 
(PDS) in volume were obtained by laser diffraction, both for n-HAp dispersions alone and in 
the presence of chitosan. Results obtained are shown in Figure 3.14. It is important to 
highlight that the obtained results in this section are not intended for comparison with 
previous results obtained by DLS, but only to evaluate particle size of n-HAp dispersions at 
higher concentrations. 
 
Figure 3.14. Particle size distributions in volume by laser diffraction 
for n-HAp dispersions with concentrations of 20 g/l: 
(a) n-HAp alone; (b) n-HAp/CS dispersions 
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It is observed that HAp nanoparticles form aggregates at this concentration level, 
, both for n-HAp dispersions alone and in the presence of chitosan. Furthermore, 
the agglomerates formed are larger in the presence of chitosan, in accordance with results 
previously discussed. Aggregation is caused by the collision and subsequent adhesion of 
particles. Collision of particles is mainly due to their Brownian motion, thus, the flow regime 
and the effects of external fields predominantly govern it. In addition, particle collisions are 
affected by the double layer interactions, which determine the repulsive forces. Finally, 
particle concentration is the third factor affecting particle aggregation since collisions 
frequency increases with particle concentration [23]. Therefore, the increase in particle size 
obtained for both types of n-HAp dispersions can be attributed to the increase in particles 
collision frequency, and the differences observed due to the incorporation of chitosan are 
probably related mainly to differences in the flow regime. However, even at high 
concentrations, n-HAp dispersions in the presence of chitosan showed improved electrostatic 
stability with zeta potential values >+30 mV (pH ~5.5). 
 
3.4 Conclusions 
Aqueous dispersions of n-HAp alone and in the presence of chitosan were prepared by 
ultrasonication and new insights on charge stability and particle size were explored. The 
study was carried out by preparing the dispersions using an optimum energy input of 
approximately 50 J/g of sample, corresponding to 50 % amplitude and 50 s of ultrasonication 
time. The Z-average presented low variability for ultrasonication times of 50 s and higher, 
showing that the breakup of agglomerates does not improve with longer processing times, 
and even there was a risk of re-agglomeration if long ultrasonication (processing times 
>100 s) are used. This was confirmed by the energy balance study. 
The presence of KCl was analysed and, although no considerable influence on particle size 
was observed, it appears to improve the zeta potential of n-HAp dispersed in water, whereas 
in the presence of chitosan, the higher zeta potential values were obtained for the n-HAp/CS 
dispersions without KCl, indicating that the stabilizing effect of chitosan is better without 
the interference of salts. Furthermore, measurements carried out at different n-HAp/CS 
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weight ratios indicated that the zeta potential increases linearly with the increase of chitosan 
content. 
It was also found that pH greatly influences the zeta potential of n-HAp dispersions. Zeta 
potential decreases with the increase of acidity in the dispersions of n-HAp alone, whereas 
the opposite behaviour is observed in the presence of chitosan. Thus, in slightly acidic 
environment (pH~5.5), the presence of chitosan greatly improves the electrostatic stability of 
n-HAp dispersions, exhibiting zeta potential values >+30 mV. Such zeta potential values 
remain nearly constant along time. 
Finally, higher concentrations of n-HAp particles result in the formation of aggregates, as 
expected. However, it has been proven that chitosan acts as a stabilizer in aqueous 
dispersions of HAp nanoparticles, even when its presence promotes particle agglomeration 
(higher particle sizes were observed).  
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4 Production of nano-hydroxyapatite/chitosan (n-
HAp/CS) hybrid microparticles 
This chapter is based on the published scientific article: 
Ruphuy, G. et al. Spray drying as a viable process to produce nano-hydroxyapatite/chitosan 
(n-HAp/CS) hybrid microparticles mimicking bone composition, Advanced Powder 
Technology 27, 575-583 (2016). Doi:10.1016/j.apt.2016.02.010 [1] 
In this work nano-hydroxyapatite/chitosan (n-HAp/CS) hybrid microparticles were prepared 
by spray drying following a methodology where, in a first step, aqueous nanodispersions of n-
HAp in the presence of chitosan were produced by fast stirring at pH values below and above 
chitosan pKa (5.5 and 7.0, respectively). The mixing system used allowed the production of 
homogeneous and stable nanodispersions, and the subsequent spray-dried microparticles, 
incorporating highly pure HAp nanoparticles of approximately 50 nm, were successfully 
produced without degrading the organic component, chitosan. Comparatively with the n-
HAp/CS-7.0, the n-HAp/CS-5.5 dispersions were characterized by a lower particle size and a 
higher zeta potential, being then more stable. Differences in the spray-dried microparticles 
were also evident from a morphological point of view. The n-HApCS-5.5 microparticles, 
which present an average size in volume of 15.8 µm and n-HAp crystals homogenously 
distributed, were found to be preferred over the n-HApCS-7.0 counterparts, which require an 
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extra step in the productive process and presented a tendency to form large agglomerates. 
Both prepared hybrid particles presented similar composition to that one of natural bone 
(HAp/CS of 70/30) and no traces of KCl salts were observed if a washed n-HAp paste was 
used. 
 
4.1 Introduction 
The combination of HAp with chitosan for bone tissue engineering applications is typically 
based in the production of porous scaffolds [2-4]; nonetheless, advances in science and 
technology have led to the development of particulate materials that, thanks to their reduced 
size, can be suitable as injectable systems or shaped into a solid substrate with increased 
surface area that will promote chemical and biological reactions [5-7]. In this context, the 
development of a particulate system containing n-HAp in a micrometer-sized matrix is 
advantageous; this approach allows HAp's superior properties at the nanoscale to be 
preserved in the form of microparticles that are easier to handle [8]. 
Among the existing techniques, spray drying appears as a promising technology for the 
manufacturing of microparticles with controllable size and morphology [9]. It is a process 
widely used as a microencapsulation/stabilization technique in the food [10, 11] and 
pharmaceutical [12, 13] industries. Easy industrialization, cost-effectiveness and continuous 
production are attractive features of this technique; however, special care must be taken with 
heat-sensitive materials, since prolonged contact with high temperatures can cause product 
degradation [14]. This method is based in the drying of atomized droplets of a previously 
prepared solution or emulsion/dispersion using a co-current stream of hot gas (see Figure 
4.1). In the case of the process developed here, the first step comprises the preparation of 
HAp/CS nanodispersions. 
One of the most common established methods used to prepare HAp/CS hybrid dispersions 
consists in simply mixing previously prepared HAp microparticles, usually as a powder, into 
a chitosan solution. This technique can lead to non-homogenous dispersions at a microscopic 
level, due to the difficulty in controlling the mixing between two dissimilar phases that can 
lead to phase separation. In efforts to overcome such problem, an adequate incorporation of 
HAp into the chitosan solution has been reported [15, 16] by using the so-called co-
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precipitation method; nevertheless, this method implies the synthesis of HAp in the presence 
of chitosan, which hinders the formation of HAp particles with high purity and desired 
morphology. 
Another important parameter to consider when preparing n-HAp/CS hybrid dispersions is 
pH, especially if HAp has to be introduced into an acidic environment that can influence its 
solubility, chemistry and phase stability [17]. Due to the amino-groups protonation character 
, chitosan net charge can change with pH thus influencing solubility and 
reactivity. With a pKa value around 6.5, chitosan is insoluble in neutral and alkaline pH 
solutions, but it is soluble in aqueous acidic medium, allowing it to be processed under mild 
conditions [18, 19]. In the simple mixing method, HAp is often introduced in an acidic 
chitosan solution, resulting in dispersions with pH typically around 4-5. In the case of the co-
precipitation method, the combination of both components is carried out in a neutral or basic 
environment (pH ≥ 7), causing the precipitation of chitosan along with HAp simultaneously. 
 
 
Figure 4.1. Schematic representation of the spray-drying process 
(Reproduced from BÜCHI Labortechnik AG [20]) 
 
To the best of our knowledge, before this work, the only one reporting the production of 
HAp/CS microparticles by spray drying was the one of Başargan et al. (2015) [21]. In the 
approach used by the authors, a HAp/CS-slurry using the co-precipitation method (pH ≥ 
9.0) was prepared, followed by spray drying. The effect of inlet temperatures (120 ºC and 160 
NH
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3
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ºC) and different HAp/CS weight ratios was studied. Spherical microparticles of mean size 4-
6 µm were produced, and an increase in the surface area with the addition of chitosan, as 
well as with the highest inlet temperature, were observed. However, the FTIR analysis 
suggested the substitution of carbonate in the apatite structures, compromising the purity of 
HAp. Thermal degradation studies were not reported. Other methods that have been 
explored to produce HAp/CS microparticles are: water-in-oil (W/O) emulsion [22]; 
supercritical assisted atomization [23], spray-coagulation [24], electro-spray coagulation [25], 
and dispersion polymerization [26]. 
In this work, n-HAp/CS microparticles mimicking bone composition, and containing highly 
pure HAp nanoparticles, were produced in a two-stage process. First, homogeneous and 
stable n-HAp/CS dispersions were produced using an innovative fast stirring set-up. With 
the aim of analysing the effect of pH on the final products, the dispersions were produced at 
two different pH values, right above and below the chitosan pKa. For the case of pH below 
chitosan pKa, special care was taken to assure pH values higher than 5.0 to avoid 
solubilisation of HAp. In a second step, hybrid microparticles were produced from the n-
HAp/CS dispersions by spray drying. The effect of KCl content was also studied, since this 
salt is present in the original HAp paste used. 
The n-HAp/CS nanodispersions were characterized by measuring particle size and zeta 
potential by static and electrophoretic light scattering methods, respectively. The produced 
microparticles were characterized by scanning electron microscopy (SEM) coupled with 
energy-dispersive X-ray spectroscopy (EDS), thermogravimetry (TG/DTG) and differential 
scanning calorimetry (DSC). In order to infer the effect of spray-drying conditions on 
material degradation, freeze-dried samples were also produced and characterized. 
4.2 Materials and methods 
4.2.1 Materials  
The n-HAp/CS dispersions were prepared by using the chitosan brand 90/200/A1 from 
Biolog-Biotechnologie GmbH (Germany), composed of flakes with size <200 µm, with a 
deacetylation degree of 91.9%, and dynamic viscosity of 128 mPa·s (1% at 20ºC in 1% acetic 
acid solution). The hydroxyapatite aqueous paste used, nanoXIM-CarePaste, was supplied 
by Fluidinova S.A. It is composed of 15.5 ± 0.5 wt%. of HAp nanoparticles with particle size 
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<50 nm, 4.5 ± 0.5 wt%. KCl and a water content ≤ 81.0 wt%. Acetic acid, sodium 
hydroxide and sodium acetate tri-hydrate of analytical grade from Sigma Aldrich were used 
to prepare the solutions. 
4.2.2 Dispersions preparation 
Aqueous nanodispersions of HAp in the presence of chitosan, with a HAp concentration of 20 
g/l, were prepared by using a high speed dispersing and homogenizing device Miccra D-9 at 
speed rate of 11 000 rpm. The mixing system was designed such that the HAp paste was 
injected into the chitosan solution inside the vessel right below the dispersing tip, as shown 
in Figure 4.2. The mixing time using a pump rate of 240 rpm (32 ml/min) was estimated to 
be less than 100 ms. A detailed description of the mixing time estimation is presented in 
Appendix B. All n-HAp/CS nanodispersions were prepared with a HAp-to-chitosan weight 
ratio of 70/30, since this ratio represents the typical bone composition in terms of 
inorganic/organic balance. 
Two different pH values were considered, one lower and one higher than the chitosan pKa 
(5.5 and 7.0, respectively). For the preparation of the nanodispersion with lower pH, labelled 
as “n-HApCS-5.5”, a pre-mixed solution prepared by adding a chitosan solution (3.0%, w/v) 
with an acetate buffer of pH = 5.5 was added to the reactor vessel, followed by the injection 
of the HAp paste (15%, w/w) continuously at a pump rate of 240 rpm into the chitosan 
solution. The sample with higher pH, labelled “n-HApCS-7.0”, was prepared following the 
same procedure but with an extra final step consisting in the dropwise addition of NaOH 1M 
under fast stirring until neutralization. 
For comparative purposes, analogous n-HAp/CS dispersions, with HAp concentration of 20 
g/l and final pH 5.5 (room temperature), were prepared by ultrasonication using the 
optimum energy input determined in Chapter 3. Briefly, the sample was subjected to an 
energy input of 50 J/g of sample, using an Ultrasonic Processor (Sonicator) QSonica Q700 at 
50% amplitude, with a maximum power output of 700 W, frequency output of 20 kHz and 
12.5 mm diameter horn with replaceable tip. The produced nanodispersion, labelled “n-
HApCS-5.5-ultrasonication”, was characterized in terms of particle size and zeta potential, 
and a comparative analysis was carried out relative to the analogous n-HApCS-5.5 sample 
obtained by fast stirring as previously described. 
4 Production of nano-hydroxyapatite/chitosan (n-HAp/CS) hybrid microparticles 
86 
The nanoXIM-CarePaste used in this work contains 4.5 wt%. KCl. In order to study the 
effect of KCl presence on the stability of the produced nanodispersions and morphology of 
the final microparticles, samples were obtained both with the original, unwashed paste and 
with a paste that was subjected to a washing process with water 3 times to remove the salt. 
The potassium content of the washed paste was found to be 15.0 ± 0.9 ppm, determined by 
Atomic Absorption Spectroscopy (AAS). 
 
 
Figure 4.2. Experimental setup used to prepare the n-HAp/CS nanodispersions: (1) Beaker 
containing the n-HAp, nanoXIM-CarePaste, under stirring; (2) peristaltic pump; (3) tubing; 
(4) vessel containing the chitosan solution and buffer; (5) ultraturrax. 
 
4.2.3 Microparticles preparation 
The n-HAp/CS hybrid microparticles were prepared by spray-drying a volume of 150 ml of 
the prepared dispersions. The used apparatus was a Mini Spray Dryer B-290 from Büchi 
equipped with a nozzle of 0.7 mm of diameter and the operating conditions were: inlet 
temperature of 170ºC; aspiration at 100%; spray gas flow at 30% (approximately 6 L/min); 
and pump rate at 15% (4.5 ml/min). The spray-drying yield was estimated as the ratio 
between the weight of the recovered powder and the initially used weight of solids of the 
atomized nanodispersions. 
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4.2.4 Preparation of freeze-dried samples 
In order to infer the effect of spray-drying conditions on the micro particles’ thermal 
degradation, samples prepared by direct freeze-drying of the obtained dispersions were 
produced. For that, 10 ml of each sample were firstly congealed by storing in a freezer for 
about 24 h followed by freeze-drying in a VirTis BenchTop 6K Freeze Dryer (model 
nº6KBTEL) during 48 h. 
4.2.5 Characterization of dispersions 
Particle size of the obtained dispersions, n-HApCS-5.5 and n-HApCS-7.0, was determined by 
using a Mastersizer 3000 laser diffraction analyser from Malvern Instruments. Dispersions 
stability was studied by electrophoretic light scattering using the Zetasizer Nano ZS from 
Malvern Instrument. The effect of pH on zeta potential was studied using the same 
equipment, Zetasizer Nano ZS, coupled with a MPT-2 Autotitrator using NaOH (0.25 M) as 
the titrant solution. 
4.2.6 Characterization of microparticles 
Morphology of the spray-dried microparticles was inspected by scanning electron microscopy 
(SEM) coupled with Energy-dispersive X-ray spectroscopy (EDS) by using a Phenom Pro 
microscope from Phenom World. High resolution images were obtained by High resolution 
(Schottky) Environmental Scanning Electron Microscope with X-Ray Microanalysis and 
Backscattered Electron Diffraction Pattern Analysis (FEG-ESEM/EDS/EBSD) using a FEI 
Quanta 400 FEG ESEM / EDAX Genesis X4M. 
FT-IR spectra were recorded in a FT-IR BOMEN (model MB 104) in transmittance mode by 
using the KBr pellet technique at a concentration of about 1% (w/w). Scanning was carried 
out between 500 and 4000 cm-1 at a resolution of 4 cm-1 and co-adding sixty-four scans. The 
characterization of the n-HApCS-5.5 and n-HApCS-7.0 microparticles was achieved by 
analogy with the spectra of HAp and chitosan standard samples. Thermal characterization 
was obtained by thermogravimetry (TG) using a TG 209 F3 Tarsus® and differential 
scanning calorimetry (DSC) using a DSC 200 F3 Maia. The reproducibility of the 
experimental procedure was checked based on 3 replicas. 
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4.3 Results and discussion 
4.3.1 Preparation and characterization of the hybrid dispersions 
Particle size distributions in volume obtained for the n-HAp/CS dispersions prepared by fast 
stirring and ultrasonication are presented in Figure 4.3. In accordance with the results 
discussed in Chapter 3, HAp nanoparticles form aggregates in the presence of chitosan at the 
studied concentration, , but with zeta potential values larger than +30 mV. 
Small differences are observed in terms of particle size depending on the mixing device used. 
When comparing n-HAp/CS dispersions produced at the same pH (5.5), the nanodispersion 
prepared by fast stirring (n-HApCS-5.5 sample) exhibited slightly smaller particle sizes than 
the n-HApCS-5.5-ultrasonication sample. However, no considerable differences in zeta 
potential are observed, as shown in Figure 4.4; for different storage times, a good 
electrostatic stability, with zeta potential values between +36 mV and +42 mV, was 
obtained for both samples with pH 5.5, independently of the used mixing device, either 
ultraturrax (fast stirring) or ultrasonicator. 
 
 
Figure 4.3. Particle size distributions in volume of the n-HApCS-5.5 sample prepared by fast 
stirring, and of the n-HApCS-5.5-ultrasonication sample. 
C
HAp
= 20 g/l
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Figure 4.4. Zeta potential measured at different storage times for: (a) n-HApCS-5.5 sample 
prepared by fast stirring; and (b) n-HApCS-5.5-ultrasonication sample 
(For both samples, pH 5.5 at room temperature) 
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In addition, energy efficiency was considered. The n-HApCS-5.5-ultrasonication sample was 
prepared using an optimum energy input of 50 J/g of sample, which is notably higher than 
the energy input obtained for the fast stirring device, estimated in less than 2.1 J/g of sample 
(see Appendix B). Therefore, the fast stirring set up used is energetically more efficient than 
ultrasonication, allowing the production of n-HAp/CS dispersions with smaller particle sizes, 
and similar zeta potential values if compared with the n-HApCS-5.5-ultrasonication sample. 
Relative to the presence of KCl, Table 4.1 shows the number mean particle size and zeta 
potential values obtained for the n-HAp dispersions produced at pH of 5.5, alone and in the 
presence of chitosan, both with and without KCl. Monodispersed distributions were obtained 
in all cases, with larger particle sizes for the hybrid ones when compared with the n-HAp 
alone, but with no significant differences derived from the presence of KCl. In terms of 
charge stability, the n-HAp dispersions containing KCl presented higher zeta potential values 
(>30 mV), which indicate that the salt improves the stability of the n-HAp dispersion. In the 
case of n-HApCS-5.5 dispersions with KCl a good zeta potential value (>30 mV) was 
obtained, but an even higher zeta potential value was obtained for the n-HApCS-5.5 sample 
without KCl, which shows that chitosan also acts as an effective stabilizer besides providing 
the aforementioned list of desirable properties for bone repair and regeneration. 
 
Table 4.1. Zeta potential and number mean particle size values 
obtained for nanodispersions of n-HAp with and without KCl 
Sample 
Zeta potential 
(mV) 
Number mean 
(nm) 
n-HAp-5.5 without KCl 24.1 ± 0.6 43.0 ± 3.1 
n-HAp-5.5 with KCl 31.2 ± 0.3 42.7 ± 4.8 
n-HApCS-5.5 without KCl 33.7 ± 0.2 198 ± 25 
n-HApCS-5.5 with KCl 32.8 ± 0.2 222 ± 20 
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Particle sizes obtained by laser diffraction for samples n-HApCS-5.5 and n-HApCS-7.0 are 
summarized in Table 4.2; n-HAp/CS nanodispersions prepared at pH 5.5 presented a Dv50 of 
28.4 µm, while the ones produced at higher pH (7.0) presented a Dv50 of 72.2 µm suggesting 
not only that HAp nanoparticles remain as clusters when dispersed in chitosan solutions, but 
also that the higher-pH condition produces larger clusters. Relative to zeta potential 
measurements, nanodispersions of n-HAp alone with an initial pH of approximately 9.0 and a 
zeta potential of +29 mV, showed a tendency of zeta potential to decrease as the pH 
decreases (see Figure 4.5). However, with the use of chitosan, a high zeta potential was 
obtained even at low pH values and, in contrast to what happens with n-HAp alone, a linear 
tendency of zeta potential to decrease with the increase of pH is observed (Figure 4.5). 
 
Table 4.2. Particle size percentiles obtained for n-HApCS-5.5 and n-
HApCS-7.0 samples from laser diffraction measurements 
Sample Dv10 Dv50 Dv90 
n-HApCS-5.5 14.8 28.4 50.2 
n-HApCS-7.0 23.5 72.2 165 
 
4.3.2 Characterization of the n-HAp/CS hybrid microparticles 
Nano-hydroxyapatite/chitosan hybrid microparticles were successfully produced by spray 
drying with average yields of 62 and 52% for the n-HApCS-5.5 and n-HApCS-7.0 samples, 
respectively. Figure 4.6 shows SEM images of microparticles obtained with the unwashed, i.e. 
with KCl, HAp paste. The formation of mushroom and doughnut-like microparticles was 
observed for the n-HApCS-5.5 sample. This type of morphology is ruled by hydrodynamics, 
both in- and outside the droplet, causing a droplet-transformation phenomenon going from a 
spherical to mushroom-like, to a final doughnut shape, as described by some authors [9, 27]. 
When compared to analogous spherical microparticles, studies have found that particles with 
torus geometry (doughnut) present advantages such as a higher stability for long-term 
storage in an aqueous environment and after undergoing processes such as freeze-drying [28]. 
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Figure 4.5. Zeta potential evolution with changing pH for: 
(a) n-HAp dispersion (CH3COOH 0.25 M as titrant); 
and (b) n-HAp/CS nanodispersion (NaOH 0.25 and 1 M solutions as titrants) 
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Figure 4.6. High-resolution SEM images of n-HAp/CS microparticles 
obtained with unwashed HAp paste (i.e. with KCl): 
(a) n-HApCS-5.5 microparticles; (b) n-HApCS-7.0 microparticles 
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The n-HApCS-7.0 derived powder, on the other hand, presents better-defined spherical shape 
with spikes on the surface (see Figure 4.7). The maximum structural stability of spheres is 
the main reason why this shape is typically produced by spray drying. Drying temperature 
and velocity of the carrier gas are the main parameters influencing hydrodynamics of the 
droplets, but variables such as viscosity, density and concentration of the dispersions, as well 
as size of the nanoparticles are also fundamental factors influencing the final morphology of 
the microparticles [9, 27]. 
 
 
Figure 4.7. Elemental mapping by EDS of HAp/CS microparticles obtained with unwashed, 
with KCl, HAp paste, Cl is shown in green and K is shown in blue. 
 
Elemental mapping by EDS (Figure 4.7) allowed the identification of the spikes observed in 
the n-HApCS-7.0 microparticles as KCl microcrystals. The salt was also detected in the n-
HApCS-5.5 microparticles, even the crystals were significantly smaller and presented quite 
distinct morphology. As it is desired to produce microparticles with high purity, containing 
mainly HAp and chitosan, KCl appears as a contaminant in large quantities as seen in the 
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SEM images. In addition, it was proven that it has no beneficial effect on the stability of the 
n-HAp/CS dispersions and it could eventually create a hypertonic environment that could 
cause an inhibitory effect on cells metabolism [29].  
High-resolution images of the microparticles produced from the nanodispersions prepared 
with the washed HAp paste are shown in Figure 4.8 and Figure 4.9. The n-HApCS-7.0 
microparticles (Figure 4.9) seem to have a tendency to form strong agglomerates; this 
phenomenon is not observed in the case of the n-HApCS-5.5 microparticles (Figure 4.8). No 
traces of KCl salts were detected by EDS, and HAp rod-like particles of nanometer sizes can 
be observed at the surface of the microparticles, for both samples. The n-HApCS-5.5 
microparticles present a rough surface that can be beneficial for biomedical applications, 
since it has been proven non-smooth surfaces can enhance cell adhesion and proliferation [30]. 
Particle sizes of the microparticles were obtained by image analysis; very similar number 
mean values, corresponding to 6.83 µm and 6.67 µm for n-HApCS-5.5 and n-HApCS-7.0 
respectively, were obtained for both samples. In terms of Dv50, n-HApCS-7.0 sample 
presented a slightly smaller value of 12.4 µm based on the circle equivalent diameter of 1493 
particles, compared to a Dv50 of 15.6 µm for the n-HApCS-5.5 sample based on the circle 
equivalent diameter of 1072 particles. These results suggest that n-HApCS-5.5 presented a 
few particles with larger sizes when compared to n-HApCS-7.0 sample, but also large amount 
of particles with small sizes. It is important to point out as well that n-HApCS-7.0 
microparticles formed agglomerates of up to approximately 170 µm. 
The IR spectra of n-HApCS-5.5 and n-HApCS-7.0, and the spray-dried HAp paste and 
chitosan, used as standard samples, are shown in Figure 4.10. Spray-dried HAp-paste spectra 
presented the typical bands of phosphate group, PO4. Peaks at 1093 and 1032 cm-1 
correspond to a triply degenerated asymmetric stretching mode vibration of the P–O bond of 
the phosphate group. A non-degenerated symmetric stretching mode of the P–O bond of the 
phosphate group is observed at 962 cm-1. Peaks at 603 and 566 cm-1 correspond to a triply 
degenerated bending mode of the O–P–O bond. Peak at 632 cm-1 is assigned to the hydroxyl 
group deformation mode and it is considered to be overlapped with asymmetric P–O 
stretching vibration of PO43-. Band at 3567 cm-1 was attributed to the stretching mode of the 
hydroxyl group, OH, while bands at 3421 and 1653 cm-1 are assigned to absorbed water, 
which appeared even when precautions were taken to eliminate moisture from the samples 
before analysis. 
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Figure 4.8. High-resolution SEM images of n-HApCS-5.5 microparticles obtained with 
washed, HAp paste (i.e without KCl) at magnifications of: 
(a) 500X; (b) 10 000X; (c) 200 000X 
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Figure 4.9. High-resolution SEM images of n-HApCS-7.0 microparticles obtained with 
washed, HAp paste (i.e. without KCl) at magnifications of: 
(a) 500X; (b) 10 000X; (c) 200 000X 
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Figure 4.10. Infrared spectra of standards HAp and chitosan, n-HApCS-5.5 and n-HApCS-7.0 
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The characteristic groups of chitosan were also confirmed in the corresponding chitosan 
spectrum. The band at 3468 cm-1 was assigned to the stretching mode of the OH group, 
overlapped with the stretching mode of NH. Peaks at 1300-1450 cm-1 may correspond to a 
combination of CN-NH, CH2-OH and CH3 bands [31]. Bands at 2874 and 1424 cm-1 can be 
attributed to CH stretching and bending vibrations respectively, while peaks at 1657 and 
1076 cm-1 correspond to NH, and C–O–C groups correspondingly. 
IR spectra of both hybrid microparticles, n-HApCS-5.5 and n-HApCS-7.0, presented all 
typical bands of the characteristic groups of HAp and chitosan, proving that the HAp 
nanoparticles were successfully incorporated into the chitosan solution. For primary amines, 
the N–H bending (scissoring) vibration is observed in the region 1650-1580 cm-1 of the 
spectrum. This band of medium-strong intensity appears at slightly higher frequencies when 
the primary amine is associated with other groups. In particular, when the amine is 
protonated, the NH3+ group can form ionic bonds with opposite charged groups. In this case 
the NH3+ group of the primary amine will give rise to absorptions in the regions 1600-1575 
and 1550-1504 cm-1, close to the corresponding bands of the CH3 group [32]. 
Particularizing, n-HApCS-5.5 spectrum shows only one peak at 1585 cm-1, while n-HApCS-
7.0 spectrum shows two peaks in this region (1656 and 1571 cm-1). The peak at 1656 cm-1 can 
be attributed to the N–H of the NH2 group due to the neutralization of the amine groups 
when increasing the pH of the nanodispersions. The peaks observed near 1580 cm-1, in both 
n-HApCS-5.5 and n-HApCS-7.0, can be attributed to a possible formation of ionic bonds 
between the NH3+ groups from chitosan and the PO43- groups from hydroxyapatite. These 
differences show that the pH at which the nanodispersions were prepared affected the 
chemical interactions between HAp and chitosan, leading to final products with different 
properties. 
Results obtained from TG/DTG analysis of all the prepared samples are shown in Figure 
4.11. For comparative purposes, solutions of chitosan in acetic acid were prepared and the 
pH was adjusted above and below 6.5, labelled CS-5.5 and CS-7.0, followed by spray-drying 
to obtain microparticles of such solutions. The first mass loss is observed between 30-100ºC 
for all cases and it is attributed to water evaporation. Another peak is observed between 100 
and 170ºC in the curves of both CS-5.5 and n-HApCS-5.5, which can be related to the 
degradation of the acid used in the preparation of such samples. This peak is substantially 
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smaller in the thermograms of the samples prepared at higher pH since the acid was 
neutralized by the addition of base to increase the pH. The peak observed around 730°C in 
the n-HApCS-7.0 thermograms can be related to the degradation of the base used to increase 
the pH of this dispersion. 
Finally, a mass loss observed between 200-310°C can be attributed to the thermal 
degradation of chitosan. This degradation step appears approximately at the same 
temperature (240ºC) for all samples analyzed. Moreover, the n-HApCS-5.5 curves present 
what seems to be a retardation of the decomposition of the polymer at 400ºC. It is 
noteworthy to point out that the hybrid samples show different patterns of degradation for 
chitosan that could be associated with differences in the interactions between chitosan and 
HAp depending on the pH at which the dispersions were prepared. 
Both hybrids, n-HApCS-5.5 and n-HApCS-7.0, presented similar composition to that one of 
natural bone (see Table 4.3). Residual masses near 70% were attributed to HAp since the 
acid and base used in sample preparation were degraded below 800ºC. The residual mass 
obtained agrees with the used HAp content. 
 
Table 4.3. Comparative table of the composition of natural bone relative to the 
composition of n-HApCS-5.5 and n-HApCS-7.0 based on thermal degradation 
(TG/DTG analysis) 
Component Natural Bone HApCS-5.5 HApCS-7.0 
Inorganic 60-70% n-HAp 72% n-HAp 71.5% n-HAp 
Organic 25-30% collagen 22% chitosan 21% chitosan 
Water 5-10% 6% water and acetic acid 7.5% water and 
residual acid and base 
 
The TG-DTG plots obtained for freeze-dried samples, n-HApCS-5.5-FD and n-HApCS-7.0-
FD, are also shown in Figure 4.11. No significant differences are observed when compared to 
the thermograms of the analogous samples, the spray-dried n-HApCS-5.5 and n-HApCS-7.0 
samples respectively, which proves that the chitosan was not degraded during the spray-
drying process at the used conditions. 
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Figure 4.11. TG and DTG (dm/dt) of spray-dried n-HApCS-5.5, n-HApCS-7.0, CS-5.5, CS-
7.0 and freeze-dried samples n-HApCS-5.5-FD and n-HApCS-7.0-FD 
(From 30 to 800ºC at 10ºC/min; N2 atmosphere) 
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The DSC plots (Figure 4.12) confirm the results obtained by TG-DTG in terms of thermal 
degradation of chitosan, which has an exothermic peaks near 300ºC. For both, TG and DSC 
analysis, a good reproducibility was observed since all transitions obtained coincide between 
batches of the same type of sample, either for n-HApCS-5.5 or n-HApCS-7.0. 
 
 
Figure 4.12. DSC of n-HApCS-5.5 (continuous line) and n-HApCS-7.0 (dotted line); from 50 
to 450ºC at 10ºC/min; N2 atmosphere 
 
4.4 Conclusions 
In this study, it was observed that different types of spray-dried microparticles are produced 
depending on the pH at which the initial nanodispersions were prepared. Dispersions with 
smaller particle sizes and higher zeta potential values are produced with the n-HAp/CS 
dispersions with pH < 6.5, compared to dispersions with pH > 6.5. The presence of KCl, a 
component of the original HAp paste used, has no beneficial effect on the stability of the n-
HAp/CS dispersions, and its removal can be easily achieved by a prewashing procedure. 
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Differences on the spray-dried microparticles due to the effect of pH conditions were also 
evident from a morphological point of view. Doughnut-like n-HApCS-5.5 microparticles, with 
15.8 µm average size in volume comprising n-HAp particles homogenously distributed, are 
preferred over n-HApCS-7.0 microparticles, which require an extra step in the productive 
process and also presented a tendency to form large agglomerates. 
FTIR analysis of both n-HApCS-5.5 and n-HApCS-7.0 showed all typical bands of the 
characteristic groups of HAp and chitosan, proving that the HAp nanoparticles were 
successfully incorporated into the chitosan solution. Evidence of formation of ionic bonds of 
the primary amine groups, NH3+, was observed which is compatible with ionic bonds 
formation between NH3+ from chitosan and PO43- from hydroxyapatite. 
The spray-dried microparticles presented different thermal degradation behaviour that can be 
related with differences in HAp-CS interactions depending on the pH at which the products 
were prepared. The residual mass from TG results was near 70%, attributed to 
hydroxyapatite in accordance with the weight ratio pretended. No significant differences were 
observed between spray-dried and freeze-dried samples, which evidences that chitosan was 
not degraded during the spray-drying process at the used conditions. The reproducibility of 
the experimental procedure was checked based on 3 replicas. 
Most importantly, hybrid n-HAp/CS microparticles containing 50 nm HAp nanoparticles 
were produced successfully by spray drying; such microparticles can potentially be used for 
biomedical applications, such as bone repair and drug delivery systems. 
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5 Production of nano-hydroxyapatite/chitosan (n-
HAp/CS) hybrid scaffolds 
Since long, it has been proven that hybrid scaffolds composed of hydroxyapatite (HAp) and 
chitosan (CS) are suitable for non-load-bearing bone graft applications. However, the 
productive process of such materials still faces challenges limiting process scalability and 
their commercialization. The main constraints comprise the need of final steps for 
purification/neutralization, as well as, sterilization that may be critical in view of achieving 
adequate properties. The purification/neutralization stage, needed to eliminate the residual 
acetic acid used to solubilize the chitosan, and thus make viable cell growth, can compromise 
the scaffold structural features. On the other hand, conventional sterilization procedures, can 
cause thermal degradation of the material, affect its chemical properties, and/or leave toxic 
residues on material’s surface. 
In this context, this chapter presents a process to produce n-HAp/CS scaffolds mimicking 
bone composition and structure, where an innovative step based on supercritical CO2 
extraction, was used as both, a purification step to eliminate the residual acetic acid, and as 
a potential sterilization step for thermosensitive materials. Process parameters such as 
temperature (40 and 75 ºC) and number of extraction cycles (1 and 2) were tested. The 
pressure was kept constant at 8.0 MPa. With the best-achieved conditions (T = 75 ºC and 
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P = 8.0 MPa) it was possible to remove 80% of the residual acetic acid (i.e. of the acid 
remaining after the freeze-drying step). The produce scaffolds exhibited adequate 
interconnected porous structure with a mean pore size of (72 ± 35) µm, fast swelling, and a 
storage modulus of (20.5 ± 2.9) kPa at 1 Hz frequency. Furthermore, the obtained scaffolds 
were sterile (microbiological assay revealed no microbial growth) and showed 
cytocompatibility, osteoconductivity, allowing the adhesion of osteoblast-like cells to its 
surface. Thus, the proposed process, which comprises 3-steps (n-HAp/CS dispersion 
preparation, freeze-drying stage to fix scaffold shape and supercritical CO2 extraction to 
remove acetic acid and promote sterilization) is a simple and straightforward technique, 
allowing the successful production of n-HAp/CS scaffolds, exhibiting desirable properties for 
the treatment of small, non-load-bearing bone defects. 
5.1 Introduction 
Bone tissue engineering is an expanding research area due to its promising contributions to 
achieve materials that, in comparison with orthodox treatments, have great potential to 
improve bone regeneration, or ensure replacement when damaged, with the advantage of 
enabling customization to satisfy particular requirements [1, 2]. However, the design of bone 
grafts can be very challenging due to the specificities an ideal graft should fulfil; it must be 
biocompatible, biodegradable, exhibit appropriate mechanical properties, and present 
interconnected porous structure with adequate micro- and macro porosity, among others [1, 
3]. In addition, off-the-shelf availability of the grafts is highly desirable and, therefore, an 
easily scalable manufacturing process is a key requirement as well [3]. 
The production of bone grafts based on hydroxyapatite (Ca10(PO4)6(OH)2, HAp) and 
chitosan (CS) has been widely studied and proven to be a suitable combination for bone 
tissue engineering applications [4]. HAp by itself is highly brittle and chitosan on its own 
does not induce the deposition of bone minerals even though it does promote osteogenic cells 
attachment and proliferation. However, when combining both components, HAp provides the 
required bioactivity while chitosan adds elasticity to the final material, resulting in a great 
candidate for non-load-bearing bone graft applications [4, 5]. In this sense, the production of 
n-HAp/CS hybrid materials in the form of scaffolds is of great interest. 
5 Production of nano-hydroxyapatite/chitosan (n-HAp/CS) hybrid scaffolds 
109 
Taking advantage of the remarkable ability of bone self-regeneration, the idea behind a 
scaffold is to act as a 3D template that once implanted in the bone defect, allows cell 
migration, adhesion, proliferation and eventually, the formation of new bone tissue. To 
achieve this goal, the scaffold’s microstructure is critical; it should be highly porous with 
interconnected pores allowing cells mobility, diffusion of nutrients and vascularization. 
Besides the scaffolds architecture, the manufacturing process is another major factor to 
consider; the final product should be clinically and commercially viable, therefore, the process 
must be reproducible and scalable to industrial production. Additionally, from a clinician’s 
point of view, a bone graft should be, preferably, an off-the shelf product able to be easily 
adapted into different shapes and with few or non-extra surgical procedures prior to 
implantation [3, 6].  
In order to obtain the scaffolds, first the hydroxyapatite nanoparticles are introduced into a 
chitosan solution, resulting in an n-HAp/CS aqueous dispersion. This dispersion preparation 
is a key step that can be done in a number of ways. One of the most commonly used 
methods, because it is simple and straightforward, is the so-called simple mixing method. It 
consists in physically mixing HAp particles, micro- or nanometer sized, into a chitosan 
solution [4, 7]. Afterwards, the scaffolds are obtained, frequently by freeze-drying, a simple 
technique in which phase separation is induced by the formation of ice crystals upon freezing, 
followed their sublimation [4, 8]. Many authors working with the preparation of n-HAp/CS 
based hybrid scaffolds by freeze-drying reported the achievement of materials with desirable 
high porosity and pores interconnectivity [9-16]. 
In most cases, n-HAp/CS scaffolds prepared by freeze-drying from dispersions obtained by 
simple mixing still contain residual acetic acid remaining from the one used to solubilize 
chitosan. Therefore, a purification/neutralization step is needed since acidification of the 
medium can cause structure disruption upon contact with water or deviate culture medium 
pH from the ideal range (7.2-7.4) thus inhibiting cell growth and proliferation [8, 17]. 
Typically, purification/neutralization of the scaffold is carried out by immersion in an 
alkaline solution, washing with ultrapure water, and drying usually through another freeze-
drying step [4, 10, 12-14, 18]. This neutralization process to remove the residual acetic acid is 
time consuming and can lead to low purity materials, i.e. materials with residual salts 
remaining from the used alkaline solution, as well as with compromised structural integrity, 
e.g. the second freeze-drying step applied to the already formed scaffold can damage its 
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porous structure. In fact, it has been reported that chitosan-based scaffolds undergo 
shrinkage and distortion after neutralization with NaOH solutions [19, 20]. 
Furthermore, when designing n-HAp/CS hybrid materials, sterilization is an important 
procedure to consider. Given that chitosan is a thermo-sensitive material, common 
sterilization techniques, such as dry heat and steam, are not appropriate since they can cause 
thermal degradation of the material. Ethylene oxide and gamma irradiation, on the other 
hand, can affect its chemical properties; the use of ethylene oxide risks the deposition of toxic 
residues on the materials surfaces and high-energy gamma irradiation can cause material 
degradation as well [21]. 
In this context, the use of scCO2 as an innovative sterilization technique [21-26] has attracted 
great attention since it gathers a large amount of advantages; it is environmentally benign, 
nontoxic, non-flammable, non-corrosive, readily available, and inexpensive solvent [27, 28]. 
This supercritical fluid has been well known for its outstanding solvent capacities due to its 
high diffusivity; it has been widely used in food industry as an extraction medium, but also 
for processing pharmaceuticals due to its low critical temperature [29]. However, no reports 
were found regarding the effects of scCO2 extraction using sterilizing conditions on the 
structural, physicochemical, and mechanical properties of scaffolds for bone tissue 
engineering. 
In this work, a 3-step process to produce n-HAp/CS scaffolds mimicking bone composition 
and structure is presented, where an innovative step based on supercritical CO2 extraction, is 
introduced for the purification and potential sterilization of the scaffolds. The advantages of 
this method were studied over other currently used procedures, often based on neutralization 
steps. The obtained scaffolds were characterized in what concerns morphology, porosity and 
pore size distribution, swelling capacity, and mechanical properties. A microbiological test 
was performed in order to evaluate if the scaffolds were sterilized, and biological assays were 
also carried out in order to assess cytotoxicity of the produced scaffolds. 
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5.2 Materials and methods 
5.2.1 Materials  
Hydroxyapatite aqueous paste nanoXIM-HAp102, supplied by Fluidinova S.A., was used to 
prepare the n-HAp/CS dispersions. It is composed of 15.0 ± 1.0% wt. of HAp rod-like 
nanoparticles suspended in pure water, with particle size <50 nm. Chitosan brand 
90/200/A1, with deacetylation degree and dynamic viscosity of 91.9% and 128 mPa·s (1% at 
20ºC in 1% acetic acid solution) respectively, was purchased from Biolog-Biotechnologie 
GmbH (Germany). Solutions were prepared using glacial acetic acid and sodium acetate tri-
hydrate, both of analytical grade, 8 M sodium hydroxide solution brand Fluka, trypsin, 
EDTA, resazurin sodium salt, and PBS, all acquired from Sigma Aldrich. Brain heart 
infusion (BHI) was acquired from Liofilchem® s.r.l. Eagle, while minimum essential medium 
(MEM), alpha modification (α-MEM), fetal bovine serum, penicillin, streptomycin, and 
amphotericin B brand GibcoTM were acquired from Thermo Fisher Scientific Inc. 
5.2.2 Dispersions preparation 
Hydroxyapatite nanoparticles were incorporated in the chitosan solution by simple mixing, 
with rigorous control of the mixing and pH conditions, as described elsewhere [30]. Briefly, 
the n-HAp paste was pumped at 240 rpm (approximately 32 ml/min) and dispersed into the 
chitosan solution with a high speed dispersing and homogenizing device Miccra D-9 at its 
minimum speed rate (11 000 rpm), using a set up designed to achieve mixing times lower 
than 100 ms. The n-HAp/CS dispersions were prepared with a n-HAp concentration of 20 g/l 
and a final pH value of approximately 5.5 (room temperature). Typical bone composition, n-
HAp/CS weight ratio of 70/30, was considered for the produced dispersions. 
5.2.3 Scaffolds preparation 
A schematic representation of the process used to produce the scaffolds, from dispersion 
preparation to purification steps, is shown in Figure 5.1. The hybrid n-HAp/CS scaffolds 
were obtained by freeze-drying. Samples of 10 ml of the n-HAp/CS dispersions were firstly 
frozen in 55 mm diameter polystyrene petri dishes by storing in a freezer at -20 ºC overnight. 
Then, scaffolds were obtained by freeze-drying during 24 h using a VirTis BenchTop 6K 
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Freeze Dryer (model nº6KBTEL). The samples obtained in this step are referred as n-
HApCS-5.5-untreated. 
 
 
Figure 5.1. Schematic representation of the three studied procedures (I, II and III) for the 
production of n-HAp/CS scaffolds, that comprise the following steps: (A) Dispersion 
preparation; (B) Neutralization of acetic acid by dropwise addition of NaOH 1M; (C) Freeze 
drying; (D) Neutralization by immersion in NaOH/ethanol solution; (E) Washing with 
ultrapure water; (E) Acetic acid extraction with scCO
2
. 
 
5.2.4 Scaffolds purification 
Two different purification methodologies based on acetic acid neutralization were first 
attempted: one consisted in neutralizing the dispersion before the formation of the 3D porous 
structure by freeze-drying (Figure 5.1, 5-step procedure I); and the other one consisted in 
immersing the formed 3D structure in an alkaline solution (Figure 5.1, 5-step procedure II). 
A third and innovative approach comprising the extraction of the acetic acid through scCO2, 
was also tested (Figure 5.1, 3-step procedure III). 
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5.2.4.1 Procedure I 
Procedure I comprises sequentially the following stages: dispersion preparation, neutralization 
of acetic acid, freeze drying, washing and freeze-drying again. In the neutralizing step the n-
HApCS-5.5 dispersion, was neutralized by dropwise addition of NaOH (1 M) until a pH of 
7.0 was reached (room temperature). After freeze-drying, the scaffolds were washed thrice 
with ultrapure water and freeze-dried again. Scaffolds subjected to this neutralization 
procedure are referred to as n-HApCS-7.0. 
5.2.4.2 Procedure II 
Procedure II comprises, sequentially, the following stages: dispersion preparation, freeze-
drying, neutralization of acetic acid, washing and freeze-drying again. In this second 
approach (samples referred as n-HApCS-NaOHEtOH), neutralization was performed directly 
on the scaffolds obtained by freeze-drying, by immersion in a solution containing NaOH and 
ethanol according to the procedure described by He et al. (2011) [18]. The scaffolds were also 
washed thrice with ultrapure water and freeze-dried again. 
5.2.4.3 Procedure III 
Procedure III comprises sequentially the following stages: dispersion preparation, freeze-
drying, and supercritical CO2 extraction. The extraction of the residual acetic acid was 
carried out using a supercritical fluid extraction unit previously described by Gomes et al. 
(2007) [31]. Concisely, samples were placed equally distributed inside the 1 L extraction cell. 
Afterwards, CO2 from a standard cylinder was cooled down, pumped into the cell and 
compressed until reaching the desired pressure. Temperature was then increased to reach the 
supercritical state. Experiments were carried out in static mode for 5 samples per experiment. 
In order to find the best conditions to remove acetic acid from the produced n-HAp/CS 
scaffolds, different experimental conditions were tested, as summarized in Table 5.1. The 
objective was to guarantee that the scaffold presents viability to support cell attachment and 
proliferation. 
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Table 5.1. Experimental conditions tested for the scCO2 extraction process 
Sample 
Extraction time 
(h) 
Temperature 
(ºC) 
Cycle 1 Cycle 2 Cycle 1 Cycle 2 
(A) n-HApCS-scCO2-40 2 - 40 - 
(B) n-HApCS-scCO2-75 2 - 75 - 
(C) n-HApCS-scCO2-75/75 2 2 75 75 
 
All experiments were carried out at a pressure of 8.0 MPa and an extraction time of 2 h per 
cycle. Each experiment varied according to the number of cycles (1 and 2 cycles) and 
temperature (40 and 75ºC). For the first experiment (A), mild conditions right above the 
critical pressure and temperature were chosen (T = 40ºC, P = 8.0 MPa). For experiments B 
and C, sterilization conditions were chosen, with a temperature of 75ºC, selected based on 
Spilimbergo et al. (2003) [32] who reported total inactivation of Bacillus subtilis spores using 
scCO2 treatment at 75ºC for 2 hours. Table 5.2 shows the ratio, mass of CO2 per mass of 
scaffold, used in each experiment, estimated based on the CO2 density under the used 
conditions, the volume of the extraction cell and the mean scaffold mass (0.3105 ± 0.0011) g. 
Supercritical CO2 density data based on NIST Reference Fluid Thermodynamic and 
Transport Properties Database [33] is presented in Appendix C. 
Table 5.2. Estimated mass of CO2 per mass of scaffold for each experiment 
Sample 
Mass of CO2 / mass of scaffold 
(g/g) 
(A) n-HApCS-scCO2-40 179.0 
(B) n-HApCS-scCO2-75 107.3 
(C) n-HApCS-scCO2-75/75 214.6 (107.3+107.3) 
 
Subsequently to each cycle, a first depressurization step at 4 MPa, and a second one at 
0.2 MPa were carried out. After each experiment, samples were taken out of the extraction 
chamber under a sterile environment, and store in sterile bags until characterization. 
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5.2.5 Characterization of the dispersions 
The produced n-HAp/CS dispersions were characterized by using a Zetasizer Nano ZS from 
Malvern instruments (particle size and zeta potential). The final pH was measured using a 
microprocessor pH-mV-meter, brand pH-538 from WTW GmbH. 
5.2.6 Characterization of scaffolds 
5.2.6.1 Thermal degradation and extraction yield 
All samples were subjected to thermogravimetric analysis using a TG 209 F3 Tarsus® under 
nitrogen atmosphere, and with a temperature ramp increasing from 30 to 700 ºC at a rate of 
10ºC/min. The peak attributed to the degradation of acetic acid was analysed and the 
content of residual acetic acid (wt.%) in each sample was estimated relative to the scaffold 
weight. The extraction yield obtained for each sample was calculated relative to the content 
of acetic acid of an untreated sample, i.e. a sample not subjected to any 
purification/neutralization procedure, designated as n-HApCS-untreated. 
5.2.6.2 Morphological characterization and elemental analysis 
The produced scaffolds were analysed by scanning electron microscopy (SEM) coupled with 
Energy-dispersive X-ray spectroscopy (EDS) using a Phenom Pro microscope from Phenom 
World. Based on the acquired SEM images, mean pore size and pore size distributions were 
obtained by image analysis using the public domain software ImageJ developed by Wayne 
Rasband at the National Institute of Health (NIH). A minimum of 200 pores was analysed 
for each sample. Elemental analysis was used to inspect the Ca/P ratio, as well as the 
presence of impurities (e.g. salts derived from applied neutralization procedures). 
5.2.6.3 Swelling tests 
Samples were weighted dried (W
d
) and swollen ( Ws ) after immersion in PBS solution (pH 
7.4 at room temperature). These weights were used to calculate the swelling capacity ( Cw ) as 
a mass-swelling ratio [34, 35]: 
   (5.1) C
w
g ⋅ g −1( ) =Ws −Wd
W
d
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The samples had dimensions of 2 cm diameter and 4 mm thickness. Measurements were 
carried out at immersion times ranging from 0 to 60 min. Special care was taken to gently 
remove the excess of PBS using filter paper before measuring the weight of the swollen 
sample. Results are reported as mean ± SD based on 3 replicas. 
5.2.6.4 Porosity determination 
Total porosity, , of the n-HAp/CS scaffolds was estimated as: 
   (5.2) 
where 
 
ρ
apparent
 and  are the apparent and real densities respectively. The apparent 
density was determined experimentally for 3 specimens of each sample by measuring, in 
triplicate, their height and diameter using a vernier caliper, and their weight using an 
analytical balance. The real density was determined experimentally by carrying out 
measurements per triplicate using a gas pycnometer (in-house made equipment). 
5.2.6.5 Mechanical properties 
The mechanical behaviour of the produced scaffolds was characterized by dynamic 
mechanical analysis (DMA) in wet state under dynamic compression solicitation following the 
procedure used in the work of Rodrigues et al. (2013) [34]. The samples were cylinders with 
9 mm diameter and 4 mm thickness immersed in PBS solution (pH 7.4 at room temperature) 
for 60 minutes before measurements. Afterwards, the samples were carried out in 
compression mode following cycles of increasing frequency from 0.1 to 10 Hz. The 
measurements were carried out in triplicate at 20 ºC using a DMA 242 E Artemis, dynamic 
mechanical analyser by NETZSCH-Gerätebau GmbH. 
5.2.6.6 Microbiological assay 
A microbiological assay was carried out in order to test sterility of the n-HAp/CS-scCO2-
75/75 scaffolds after the scCO2 extraction. Samples of approximately 5x5x5 mm were cut in 
sterile conditions, avoiding cross contamination, and placed in individual sterile eppendorfs. 
Afterwards, 1 ml of brain heart infusion (BHI) broth was added to each eppendorf, which 
 φ
φ = 1 −
ρ
apparent
ρ
real
ρ
real
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was then sealed and incubated at 37 ºC. Samples from 3 different batches were tested in 
triplicate. Additionally, two extra eppendorfs were prepared in the same conditions, without 
n-HAp/CS-scCO2-75/75 samples, and used as negative controls. 
The presence or absence of turbidity was verified after 24, 48 and 120 hours of incubation. At 
the end of the 120 hours, each eppendorf was vortexed for a few seconds, and 20 µl of the 
BHI suspension, per duplicate, were plated into a non-selective trypticase soy agar (TSA) 
culture medium. Bacterial growth was assessed after 24 hours of incubation at 37 ºC, by 
colony forming units (CFU) counting in the TSA plates. 
5.2.6.7 In-vitro cell culture 
To infer the viability of the produced scaffolds for in-vitro cell culture, a preliminary test was 
preformed to check if the pH of the culture medium in contact with the scaffold suffers 
deviations from the optimal range (7.2-7.4). The test comprises the contact of the scaffold 
with culture medium. For that, samples of 5x5x5 mm (approximately  g), were 
placed in 48-well plates in sterile conditions, and 0.5 ml of culture medium were added. If pH 
changes from the optimal range, a change in colour due to the presence of phenol red will be 
noticed. In the case of acidification, a change from red colour (neutral pH) to yellow (acid 
pH) is observed; in the case of alkalinisation, a change from red to pink colour (alkaline pH) 
is observed. Only samples passing this test were subjected to the cell culture assays. 
Osteoblast-like cells (MG63 cell line, ATCC number CRL-1427™) were seeded in Eagle 
minimum essential medium (MEM), alpha modification (α-MEM) supplemented with 10% 
fetal bovine serum, 100 IU/ml penicillin, 2.5 µg/ml streptomycin, and 2.5 µg/ml 
amphotericin B, and incubated in a humidified atmosphere of 5% CO2 at 37 ºC. The culture 
medium was replaced 2 to 3 times a week. At 70 – 80% confluence, cells were removed from 
the culture plates by enzymatic digestion, using 1 ml of 0.05% trypsin in 0.25% EDTA for 10 
min in standard culture conditions, and the cell suspension was used in the experiments. The 
cell culture was sub-cultured at least for 2 passages before the experiments. 
Without subjecting samples to further traditional disinfection or sterilization methods, 
samples of approximately 5x5x5 mm were cut with a scalpel blade in sterile conditions and 
incubated 15 minutes at 37 ºC in fresh supplemented α-MEM for swelling. The wet samples 
were placed in 48-well plates and seeded with MG63 cells (1.25 x 105 cells/cm2) in standard 
5.29 × 10−3
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conditions. Seeded scaffolds were cultured for up to 21 days, and characterized for cell 
viability/proliferation by the Alamar blue assay and SEM observation. Cultures performed in 
the absence of material samples were used as control in order to assess the suitability of this 
cell culture model. In addition, a parallel experiment was run as a blank with culture medium 
alone, using the same protocol as the cell cultures. 
5.2.6.8 Alamar blue assay 
Seeded scaffolds were monitored for cell viability/proliferation at time-points 1, 3, 7, 10, 14, 
17 and 21 days by the non-toxic Alamar blue dye assay. In this assay, the redox activity by 
intracellular enzymes within the cytosol of the viable cells was assessed through the reduction 
of Alamar blue dye, also known as resazurin, into a fluorescent, red compound called 
resorufin [34]. At the first time-point, 1 day, the culture medium (supplemented α-MEM 
without resazurin) was removed from the wells, the seeded samples were transferred to a 
different well, and fresh supplemented α-MEM with 10 vol.% of resazurin solution was added. 
The seeded samples were incubated for 4 hours in standard conditions; then 100 µl of the 
medium (α-MEM with resazurin) were collected from each well, transferred to a black opaque 
96-well plate, and resorufin content was determined by measuring fluorescence intensity. The 
fluorescence was read at a 530 nm and 590 nm wavelengths, for excitation and emission 
respectively, with a microplate reader brand Synergy HT, from BioTek Instruments, 
Winoosky, VT, USA. 
The remaining medium was removed from the 48-well plates, the samples were washed with 
sterile PBS to remove any residual rezasurin and fresh supplemented α-MEM was added to 
the wells. Finally, the plates were incubated in standard conditions until the next time point. 
The assay was carried out based on 6 replicates. 
5.2.6.9 Sample preparation for SEM observation 
Samples were fixed by immersion in 1.5% glutaraldehyde in 0.14 M sodium cacodylate buffer 
for 10 minutes (pH = 7.3) and preserved in sodium cacodylate buffer at 4 ºC. Before SEM 
observation, samples were washed in deionized water for 30 minutes and dehydrated in 
graded ethanol (50, 60, 70, 80, 90, 100%) for 30 minutes in each solution. Finally, samples 
were dried using a CO2 critical point dryer, brand CPD 7501 from Polaron Range, and 
analyzed using a Phenom ProX scanning electron microscopy (SEM) from Phenom World. 
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5.3 Results and discussion 
5.3.1 Dispersions stability and macroscopic analysis of the produced scaffolds 
The produced n-HAp/CS dispersions were highly homogeneous and stable, with a number 
mean size of 230 ± 89 nm, a zeta potential > +30 mV, measured at the dispersion’s final pH 
of 5.5 at room temperature. Therefore, even when the presence of chitosan in HAp 
dispersions caused an increase in particle size by particle aggregation, it had a positive 
impact on the stability of the dispersions, which is a desirable characteristic. 
5.3.2 Thermal degradation and extraction yield 
Figure 5.2 shows the TG plots obtained for the n-HAp/CS-untreated sample, and the 
samples exposed to scCO2 extraction under the different tested conditions. Figure 5.3 
presents the TG plots obtained for the n-HAp/CS-untreated sample, and the samples 
subjected to different purification/neutralization treatments, including the one subjected to 
CO2 extraction under the best-achieved conditions (n-HApCS-scCO2-75/75). In all cases, the 
first mass loss observed between 30 ºC and 100 ºC is assigned to water evaporation. From 
100 ºC to approximately 190 ºC, a second peak is observed and attributed to the evaporation 
of acetic acid. The mass loss starting from 200 ºC corresponds to the degradation of chitosan. 
Finally, the residual mass, between 65 to 70 wt.%, is attributed to the mass of n-HAp, which 
is in accordance with bone composition [36] and used in the present work. 
By quantifying the mass loss identified as the evaporation of acetic acid, it was possible to 
calculate the extraction yield by scCO2. From the TG analysis it was determined that the n-
HApCS-untreated sample contained about 4.1% of acetic acid (designated in this work as 
residual acetic acid), which corresponds to a significant reduction; based on the acetic acid 
present in the used base dispersion a content of 11% is expected to remain in the final 
scaffold. Therefore, about 63% of the acid was eliminated during the freeze-drying step. 
After purification with scCO2 extraction at 40 ºC (n-HApCS-scCO2-40 sample), with a 
CO2/scaffold mass ratio of approximately 179.0 gCO2/gscaffold, about 44% of the residual acid 
was successfully eliminated (the acetic acid content reached 2.4%). By using a higher 
temperature of 75 ºC (n-HApCS-scCO2-75 sample), CO2/scaffold mass-ratio of 
107.3 gCO2/gscaffold, no considerable differences were observed in the obtained extraction yield 
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(46%). By carrying out two cycles, a noticeably increase in the extraction yield was obtained. 
With a total 214.6 gCO2/gscaffold ratio (107.3+107.3) almost complete elimination of residual 
acetic acid was obtained in the n-HApCS-scCO2-75/75 sample (80% in total corresponding to 
an acid content of 0.8%). 
 
 
Figure 5.2. Thermograms of: (a) n-HApCS-5.5-untreated; (b) n-HApCS-scCO2-40; (c) n-
HApCS-scCO2-75; and (d) n-HApCS-scCO2-75/75 
(From 30 to 700ºC at 10ºC/min; N2 atmosphere)  
 
Based on the preliminary test used to evaluate the viability of cell growth and proliferation, 
only this last sample did not influence the pH of the culture medium, which was maintained 
within the required range for cell growth. For all the other samples treated with scCO2, a 
change of culture medium to yellow (acidic) was observed. Therefore, these tested conditions, 
2 cycles of 2 hours each in static mode at a temperature of 75ºC and a pressure of 8.0 MPa, 
were considered suitable. Samples prepared using these conditions were further characterized 
and examined in what concerns microbial growth and cytotoxicity. 
Relative to the different purification/neutralization procedures, the yield of residual acetic 
acid extraction corresponds to 80%, 70% and 80% for n-HApCS-5.5-NaOHEtOH, n-HApCS-
7.0 and n-HApCS-scCO2-75/75 samples respectively. Based on these results the neutralization 
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with an alkaline solution, under the used conditions of sample n-HApCS-5.5-NaOHEtOH 
(conventional purification/neutralization procedures), leads to a final acetic acid content in 
the sample of 0.8%, the same level as the one achieved with sample n-HApCS-scCO2-75/75. 
Thus, using the best-achieved conditions of scCO2 extraction, it is possible to extract as 
much residual acetic acid as with the most conventional purification/neutralization 
procedures. Nevertheless, the sample n-HApCS-5.5-NaOHEtOH did not pass the preliminary 
test of viability for in-vitro cell culture, since culture medium exhibited deviations from ideal 
pH (culture medium turned pink indicating the presence of alkaline residual salts) when it 
entered in contact with the sample. 
 
 
Figure 5.3. Thermograms of: (a) n-HApCS-5.5-untreated; (b) n-HApCS-scCO2-75/75; (c) n-
HApCS-5.5-NaOHEtOH and; (d) n-HApCS-7.0 
(From 30 to 700ºC at 10ºC/min; N2 atmosphere) 
 
5.3.3 Morphological characterization and elemental analysis 
Photographs of the produced scaffolds are shown in Figure 5.4, where differences deriving 
from the purification procedure used may be already observed at a macro scale. The n-
HApCS-5.5-untreated sample (Figure 5.4a) generated homogeneous, porous and elastic 3D 
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structures, characteristics that were maintained after scCO2 extraction (n-HApCS-5.5-scCO2-
75/75 sample, Figure 5.4b). The n-HApCS-NaOHEtOH sample also showed a porous and 
elastic-like structure; nevertheless some deterioration was noticed (Figure 5.4c). Finally, the 
main difference observed at a macro-scale level was for the n-HApCS-7.0 sample (Figure 
5.4d), even though its integrity in terms of shape was preserved, the sample became highly 
brittle. 
SEM micrographs (Figure 5.5) and pore size distribution plots, deriving from image analysis 
(Figure 5.6), were obtained for the produced scaffolds samples. Microstructure is a key factor 
to be evaluated when producing scaffolds for bone regeneration. A combination of adequate 
pore sizes and interconnectivity allows the motion of cells throughout the scaffolds and the 
required nutrients and metabolites diffusion for cells survival and proliferation [3]. Several 
studies have been conducted regarding the relationship between pore size and cell activity, 
showing that pores larger than 100 µm allow angiogenesis and contribute to nutrient and 
waste transport, whereas pores smaller than 50 µm can improve osteointegration and 
generate cell anchoring sites [1, 37-41]. 
The n-HApCS-untreated sample (Figure 5.5a) exhibits the desired interconnected porous 
structure, with a mean pore size of (86 ± 40) µm (Figure 5.6a). The pore interconnectivity is 
also observed in the n-HApCS-scCO2-75/75 sample (Figure 5.5b), with (72 ± 35) µm mean 
pore size (Figure 5.6b), showing that the obtained desired morphology is not affected by the 
scCO2 extraction at the best-achieved conditions. In what concerns the HApCS-5.5-
NaOHEtOH sample, with a mean pore size (63 ± 27) µm, modifications in structure’s 
architecture were observed after the second freeze drying step, as seen in the SEM image 
(Figure 5.5c), affecting not only the morphology but also pore size distribution (Figure 5.6c). 
All these three samples, n-HApCS-untreated, n-HApCS-scCO2-75/75, and HApCS-5.5-
NaOHEtOH, present adequate pore sizes; pores sizes larger than 100 µm and smaller than 50 
µm are present, however in different proportions. The n-HApCS-NaOHEtOH sample 
presented the least amount of pores >100 µm (14%), and the n-HApCS-untreated sample the 
larger amount (42%), whereas the n-HApCS-scCO2-75/75 sample presented pores >100 µm 
and pores pores <50 µm in a similar proportion of about 30%. 
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Figure 5.4. Images of the produced scaffolds: (a) n-HApCS-5.5-untreated; 
(b) n-HApCS-5.5-scCO2; (c) n-HApCS-5.5-NaOH/EtOH; (d) n-HApCS-7.0. 
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Finally, for the n-HApCS-7.0 sample (Figure 5.5d) a brittle structure was obtained right 
after its preparation, even before the washing and second freeze-drying steps, showing that 
the pH at which the hybrid dispersion was prepared affected the structure of the final 
scaffold. Due to the evident high brittleness and structural disruption of n-HApCS-7.0 
sample, it is not further considered for analysis. The observed distortion of the samples 
neutralized with a basic solution has been attributed by other authors to base-induced 
changes in crystallinity and associated structural stresses [19, 20, 42]. 
 
 
Figure 5.5. SEM micrographs (400X) of a cross-section of: (a) n-HApCS-5.5-untreated; (b) n-
HApCS-5.5-scCO2-75/75; (c) n-HApCS-5.5-NaOHEtOH; (d) n-HApCS-7.0. 
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Figure 5.6. Particle size distributions of: (a) n-HApCS-untreated; 
(b) n-HApCS-scCO2-75/75; (c) n-HApCS-NaOHEtOH. 
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In addition to the morphological study, elemental analysis of the samples was performed. 
Results presented in Figure 5.7 show that despite the repeated washing steps, impurities were 
detected in the n-HApCS-NaOHEtOH sample. Such impurities were identified as sodium 
salts, whose origin can be the alkaline solution used during the neutralization step (Figure 
5.7c, cross symbol 1). Salt impurities were not observed in the SEM image of n-HApCS-
untreated (Figure 5.7a) and n-HApCS-scCO2-75/75 (Figure 5.7b) samples and the respective 
EDS analysis showed predominantly the presence of Ca and P from HAp. 
Elemental analysis was also used to quantify the atomic concentrations of Ca and P present 
in the produced samples (Table 5.3) in order to estimate the Ca/P ratios, reported as the 
mean values of measurements carried out in two different spots (represented as a cross 
symbol and a square in Figure 5.7) of the same sample. Ca/P ratios of 1.70 and 1.68 were 
obtained for n-HApCS-untreated and n-HApCS-scCO2-75/75 scaffolds respectively, very close 
to the Ca/P ratio of 1.67 of stoichiometric HAp. However, non-stoichiometric Ca/P ratio was 
obtained for n-HApCS-5.5-NaOHEtOH, with 2.0±0.18, showing that this neutralization 
procedure using alkaline solution can compromise the purity of the n-HAp used, due to the 
potential chemical interactions involved. 
 
Table 5.3. Atomic concentrations of Ca and P obtained by EDS 
Sample Ca (%) P (%) Ca/P atomic ratio 
Stoichiometric HAp 10 6 1.67 
(a) n-HApCS-5.5-untreated 14.4 8.45 1.70 ± 0.06 
(b) n-HApCS-5.5-scCO2-75/75 17.7 10.6 1.68 ± 0.08 
(c) n-HApCS-5.5-NaOHEtOH 10.6 5.20 2.00 ± 0.18 
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Figure 5.7. SEM micrographs and EDS analysis spectra of: 
(a) n-HApCS-untreated; (b) n-HApCS-scCO2-75/75; (c) n-HApCS-NaOHEtOH. 
The cross symbol and the square in the images represent the areas analysed by EDS. 
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5.3.4 Swelling tests 
When implanted in vivo, scaffolds are introduced in an aqueous environment, influencing 
their overall properties; therefore, it is essencial to evaluate their swelling behaviour in 
aqueous medium in order to determine their suitability for bone regeneration. Swelling 
performance of a scaffold allows the evaluation of both, its water-binding ability and its pore 
interconnectivity. First, the structural integrity of the scaffolds during swelling was assessed 
by immersing the samples in PBS during 60 min. Fast swelling was observed for all samples, 
since sample enlargement was observed right after immersion in PBS, which is typical of 
highly hydrophilic materials and/or microstructures with a large range of pore 
interconnectivity that allow a fast circulation of nutrients throughout the scaffold [34]. 
After 60-min immersion, as it may be observed in Figure 5.8, the n-HApCS-untreated sample 
exhibited the major enlargement, which can be attributed to the amount of protonated 
amino groups. According to Berger et al. (2004) [43], for chitosan-containing scaffolds 
swelling is highly influenced by ionic interactions, moreover, it is favoured by the protonation 
and repulsion of chitosan free ammonium groups. The content of residual acetic acid present 
in the n-HApCS-untreated sample induces the protonation of free amino groups favouring 
swelling; however, at the same time it promotes dissolution, causing a significant structural 
disruption as observed in Figure 5.8a. 
In the case of n-HApCS-scCO2-75/75 and n-HApCS-NaOHEtOH samples, they both 
presented similar swelling behaviour. However, while n-HApCS-scCO2-75/75 preserved its 
structural integrity (Figure 5.8b), the n-HApCS-NaOHEtOH sample suffered from a slight 
disruption after 60-min immersion (Figure 5.8c). These differences can be attributed mainly 
to structural changes produced by the purification/neutralization procedure used; the second 
freeze-drying step used to obtain n-HApCS-NaOHEtOH sample causes structural damage, 
making the scaffold easily vulnerable to disruption. For the n-HApCS-scCO2-75/75 case, it 
presented a controlled swelling (Figure 5.9), with no substantial changes observed in swelling 
capacity after 10 min immersion so that, at this time point, it is considered that swelling 
equilibrium is reached (  at 60-min immersion). Due to the 
experimental difficulties from the mass loss caused by structural disruption of samples n-
HApCS-5.5-untreated and n-HApCS-NaOHEtOH, the swelling capacity at different 
immersion times was determined only for n-HApCS-scCO2-75/75 sample. 
C
w
= 24.5 ± 2.7 g ⋅ g −1
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Based on these results, scCO2 extraction appears as a favourable process that promotes the 
extraction of the acid without interfering on the equilibrium protonated/free amino groups, 
thus promoting swelling without inducing dissolution, and without compromising its 
structural integrity. Thereby, scCO2 extraction allows the production of scaffolds with 
desirable swelling behaviour. 
 
 
Figure 5.8. Dried and swollen samples, after 60 min of immersion in PBS, of: 
(a) n-HApCS-untreated; (b) n-HApCS-scCO2-75/75; (c) n-HApCS-NaOHEtOH 
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Figure 5.9. Swelling capacity at different immersion times of sample n-HApCS-scCO2-75/75 
 
5.3.5 Porosity determination 
Structurally, natural bone is composed of a hard and very dense outer layer known as 
cortical bone, and a spongy inner layer known as cancellous bone. Depending on the surgical 
requirements, bone grafts can be either cortical, cancellous, or a combination of both, each 
one exhibiting different mechanical and structural properties [44]. Cancellous bone lacks of 
mechanical strength due to its high porosity (30-90% porosity) but it is characterized for 
inducing osteogenesis [1, 4, 8]. Thus, bone grafts mimicking cancellous bone are frequently 
used for small defects such as non-union fractures, maxillofacial and dental defects, and 
spinal fusion [44]. 
Following the implantation of a scaffold in vivo, the mechanism of bone regeneration 
comprises the attachment and penetration of cells from the surrounding hard tissue, as well 
as the process of angiogenesis; therefore, it is expected that higher porosities induce enhanced 
osteogenesis [45]. Accordingly, it has been reported that ideal overall porosity of a bone graft 
ranges from 60 to 99% [46]. All the produced scaffolds exhibit high desirable porosity, as 
shown in Table 5.4. No substantial difference is observed in the determined theoretical 
porosity between the n-HApCS-5.5-untreated and n-HApCS-scCO2-75/75 samples, showing 
that the purification with scCO2 extraction does not compromises the structural integrity of 
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the scaffold in what concerns its overall porosity. However, an increase of approximately 10% 
in porosity is obtained when the scaffold is subjected to the neutralization process by 
immersion in alkaline solution (n-HApCS-5.5-NaOHEtOH sample), probably caused by the 
microstructural changes that the scaffold undergoes mainly due to the second freeze-drying 
step. 
 
Table 5.4. Total porosity and apparent density 
obtained for the produced scaffolds 
Sample 
Total Porosity 
(%) 
Apparent density 
(g/cm3) 
n-HApCS-5.5-untreated 83% 0,0347 ± 0,0009 
n-HApCS-scCO2-75/75 81% 0,0423 ± 0,0028 
n-HApCS-5.5-NaOHEtOH 93% 0,0720 ± 0,0010 
 
5.3.6 Mechanical properties 
In order to mimic in vivo conditions, the mechanical performance of the produced scaffolds 
was evaluated by DMA in wet state and within the physiological frequency range in load-
bearing applications, ranging from 1 to 10 Hz [47, 48]. The variation of storage modulus (E’) 
and the loss factor (tan δ) as a function of frequency are shown in Figure 5.10. The storage 
modulus represents the stiffness of a material and is proportional to the energy stored during 
a loading cycle [34, 49]. The loss factor, also known as specific loss or specific damping 
capacity, is a measure of the energy lost, expressed in terms of the recoverable energy and 
represents mechanical damping or internal friction in a system. The loss factor is expressed 
as a dimensionless number (tan δ = E’’/E’, where E’’ is the loss modulus, a measurement 
proportional to the energy dissipated during one cycle) [49, 50]. 
The obtained values for the storage component at a reference frequency of 1 Hz, reported as 
(mean±SD), were (6.75±0.72) kPa, (13.3±1.5) kPa, and (20.5±2.9) kPa, for n-HApCS-
untreated, n-HApCS-NaOHEtOH, and n-HApCS-scCO2-75/75 samples respectively. A 
previous study of n-HAp/CS materials by Thein-Han and Misra (2009) [10] reported values 
in the same order of magnitude, ranging from 4 to 10 kPa, for chitosan and n-HAp/CS 
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scaffolds with 0.5-2.0 wt.% of n-HAp. Considering that the compression modulus of natural 
cancellous bone ranges from 50 to 500 MPa, scaffolds exhibiting compression modulus below 
25 MPa are only suitable for non-load-bearing applications. The low compression modulus 
values are attributed to the high porosity of the scaffolds, generally >80%, which is essential 
for bone ingrowth as previously discussed [46]. 
 
 
Figure 5.10. Storage modulus (a) and loss factor, tan delta, (b) under dynamic compression 
solicitation as a function of frequency, increasing from 0.1 to 10 Hz 
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Figure 5.10a shows data obtained for storage modulus, representative of measurements 
carried out in triplicate with less than 20% deviation. A tendency of storage modulus to 
increase with frequency was observed for all samples. The n-HApCS-untreated sample 
exhibits the lowest storage modulus values, which can be attributed to the disruption of this 
scaffold in aqueous medium, as observed during the swelling test, due to the presence of 
residual acetic acid. After subjecting the scaffolds to the tested purification/neutralization 
procedures, the scaffolds display an increase in storage modulus relative to the untreated 
scaffold, but with differences depending on the used procedure. 
The n-HApCS-scCO2-75/75 sample exhibits considerably higher compression strength than 
the n-HApCS-NaOHEtOH, dissimilarity that can also be attributed to the microstructural 
changes due to the purification/neutralization procedure. As previously discussed, the n-
HApCS-NaOHEtOH sample suffers microstructural changes, increasing its overall porosity in 
about 10%, and consequently affecting its mechanical properties. It has been reported that, 
with a 10 to 20% increase in total porous volume, mechanical strength decreases up to a 
factor four [45]. On the other hand, when using scCO2 extraction to purify the scaffolds, 
microstructural properties of the n-HApCS-scCO2-75/75 sample are preserved, and the 
scaffold does not undergo disruption induced by dissolution, thus its mechanical properties 
are improved. These results are in accordance with the observations from the swelling tests. 
Relative to the loss factor, presented in Figure 5.10b, an increase of tan δ with increasing 
frequency is observed for all cases, indicating that the samples tend to lose elasticity while 
their viscous properties become more relevant. The loss of elasticity is more evident for the 
n-HApCS-5.5-untreated scaffold, evidencing that the scaffold solubilizes due to the presence 
of residual acetic acid, and thus becomes more viscous. No substantial difference is observed 
in the loss factor values obtained for n-HApCS-NaOHEtOH and n-HApCS-scCO2-75/75 
samples, showing that the purification process does not affect the viscoelastic properties of 
the scaffolds. Moreover, the viscous contribution exhibited by the scaffolds depicts the 
damping properties of the specimens, which is pertinent for biomedical applications because 
it allows the scaffolds to partially dissipate inputted mechanical energy without suffering 
disruption [50]. 
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5.3.7 In-vitro biological studies 
After 24, 48 and 120 hours of incubation of the material samples in BHI suspension, the 
culture medium was clean and comparable to the negative controls. Furthermore, no UFCs 
were counted after culturing the medium in TSA medium, evidencing that the n-HApCS-
scCO2-75/75 scaffolds were sterile. Therefore, the cell viability test was carried out with the 
n-HApCS-scCO2-75/75 scaffolds without any further disinfection or sterilization treatment 
after scCO2 extraction. The sterility of the n-HApCS-scCO2-75/75 samples was also verified 
through the observation of the attachment and proliferation of cells to the scaffolds. 
When cells enter in contact with the surface of a biomaterial, they start a process of 
attachment, growth and proliferation that can be assessed by the morphological changes that 
cells experience throughout such process. The main stages that cells undergo after 
attachment are radial growing of filopodia, cytoplasmatic networking, and a sequential 
flattening of the cell mass [51, 52]. Figure 5.11 shows the SEM micrographs of osteoblast-like 
MG63 cells cultured on n-HApCS-scCO2-75/75 samples after 1, 7, 14 and 21 days. It can be 
observed how the cells changed from a roundish morphology from day 1 to a spindle-like 
shape on day 7. At day 14, flattening of the cells is evident. Moreover, it is observed how the 
cells presented good adherence to the scaffold, as well as filopodial-like growth along the 21 
days. At day 7 the cells already started forming continuous cell layers, and by days 14 and 
21 the scaffold was almost completely covered by cell layers, spreading in its surface and 
inside the pores. 
Cell viability and proliferation results evaluated by resazurin assay are shown in Figure 5.12, 
given in terms of fluorescence intensity, which is proportional to resorufin content. Despite a 
slight drop registered at the third day, which can be considered a normal phenomenon, cells 
exhibited good viability and proliferation, with a gradual increase in fluorescence intensity. 
Moreover, a 5-fold increase in the cell proliferation was registered from day 3 to day 21, 
which is a promising outcome. Thus, the n-HApCS-scCO2-75/75 scaffolds appear to be 
cytocompatible, osteoconductive and allow the adhesion of osteoblast-like cells to its surface. 
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Figure 5.11. SEM micrographs of osteoblast-like MG63 cells cultured on 
n-HApCS-scCO2-75/75 samples after 1 day (a, e); 7 days (b, f); 14 days (c, g); 21 days (d, h). 
Magnification: 410X (a, b, c and d); 1000X (e, f, g and h) 
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Figure 5.12. Fluorescence intensity obtained through rezasurin assay indicating cell 
proliferation of osteoblast-like MG63 cells in control and n-HApCS-scCO2-75/75 culture for 
time-points ranging from 1 to 21 days 
 
Similar results were published recently by Qasim et al. (2015) [53], who seeded MG63 
osteoblasts on a CS/HAp (50:50) porous membrane and evaluated cellular viability by 
Alamar blue assay, showing a significant increase from 1 to 7 days culture. Lai et al. (2015) 
[54] also reported a gradual enhancement on the number of viable cells of human bone 
marrow-derived mesenchymal stem cells (hMSCs) seeded on CS/silk fibroin/n-HAp 
nanofibrous membranes (10 or 30 wt.% n-HAp). In the reports described the proportion of n-
HAp in the biomaterial composition is lower than the n-HAp/CS ratio (70/30) of the present 
study; however, they evidence that materials combining n-HAp and chitosan are 
cytocompatible, osteoconductive and allow the adhesion of osteoblast-like cells to the 
biomaterial surface. Furthermore, it is worth noting that in both reports samples were 
disinfected by immersion in ethanol solution prior the cytotoxicity test, whereas in the 
present study, the rezasurin assay was carried out with the n-HApCS-scCO2-75/75 sample 
without any disinfection or sterilization treatment, confirming its sterility. 
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5.4 Conclusions 
In this work, a simple 3-step process to produce HAp/CS hybrid scaffolds was developed. 
Sterilization conditions were considered for the optimization of the process; thus, with an 
extraction yield of 80%, it was determined that the optimal scCO2 extraction conditions are 
two 2-hour cycles in static mode at temperature 75 ºC and pressure 8.0 MPa. The produced 
scaffolds presented a storage modulus of (20.5 ± 2.9) kPa at 1 Hz frequency and elastic 
properties. Moreover, the scaffolds contained highly pure nanocrystalline HAp, and mimic the 
structure and composition of bone extracellular matrix, exhibited adequate micro- and 
macroporosity, interconnected structure, and fast swelling, which are highly desirable features 
for bone regeneration. 
Based on the results obtained from this study it was shown that, opposed to the other 
purification procedures used, it was possible to preserve the structure fixed by the first 
freeze-drying step, and the salt impurities derived from the neutralization procedures with 
NaOH were avoided using the scCO2 extraction. Also, the final freeze-drying step required 
with the alternative neutralization procedures was, in this case, eliminated. To reinforce the 
potential of the developed process, it must be highlighted that the use of scCO2 as an 
innovative sterilization technique has been recently studied and proven viable [21-26]. 
Even though additional studies are necessary to validate the used scCO2 extraction 
conditions for the sterilization of the scaffolds, preliminary results presented in this work are 
promising. Results from the microbiological assay showed no microbial growth, evidencing 
that the produced n-HApCS-scCO2-75/75 scaffolds were sterile, enabling the adhesion and 
proliferation of osteoblastic cells. The biomaterial allowed cellular proliferation, which 
increased gradually along the experimental period. Moreover, cells with normal morphology, 
a tendency for pores colonization and the existence of organized cell groups, increasing in 
extension along the culture period, were observed. 
Therefore, sterile n-HAp/CS scaffolds, with desirable properties for the treatment of small, 
non-load-bearing bone defects, were successfully produced by a simple 3-step process, 
consisting of: (1) preparation of homogeneous and stable n-HAp/CS dispersion by fast 
stirring; (2) freeze-drying for the elimination of the solvent and fixation of the 
microstructure; and (3) purification, with potential sterilization capacity, of the scaffolds 
using supercritical CO2 (scCO2) extraction. 
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6 Final remarks 
In this work, hybrid materials based on highly pure nano-hydroxyapatite were successfully 
produced. For that, HAp nanoparticles were embedded in an organic component, chitosan, in 
order to generate materials mimicking bone composition and with suitable properties. Due to 
the similarity with the mineral phase of the bone, together with the exceptional 
biocompatibility and bioactivity with respect to bone cells and surrounded tissues, 
hydroxyapatite has been studied, since long, for bone tissue engineering applications. Its 
combination with chitosan presents several advantages imparted by this polymer’s particular 
features, which add value to the resulting hybrid materials. Among the most outstanding 
properties of chitosan, its hydrophilic character can promote osteoblast adhesion and 
proliferation leading to better material-cell interactions. In addition, chitosan exhibits bio-
adhesiveness (of special interest for drug delivery systems), antimicrobial capacity, can be 
processed under mild conditions, generates non-toxic biodegradation products, and is 
available in large quantities and adequate commercial grades. 
Three forms of n-HAp/CS hybrid materials, having in view different potential applications, 
were produced: dispersions, powders (microparticles), and scaffolds. In order to obtain such 
products, the following main processing stages were considered: (1) dispersion preparation in 
which n-HAp is incorporated into the chitosan solution; (2) phase separation/solvent 
elimination in which the fixation of structural forms as microparticles and scaffolds takes 
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place; and (3) purification and potential sterilization procedures. Different compositions, 
parameters and processing conditions were evaluated in order to achieve adequate properties 
of the final products. 
The dispersion preparation was carried out by physically mixing the HAp nanoparticles with 
the chitosan solution. Even though this is a simple and straightforward approach, the 
incorporation of HAp nanoparticles into an acidic environment (chitosan solution) can 
influence HAp solubility, phase stability and surface chemistry. Therefore, in a first study, 
dispersions of HAp nanoparticles were prepared by ultrasonication, alone or in the presence 
of chitosan, aiming to study the effect of different parameters (pH, chitosan content, presence 
of KCl and storage time) on the resulting dispersion’s particle size and electrostatic stability 
(zeta potential). 
One of the most important parameters, affecting particle size and zeta potential, is the pH. It 
was determined that in an alkaline environment (pH 9-10), dispersions of n-HAp alone 
exhibited good zeta potential values (+29 mV), but decreasing as the pH decreases. This 
behavior was mainly attributed to changes on surface charge by differential ion dissolution 
mechanism induced by pH variations. In the presence of chitosan, the opposite behavior was 
observed. In this case, the observed tendency was attributed to both, the changes on HAp 
surface charge by differential ion dissolution mechanism and the adsorption of positively 
charged chitosan molecules onto HAp nanoparticles surface. Therefore, in slightly acidic 
environment (pH 5.5) the electrostatic stability of n-HAp particles dispersed in water was 
poor (zeta potential +10 mV), but improving with the incorporation of chitosan (zeta 
potential >+30 mV). 
Additionally, results indicated that n-HAp dispersions in the presence of chitosan (pH 5.5) 
result in, comparatively with their aqueous counterparts, larger particle sizes, and that 
particle size increases with chitosan content. However, zeta potential also increases with 
chitosan content showing that, even when its presence promotes particle agglomeration, 
chitosan acts as a good stabilizer of HAp nanoparticles in slightly acidic environment (pH 
5.5). Such good stability was proven to be consistent along time, since zeta potential 
remained nearly constant along 30 days of storage time. Relative to KCl, while no significant 
influence on particle size was observed, an improvement on zeta potential due to its presence 
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was observed in the n-HAp aqueous dispersions. Nevertheless, the stabilizing effect of 
chitosan appeared to be better without the interference of salts. 
Taken into consideration these results, a method for the preparation of n-HAp/CS 
dispersions by fast stirring (ultraturrax) was developed. With mixing times <100 ms, the 
used fast stirring set up is energetically more efficient than ultrasonication, allowing the 
production of n-HAp/CS dispersions (pH 5.5) with smaller particle sizes, and similar zeta 
potential values (>+30 mV). The produced dispersions were highly homogeneous and stable 
and, the ones using HAp/CS weight ratio of 70/30 and n-HAp concentration of 20 g/l, were 
found suitable materials for the production of n-HAp/CS hybrids in different forms, the topic 
of this work. Additionally, they have potential to be used in other applications such as 
coating of implants by electrophoretic deposition, for example. The developed method and 
formulation can be adapted to further produce the n-HAp/CS dispersions in continuous mode 
using technologies such as the NETmix reactor. This is an interesting perspective having in 
view a future industrialization of the process. 
The production of n-HAp/CS microparticles was carried out by spray drying. This technique 
is advantageous due to its easy industrialization, cost-effectiveness and continuous 
production; however, it was found to be underexploited in what respects the production of n-
HAp/CS microparticles. The effect of pH of the n-HAp/CS dispersion (5.5 and 7.0), as well 
as the presence of KCl, on the final n-HAp/CS microparticle’s properties were studied. SEM 
images showed that KCl appeared as a contaminant on the formed microparticles, exhibiting 
different morphology depending on the pH of the n-HAp/CS dispersion, microcrystals in 
sample n-HApCS-5.5 and spikes in sample n-HApCS-7.0. In addition, it was confirmed that 
KCl has no beneficial effect on the stability of the n-HAp/CS dispersions; even risks creating 
a hypertonic environment able to cause an inhibitory effect on cells metabolism. Thus, 
removal of KCl was achieved by a simple washing procedure of the n-HAp original paste, 
before preparing the n-HAp/CS dispersions. 
The generated microparticles presented differences depending on the pH at which the n-
HAp/CS dispersion was prepared. Doughnut-like n-HApCS-5.5 microparticles, with 15.8 µm 
average size in volume incorporating n-HAp particles homogenously distributed, were found 
preferred over n-HApCS-7.0 microparticles; the late ones require one step more in the 
productive process and presented a tendency to form large agglomerates. Finally, 
6 Final remarks 
146 
thermogravimetric analysis evidenced that chitosan was not degraded during the spray-
drying process at the used conditions; therefore, hybrid n-HAp/CS microparticles containing 
50-nm HAp nanoparticles were produced successfully by spray drying. The produced 
microparticles are advantageous, as they allow HAp's superior properties at the nanoscale to 
be preserved in the form of microparticles that are easier to handle thanks to their reduced 
size. In addition, they can be suitable materials to develop injectable systems or be shaped 
into solid substrates with increased surface area that will promote chemical and biological 
activity. Furthermore, the produced n-HAp/CS hybrid microparticles present potential as 
drug delivery systems; they can be further loaded with active pharmaceutical ingredients 
(API), such as anti-cancer or anti-inflammatory drugs, or with bone growth factors, such as 
BMP-2. The resulting loaded n-HAp/CS microparticles can be used to produce embedded 
scaffolds with dual function, 3D structural support for cell invasion and angiogenesis, and for 
controlled drug delivery. 
The n-HAp/CS dispersions were also used in this work to produce n-HAp/CS hybrid 
scaffolds. For that, a simple 3-step production process was developed and proven to be 
advantageous over other existing methods. The process consists in: (1) n-HAp/CS dispersion 
preparation; (2) freeze-drying stage to fix scaffold shape; and (3) supercritical CO2 (scCO2) 
extraction to remove acetic acid and promote sterilization. From the different scCO2 
extraction conditions tested, the best-achieved ones were two 2-hour cycles at T = 75 ºC and 
P = 8.0 MPa. Using such conditions, 80% of residual acetic acid was successfully removed, 
proving that scCO2 extraction is a suitable purification procedure, with the advantage of not 
compromising the microarchitecture achieved by freeze-drying unlike other tested methods 
based on neutralization with alkaline solutions. 
In addition, the developed process requires fewer steps than other conventional processes, 
with the benefit of being able to purify and potentially sterilize the scaffolds, all in one step 
(using scCO2 extraction). The produced n-HAp/CS scaffolds mimic bone composition, are 
composed of highly pure HAp nanoparticles, and displayed desirable features for bone 
regeneration; namely, adequate interconnected porous structure with both micro- (<50 µm) 
and macroporosity (>100 µm), a mean pore size of (72 ± 35) µm, and fast swelling. In 
addition, the scaffolds exhibited elastic properties and can be cut and shaped into different 
geometries. With a storage modulus of (20.5 ± 2.9) kPa at 1 Hz, the scaffolds find 
application as cancellous bone graft, being suitable for non-load bearing applications, e.g. 
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treatment of small defects such as non-union fractures, maxillofacial and dental defects, and 
spinal fusion. The improvement of mechanical properties can be attempted by using n-
HAp/CS dispersions with higher solid content (more concentrated dispersions) to produce the 
scaffolds, and/or use different HAp/CS weight ratios. 
The microbiological test carried out revealed no microbial growth, showing that the scaffolds 
were sterile; and the resazurin assay showed that the produced scaffolds were cytocompatible 
and osteoconductive, allowing the adhesion and proliferation of osteoblast-like cells to its 
surface and within the pores. Based on the obtained results, the developed 3-step process has 
great potential to produce ready-to-use n-HAp/CS scaffolds mimicking bone composition and 
structure. 
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A Nano-hydroxyapatite based aqueous dispersions: 
Solutions preparation, mean free path and energy 
balance 
A.1 Solutions preparation 
A chitosan solution 3% (w/v) in acetic acid 1% (v/v) was prepared and diluted if needed 
using an acetate buffer 0.05 mol/l (CH3COOH/CH3COONa). The buffer was prepared by 
mixing adequate quantities of CH3COOH (1 mol/l) and NaOH (1 mol/l) for the desired pH, 
which were calculated based on Henderson-Hasselbach equation (A.1) and the chemical 
reaction: 
  
   (A.1) 
Thus, the quantities used to prepare 1000 ml of acetate buffer 0.05 mol/l 
(CH3COOH/CH3COONa) with different pH values are shown in Table A.1. 
 CH3COOH + NaOH→ CH3COONa + H2O
 
pH = pKa + log
CH
3
COO−
CH
3
COOH
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
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Table A.1. Calculated volume of reagents needed 
to prepare 1000 ml of acetate buffer 0.05 mol/l 
Desired 
pH 
Volume of 
CH3COOH 5M 
(ml) 
Volume of 
NaOH 4M 
(ml) 
5.0 10.0 7.90 
5.5 10.0 10.6 
6.0 10.0 11.8 
 
Furthermore, aqueous nanodispersions of hydroxyapatite (HAp), alone or in the presence of 
chitosan (CS), were prepared at different concentrations as shown in Table A.2 and Table 
A.3 for the corresponding free mean path  calculated based on Fonte (2013) [1]. 
 
Table A.2. Volume of solutions added to prepare 
50 ml of aqueous nanodispersion of HAp alone 
Mean free path 
 
(adim) 
Concentration of HAp 
(g/l) 
Volume to add 
(ml) 
HAp paste 15% 
Acetate buffer 
(pH~5.5) 
3.0 1.6 0.50 49.9 
1.5 6.4 2.1 47.5 
0.70 20 7.0 43 
 
Table A.3. Volume of solutions added to prepare 50 ml of aqueous 
nanodispersion of HAp in the presence of chitosan 
Mean free 
path 
 
(adim) 
Concentration of 
HAp 
(g/l) 
Volume to add 
(ml) 
HAp paste 
15% 
Chitosan solution 
3%* 
Acetate buffer 
(pH~5.5) 
3.0 1.6 0.50 1.1 48 
1.5 6.4 2.1 4.5 43 
0.70 20 7.0 14 29 
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A.2 Mean free path 
Rod-like HAp nanoparticles were approximated to a cylindrical shape, as shown in Figure 
A.1. 
 
Figure A.1. Geometrical approximation considered for HAp nanoparticles 
(Reproduced from Fonte (2013) [1]) 
 
For a HAp nanoparticle with diameter 
 
D
part
 and length 
 
L
part
, its volume is calculated as: 
 
 
V
part
= π
4
D
part
2 L
part
  (A.2) 
By dividing the total volume of HAp nanoparticles by the volume of a single particle, the 
total number of particles (
 
N
part
) in dispersion can be estimated: 
 
 
N
part
=
m
HAp
ρ
HAp
4(L
part
D
part
)2
πL
part
3
  (A.3) 
Where the total volume of HAp nanoparticles is obtained by dividing the total mass of HAp 
in dispersion (
 
m
HAp
) by the density of HAp (
 
ρ
HAp
). 
Considering the volume of the dispersion ( Vdis ) the same as the volume of a cube in which 
the total number of particles is evenly distributed, then, the distribution of the particles in 
an edge of such cube is described as: 
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N
part( )1 3 Lpart + Npart( )1 3 Δxpart = Vdis( )1 3   (A.4) 
Thus, the distance between particles, 
 
Δx
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, can be deduced as: 
 
Δx
part
L
part
= π
4
⎛
⎝⎜
⎞
⎠⎟
1 3 V
dis
ρ
HAp
m
HAp
⎛
⎝
⎜
⎞
⎠
⎟
1 3
D
part
L
part
⎛
⎝
⎜
⎞
⎠
⎟
2 3
− 1
Δx
part
L
part
= π
4
⎛
⎝⎜
⎞
⎠⎟
1 3 ρ
HAp
C
HAp
⋅M
HAp
⎛
⎝
⎜
⎞
⎠
⎟
1 3
D
part
L
part
⎛
⎝
⎜
⎞
⎠
⎟
2 3
− 1
  (A.5) 
Where C
HAp
 and 
 
M
HAp
 are the concentration of HAp in the dispersion and its molar mass 
respectively. 
 
A.3 Energy balance 
The energy absorbed by the samples as heat was estimated using equation (A.6): 
  Eabs = mdis ⋅CP ⋅ ΔT   (A.6) 
Where  is the mass of the sample; 
 
the heat capacity of the sample, calculated using 
equation (A.7) in which  is the molar fraction of the different species present in the 
dispersion, and  is the temperature increased estimated from the data obtained from the 
temperature measurements before and after ultrasonication was applied. 
 
 
C
P
= x
i
⋅C
Pi( )∑   (A.7) 
The mass ( mdis ) of the sample was calculated as: 
  mdis = ρdis ⋅Vdis   (A.8) 
Where  ρdis  and  Vdis  are the density and volume of the n-HAp/CS hybrid dispersion 
respectively. The density was estimated according to the next equation: 
 m  CP
 xi
 ΔT
Appendices 
 
153 
 
 
ρ
dis
=
m
i∑
m
i
ρ
i
⎛
⎝⎜
⎞
⎠⎟
∑
  (A.9) 
Where the symbols  mi and ρi  correspond to the mass and density of the different species 
present in the dispersion, i.e. HAp, chitosan and buffer respectively. In the case of the buffer, 
data for water was consider. 
The energy input ( Ein ), given by the energy delivered to the sample through the 
ultrasonication probe, was used to calculate the energy loss ( Eloss ) by doing an energy 
balance. The energy loss was calculated per mass of sample ( mdis ) in J/g: 
 
 
E
loss
=
E
in
− E
abs
m
dis
  (A.10) 
 
A.4 References 
[1] Pereira da Fonte, C.M., The NETmix Reactor: Application to High Added-Value 
Products, in Chemical and Biological Engineering. 2013, University of Porto: FEUP: Porto, 
Portugal. 
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B Dispersions preparation by fast stirring: 
Mixing time and energy input 
B.1 Pump calibration 
The pump used in the preparation of n-HAp/CS dispersions by fast stirring was calibrated 
by measuring per triplicate the volume and time at different flow rates. The calibration curve 
is shown in Figure B.1 and data obtained is presented in Table B.1. 
 
Figure B.1. Calibration curve obtained for the pump used 
in the preparation of n-HAp/CS dispersions by fast stirring 
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Table B.1. Calibration data 
Speed (rpm) Q (ml/min) 
20 3.0 ± 0.3 
40 5.4 ± 0.9 
80 11 ± 0.8 
120 16 ± 0.9 
160 21 ± 0.0 
200 27 ± 0.9 
240 32 ± 0.0 
  
B.2 Determination of mixing time 
The mixing system was designed such that the HAp paste was injected into the solution 
inside the vessel as shown in Figure B.2. 
 
 
Figure B.2 Mixing scheme 
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A video using the same system was taken in order to estimate the mixing time. The number 
of frames in which one droplet comes out of the inlet tube, enters the mixing device and is 
dispersed (Figure B.3) was determined and related to the velocity of the movie (29,97 
frames/second). Then, for a pumping rate of 120 rpm (~16 ml/min), one droplet is dispersed 
in the time the video runs 3 frames, which is 100 ms. 
 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Figure B.3 Estimation of mixing time: One droplet (a) right before coming out of the inlet 
tube; (b) coming out of the inlet tube; (c) entering the mixing device and; 
(d) being dispersed 
 
Now, since the actual pump rate used to prepare the nanodispersions of this study was of 240 
rpm (~32 ml/min), it is valid to affirm that the mixing time of the system used was less than 
100 ms. The estimation of the mixing time using a pump rate of 240 rpm could not be 
carried out because it was not possible to observe clearly the dynamics of the drops on the 
video. 
 
B.3 Energy input 
The energy input, , is the energy delivered to the sample through the fast stirring device 
used, Miccra D-9, in the preparation of the n-HAp/CS dispersions. It was calculated based on 
the power output of the device, according to the technical specifications given by the 
manufacturer (see Figure B.4). The time t
reaction
 necessary to pump a volume of HAp paste, 
V
HAp
, at a pump speed rate, , into the reaction vessel containing the chitosan solution 
is: 
   (B.1) 
 Ein
!V
pump
t
reaction
=
V
HAp
!V
pump
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Figure B.4 Technical specifications of the fast stirring device used, ultraturrax, 
given by the manufacturer 
(Reproduced from ART Prozess & Labortechnik GmbH & Co [1]) 
 
 
With the speed rate of the pump, , in given in volume per time units. Thus, the energy 
input, calculated per mass of sample ( mdis ) in J/g, is: 
 E
in
=
t
reaction
⋅P
output
V
dis
⋅ ρ
dis
  (A.2) 
Where P
output
 is the power output of the device, V
dis
 and ρ
dis
 are the volume and density of 
the n-HAp/CS dispersion. The volume of HAp paste 15 wt.%, V
HAp
, is determined following 
the calculations described in Appendix A, for C
HAp
= 20 g/l  and a HAp/CS mass ratio of 
!V
pump
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70/30. The density, ρ
dis
, for a dispersion with the same characteristics is (993.7 ± 7.7) 
kg/m3, expressed as (mean ± SD); it was determined experimentally per triplicate using a 
picnometer. Therefore, for 
 
P
output
= 495 J/s , the energy input is Ein =  2.1 J/g  of sample. 
Considering that the power output, 
 
P
output
= 495 J/s , given by the manufacturer refers to the 
highest speed capacity of the device (39 000 rpm), and that the speed rate used 
experimentally was the lowest capacity (11 000 rpm), then the actual energy input is less 
than 2.1 J/g for the conditions used in this thesis. 
 
B.4 References 
[1] High-Speed Dispersion and Homogenizing Devices: Operating Manual, in MICCRA 
D-9, MICCRA D-15, MICCRA D-3/PA. 2010, ART Prozess & Labortechnik GmbH & Co. 
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C Determination of CO2 mass 
C.1 Density and mass of CO2 
Supercritical CO2 density data was taken from NIST Reference Fluid Thermodynamic and 
Transport Properties Database [1]. Table C.1 shows density data for the used temperature 
and pressure. 
 
Table C.1 Supercritical CO2 density data 
Temperature 
(ºC) 
Pressure 
(MPa) 
Density 
(g/l) 
40 8.0 277.90 
75 8.0 166.54 
 
Determination of mass of CO2 ( 
m
CO2
) was estimated by multiplying its density (
 
ρ
CO2
) times 
the volume (
 
V
CO2
): 
 m
CO2
= ρ
CO2
⋅V
CO2
  (C.1) 
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C.2 NIST Database 
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C.3 References 
[1] NIST Reference Fluid Thermodynamic and Transport Properties Database. 
REFPROP version 7. 2016, U.S. Secretary of Commerce on behalf of the United States of 
America. 
 
 
